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Operative vaginal birth (OVB) remains, in skilled hands, the most efficient way of expediting 
birth in the second stage of labour and is associated with fewer poor maternal and neonatal 
outcomes. However, multiple factors including training requirements, patient perception 
and medico-legal pressures have resulted in a steady reduction in the proportion of births 
being expedited with OVB. The BD Odon Device is a new device for OVB which is envisaged 
to mitigate these pressures and reduce the number of Caesarean sections performed in the 
second stage of labour. 
Before introduction into clinical practice, any new device must be thoroughly and 
systematically evaluated to determine how likely it is to be used effectively, repeatably and 
safely. In this thesis I present an approach to this problem specific to new devices for 
operative vaginal births. 
Simulated operative vaginal births using the BD Odon Device demonstrated that the device 
sits on the fetal head in a repeatable, predictable and potentially safe way. The device 
generates more perineal distention than commonly used ventouse devices, and generates 
more pressure on the fetal head than ventouse, but less than forceps. It can be used 
intuitively by the majority of accoucheurs following brief structured training. This 
combination of features suggests that, with appropriate training, it may be used in a variety 
of healthcare settings (including areas where OVB is infrequently used) and generate 
beneficial outcomes for women and babies.   
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Chapter 1 General Introduction 
 
1.1 Definition of operative vaginal birth 
Operative vaginal birth (OVB) is a procedure performed in the final part of the second stage 
of labour in which the operator uses either forceps or a vacuum device to promote the 
extraction of the fetus from the birth canal. The goal of operative vaginal birth is to facilitate 
vaginal birth, hence expediting the birth whilst minimising maternal or neonatal 
morbidity (1). 
 
1.2 Managing the risk of birth 
Birth is a predictably risky moment for both a woman and her baby. Prior to the advent of 
modern medical practices, death in childbirth was common – in 1700 approximately 100 in 
100,000 births in the UK resulted in a maternal death (2). Maternal mortality has fallen 
precipitously since then, and currently stands at 3.9 per 100,000 births worldwide (3) – 
while this is a welcome improvement, death in pregnancy, childbirth and the puerperium 
remains the second most common cause of death in women worldwide (4). 
Within this, complications of the second stage of labour (fetal compromise, obstructed 
labour, maternal exhaustion or maternal medical conditions exacerbated by the act of 
pushing) remain a major cause of maternal and neonatal mortality and morbidity across the 
world. Such complications are responsible for 4 to 13% of maternal deaths in Africa, Asia, 
Latin America and the Caribbean (5), and in 2013 obstructed labour alone accounted for 0.4 
deaths per 100,000 women worldwide (3). 
These complications can be mitigated either by (i) delivering the fetus to change its 
mechanism of respiration to direct absorption of oxygen through it’s lungs and thereby 
treating the hypoxia or (ii) relieving the pressure generated on maternal and neonatal 
tissues by a fetus that remains within the birth canal in the setting of an obstructed labour 
or an exhausted mother. This can be achieved by the accoucheur performing either an 
operative vaginal birth or a Caesarean section - when performed in an appropriate setting 
by skilled accoucheurs, operative vaginal birth can reduce adverse outcomes for women and 
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their babies relative to Caesarean section (6). While recent improvements have been made 
in maternal outcomes following Caesarean section, for example through the use of new 
generations of uterotonics (7), OVB remains a useful and viable strategy for the 
management of complications in the second stage of labour (8).  
Historically accoucheurs have used either obstetric forceps or ventouse to expedite birth. 
The first reported use of obstetric forceps was in the 16th Century (9), and ventouse entered 
widespread practice in the 1950s as an alternative (10).  Both obstetric forceps and 
ventouse are independently associated with increased maternal and neonatal morbidity, 
including; maternal perineal trauma, neonatal facial injury (forceps), cephalohaematoma, 
subgaelal haemorrhage, and retinal detachment (ventouse) (11).  However, despite this and 
in an era with rising Caesarean birth rates, there have been few innovations to assist vaginal 
birth. New developments are needed to arrest the decline in OVB rates, and increase the 
use of appropriate OVB, in order to promote better maternal and neonatal outcomes. 
Therefore it is reasonable to develop new instruments for OVB, in addition to increased 
promotion of existing ones (8,12). This logic has laid behind the project of this doctoral 
thesis – to develop a simulation-based methodology for evaluating new devices for OVB 
prior to clinical use. This general introduction will review the current options for managing 
complications in the second stage of labour, worldwide trends in OVB, factors that may play 
a role in the clinical outcomes of OVB and how positive outcomes from OVB could be 
promoted. It will also describe how a new device for OVB may, through its mechanism of 
action and design, mitigate the downward pressure on OVB and enable better maternal and 
neonatal outcomes following OVB. 
 
1.3 Current instruments for OVB 
Non-rotational forceps (Simpson’s, Rhode’s/Neville-Barne’s and Wrigley’s), solid mushroom 
cup ventouse (Malström, Bird’s and Kiwi), bell cup ventouse (silastic) and rotational forceps 
(Kiellands) are the most common obstetric instruments currently in use. The devices are 
associated with different adverse outcome profiles and relative benefits for different clinical 
presentations (i.e. non-rotational vs rotational births), as well as specific differences 
between devices. All of these have an impact on the utilisation rates of not only the 
individual instruments, but also on OVB as a whole relative to Caesarean section. 
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1.3.1 Non-rotational births  
A non-rotational birth is an OVB where the fetal head is not rotated (either actively 
(rotational forceps/manual rotation) or passively (rotational ventouse)) by the accoucheur 
as part of the OVB. Non-rotational births can be performed using non-rotational forceps, 
solid mushroom cup or bell ventouse – of these, forceps tend to be more successful and 
associated with less harm to the baby, but more to the mother. This was demonstrated in 
the most recent Cochrane review of 10 randomised trials involving 2923 women. This found 
that the use of forceps was associated with a lower risk of failure with the primary 
instrument (RR 0.65) compared to ventouse (11). While this is an important finding given 
the known significantly higher rates of maternal and neonatal adverse outcomes associated 
with the use of sequential instruments, other significant differences remain. Relative to 
forceps, ventouse is: 
* more likely to be associated with cephalhaematoma (OR 2.4; 95% CI 1.7 to 3.4)   
* more likely to be associated with retinal haemorrhage (OR 2.0; 95% CI 1.3 to 3.0) 
* more likely to be associated with maternal worries about baby (OR 2.2; 95% CI 1.2 to 
3.9)   
* less likely to be associated with significant maternal perineal and vaginal trauma (OR 
0.4; 95% CI 0.3 to 0.5)   
* no more likely to be associated with delivery by caesarean section (OR 0.6; 95% CI 
0.3 to 1.0)   
* no more likely to be associated with low 5-minute Apgar scores (OR 1.7; 95% CI 1.0 
to 2.8)   
* no more likely to be associated with the need for phototherapy (OR 1.1; 95% CI 0.7 
to 1.8). (12) 
and possibly less likely to be associated with higher long-term morbidity as a result of 
pelvic organ prolapse (13), although this association has not been shown in recent 
population-level studies (14,15). 
 
Despite the apparent superiority in most maternal and neonatal outcomes for forceps in 
non-rotational births, the use of forceps is generally lower worldwide than ventouse (16). 
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1.3.2 Rotational births 
A rotational birth is an OVB where the fetal head is rotated (either actively (rotational 
forceps/manual rotation) or passively (rotational ventouse)) by the accoucheur as part of 
the OVB. Rotational births can be performed using mushroom cup ventouse (Bird’s or Kiwi 
cup), manual rotation followed by direct forceps birth, or rotational forceps.  
Rotational births have long been perceived by accoucheurs as being proportionally more 
risky than non-rotational OVBs (17) – reflecting this, the most recent RCOG guideline 
specifies that they should be conducted in theatre in the presence of an experienced 
operator (12). Although some small studies in previous decades have shown poorer 
neonatal outcomes following attempted rotational forceps births relative to Caesarean 
section (18), larger, more recent studies have shown that attempted rotational birth (using 
any of the three approaches) is not inherently more risky than the alternative (Caesarean 
section) (20-22), and generates comparable outcomes to non-rotational OVB (23,24). This 
has generated a renewed interest in the technique for the management of malposition of 
the fetal head at full cervical dilatation, as a viable alternative to Caesarean section (25-27). 
Despite this renewed interest, debate remains about the most effective instrument for 
rotation and delivery of the fetal head -  while the relative efficacy of all three of these 
approaches has only been compared in one retrospective cohort study (Bahl et al., 2013) 
(19), other studies have examined outcomes of various combinations of the two of the 
three approaches.   
 
1.3.2.1 Rotational forceps versus rotational ventouse 
Rotational forceps appear to be superior to rotational ventouse. The only meta-analysis of 
available studies, conducted in 2015 and analysing 8 studies (7 retrospective cohort studies 
and one prospective cohort study, total 2399 patients) reported a statistically significant 
reduced risk of failure to deliver with the intended instrument using rotational forceps over 
rotational ventouse (RR 0.32 (95% CI 0.14 to 0.76; p = 0.009), with no significant differences 
found in any adverse maternal or neonatal outcomes (20) 
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1.3.2.2 Rotational forceps versus manual rotation followed by direct forceps 
Two UK-based retrospective cohort studies have directly compared rotational forceps and 
manual rotation followed by direct forceps, and these have found varying levels of 
differences in outcomes; Bahl et al. found no differences in any maternal or neonatal 
outcomes (19), while a study published by O’Brien et al. found a significantly higher chance 
of vaginal birth using  rotational forceps than with manual rotation followed by direct 
forceps (RR 1.17, 95 % CIs 1.04 to 1.31, p = 0.017). Additionally, births by rotational forceps 
were associated with a significantly higher rate of shoulder dystocia (RR 2.35, 95% CIs 1.23 
to 4.47, p = 0.012), but not of any other maternal or neonatal injuries (21). Both of these 
studies are however limited by their design (retrospective cohort studies) and setting – both 
studies were restricted to one unit only, in the same city (Bristol, UK). Moreover, the actual 
number of accoucheurs performing the rotational forceps births reported in each study was 
low (three accoucheurs in O’Brien et al.). This raises the possibility of the specific 
practitioners being more than usually experienced and may limit the applicability of the 
study’s findings. 
 
1.3.2.3 Manual rotation followed by direct forceps versus rotational ventouse  
Success rates of manual rotation followed by direct forceps versus rotational ventouse were 
examined by Bahl et al. in their 2013 retrospective cohort study of 236 women. They found 
no significant differences in any outcomes between the two approaches (19). 
Despite renewed interest, the performance of rotational OVB remains relatively specialised 
and comparatively rare – in the USA in 1996 a majority of obstetricians had abandoned 
rotational OVB in favour of Caesarean section (22). 
 
1.4 Trends in OVB 
1.4.1 Current state of OVB 
OVB is currently performed frequently (10 to 15% of births) in the UK, Ireland, France, Spain, 
Portugal, Canada and Australia, infrequently in Algeria, Sweden and Cambodia (5 to 10% of 
births), and rarely (less than 5% of births) in the United States of America and most low and 
middle-income countries (LMICs). Rates of OVB in selected countries are shown in Figure 
1-1 (23-25) (26). 
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Figure 1-1. Percentage of births as OVBs in selected countries, 2008 to 2015 
 
* Data adapted from (23–25) (26) 
In addition to widespread low levels of utilisation, earlier surveys found significant areas 
where OVB was not used at all – in 2006 this was the case in 17 of 23 Latin American & 
Caribbean countries, as well as 30% of countries in sub-Saharan Africa and 40% of countries 
in Asia (27). This confirms that there is a wide disparity in the utilisation of OVB between 
high-income countries (HICs) and low and middle-income countries (LMICs). 
 
1.4.1.1 OVB within high-income countries 
Rates of OVB appear to have remained broadly stable within most high-income countries 
(HICs), although the utilisation of forceps versus ventouse has changed over time, with 
forceps declining and the rate of ventouse increasing. For example, in the UK in 1980, the 
overall OVB rate was 12%, with 11.3% of all births being performed with forceps versus 
0.7% performed by ventouse (28). By 2017 the overall rate of OVB was 12.8%, with 7.2% of 
all births performed by forceps and 5.6% performed by ventouse (29) – this trend is shown 
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Figure 1-2. Percentage of births performed with forceps and ventouse in the UK, 1980 to 2016 
 
* Data adapted from NHS Maternity Statistics, annually from 1980 to 2016 
There has been a similar shift in Australia, where from 1991 to 2013 the overall OVB rate 
increased, from 12.5% to 18%, with forceps deliveries reducing from 10% of births to 7% 
while ventouse increased from 2.5% to 11% (30) (31). The exception to this pattern of 
broadly stable, relatively high OVB rates in HICs is the USA. In the USA rates of OVB (both 
forceps and ventouse) have consistently declined in the past 30 years, from a level broadly 
comparable with European countries (9% of all births in 1990) to a current low of 3.12% in 
2015, of which forceps were 0.56% (32) – this trend is shown in Figure 1-3. 
Figure 1-3. Percentage of births performed with forceps and ventouse in the USA, 1990 to 2015 
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1.4.1.2 Drivers of low OVB rates in some HICs 
Recent declines in the utilisation rate of both forceps and ventouse have been observed in 
the USA, and until recently, lower rates of forceps births were observed in the UK (see 
Figure 1-2). Multiple factors have been proposed as contributing to these declines – these 
include the ability of junior obstetricians to learn these complex procedures (33), the 
regulatory environment (34), and patient perception of these interventions (35). 
 
1.4.1.2.1 Development of skills in junior obstetricians 
OVB is an complex skill that requires an understanding of the anatomy, constant re-
evaluation of the situation, fine motor skills that respond to haptic feedback, and 
continuous simultaneous communication with both professional colleagues and the patient 
(36). Experienced accoucheurs can find it difficult to clearly identify, describe and transfer 
the skills required to perform an OVB, as much of the process has been internalised by the 
time they become an identified ‘expert’ (41,42). Despite recent attempts to clearly define 
the thinking process, decision points and manual skills required to perform OVB (41,42), the 
majority of useful learning by junior accoucheurs is conducted via ‘learning-on-the-job’, 
performing either parts or whole OVBs under direct, often hands-on supervision from a 
senior accoucheur (37) – this is necessarily dependent on exposure to suitable clinical 
situations on a Labour Ward.  
The working hours of junior doctors within the UK have dramatically reduced compared to a 
generation ago – in 1990, over 70% of first-year graduates in hospitals were contracted to 
work more than 70 hours a week, and 30% were contracted to work more than 100 hours a 
week (38). This has reduced to an average of 48 hours per week as of 2014 (39). This 
reduction in junior doctor presence has been mirrored by an increase in senior presence on 
Labour Wards – since 2013, the RCOG  has recommended that large units (>4500 births per 
year) work toward achieving 24-hour consultant presence on Labour Ward (40). While there 
is good evidence that this shift in workload patterns away from junior medical staff does not 
affect end clinical outcomes for patients (41), the relative reduction in clinical exposure may 
explain the lack of confidence among obstetrics and gynaecology (O&G) trainees in 
undertaking more complex OVBs. This was highlighted in the 2013 annual General Medical 
Council survey of trainees regarding the management of malposition of the fetal head at full 
cervical dilatation (33). This is further evidenced by the shift in later acquisition of complex 
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OVB skills – while in 1979 relatively junior obstetricians routinely performed rotational 
forceps deliveries (18), the vast majority of these OVBs are now undertaken by trainees with 
at least 6 years of experience (20,24). This effect can still be seen in the levels of familiarity 
and use of rotational forceps among obstetricians of different generations, demonstrated in 
a survey of all practising and retired obstetricians in Northern Ireland in 2009. In this survey, 
82% of retired consultants felt comfortable with the use of rotational forceps, while only 
22% of current consultants did so. Moreover, while 54% of current trainees had performed 
at least one rotational forceps birth, none had done so independently (42). 
 
Obstetricians in training in the USA have been shown to need to perform at least 12 
independent, unsupervised forceps births prior to the end of their training in order to be 
likely to use forceps themselves in later, independent practice (43). With the shifting of the 
acquisition of some complex OVB skills toward the end of the training program, the time 
available for the embedding of these newly acquired skills reduces. This may therefore help 
to explain the reduction in the number of fully qualified obstetricians who, in the USA, 
perform rotational operative birth at all (22), or in the UK, use rotational forceps (42). 
It may therefore be reasonable to assume that while this shift away from obstetricians being 
both present and learning relatively complex skills early in their career may reduce the risks 
exposed to women and their babies during the training itself but may come at the expense 
of the acquisition of skills at a stage of training which will allow them to become solidified 
and utilised in later practice.  
 
1.4.1.2.2 Public perception 
OVB in general, and forceps in particular, do not possess a positive public image. While no 
studies have directly evaluated women’s perceptions of OVB, a negative media environment 
surrounding OVB, particularly forceps, does exist (16). This is reflected in coverage such as 
negative newspaper headlines following adverse outcomes after the use of OVB (35), recent 
political campaigns to ban the use of forceps within individual jurisdictions in the USA (16) 
and the positive media response to these campaigns (44). While it is difficult to quantify the 
effect of these drivers on actual rates of OVB, it would be reasonable to assume that this 
negative perception would result in some women expressing a preference for a Caesarean 
section over an indicated OVB. 
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1.4.1.2.3 Concerns over long-term maternal outcomes 
In recent decades, evidence has begun to emerge regarding long-term urogynaecological 
outcomes and mode of birth. Any form of vaginal birth is associated with an increased risk 
of reporting symptoms of pelvic organ prolapse (POP) - large-scale epidemiological studies 
have found this to be between 2 to 5 times that following Caesarean birth alone (45,46). 
Within this increased risk, multiple retrospective cohort studies have found increased risks 
of symptoms in those women who underwent OVB, with the increase in risk varying 
between 1 to 2 times that following normal birth (14,15,47,48). 
Furthermore, some studies have found increases in symptoms among women who have had 
forceps births relative to those who have had ventouse births (13,15)  – however, this 
finding has not been replicated in all studies (14). While there is no direct evidence that 
these emerging concerns directly affect individual clinical decisions, they are likely to be 
borne in mind by practising obstetricians and will contribute to a reasonable perception that 
OVB is not without long-term maternal risks which should be communicated to the woman 
at the time. 
 
1.4.1.2.4 Concerns over neonatal outcomes 
In 1999 the Food and Drug Agency (FDA) in the USA issued a Public Health Notification, 
recommending caution when using a ventouse device for OVB (34), following 11 neonatal 
deaths and nine serious injuries arising from cerebral bleeds secondary to the use of 
ventouse devices in 1995 to 1998. This notice contained specific instructions on the training 
required to use such devices, the importance of communicating the use of the device to the 
receiving paediatric team, and the importance of monitoring babies delivered using such a 
device. Again, while there is no direct evidence that this advisory notice has affected the 
decision-making of individual obstetricians, it is likely to contribute to an atmosphere where 
the use of such a device is carefully considered prior to use. 
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1.4.1.3 OVB in LMICs 
While OVB is underutilised in LMICs relative to HICs (36), it cannot be assumed that demand 
for OVB is the same in LMICs as in HICs. Several factors are present to a greater degree in 
LMICs which may reduce the rate of OVB. These include the greater mean parity of women 
in LMICs, as well as the frequent absence of electronic fetal monitoring (EFM), which 
removes or makes it more challenging for the healthcare provider to establish a diagnosis of 
presumed fetal compromise (49). Furthermore, in Latin America the relatively lower 
percentage of women who reach the second stage of labour (due to high Caesarean section 
rates) will reduce the proportion of women in whom an OVB might ever be indicated. 
However, despite these factors, given the relatively much higher rates of severe maternal 
and neonatal morbidity and mortality reported as a result of complications in the second 
stage of labour in LMICs relative to HICs (four to 13% of maternal deaths in Africa, Asia, 
Latin America and the Caribbean (5)), it seems reasonable to assume that there remains 
significant unmet demand for OVB in LMICs. Despite this likely increased demand, rates of 
OVB within LMICs are broadly lower than those in HICs (26). 
 
In addition to the generally low absolute rates of OVB in Asian, African and Latin American 
countries reported by the WHO in 2010 (Africa 3%, Asia 3.2%, Americas 1.6%) (26), access to 
OVB is fragmented and reflects the varying levels of care available to women based on 
geographical relationship to care centres, with larger hospitals more likely to be able to 
perform OVB, and smaller clinics less likely. A majority of women in Sub-Saharan Africa may 
not have access to OVB at all when required – this was shown by a secondary analysis of 
unit-level survey data covering selected countries in Asia, Africa and Latin America from 
2005 to 2015 by Bailey et al. This found that in sub-Saharan Africa OVB was recently 
performed in only 6% of non-hospital settings and 53% of hospitals. Although the absolute 
rates of availability were better in some other countries, the disparity in performance of 
OVB between hospitals and non-hospitals remained in almost all countries (i.e. Haiti 24% vs 
3%, Bangladesh 52% vs 12%, Nepal 31% vs 5%) (50). 
 
1.4.1.4 Drivers of low OVB rates in LMICs  
Multiple factors have been postulated in the low rates of OVB in LMICs; lack of appropriate 
training in OVB techniques, lack of awareness of OVB as a suitable option for management 
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of complications in the second stage of labour, and the utility of instruments used to 
perform OVB. 
 
1.4.1.4.1 Lack of training 
Skilled birth attendants (SBAs) should have the knowledge and skills required to perform 
straightforward OVBs (low and non-rotational) (51). However, it is well established that 
there are significant shortfalls in the availability of SBAs, and therefore the availability to 
provide effective emergency obstetric care, including OVB, worldwide (52). On this 
background of non-universal access to SBAs, Bailey et al. reported a lack of trained staff able 
to perform an OVB as the main reason for the inability of non-hospitals (and some hospitals) 
to perform OVB in seven countries out of 40 surveyed (notably this was the case in 72% of 
units in Cote d’Ivoire) (50). Furthermore, despite the WHO clearly stating that SBAs should 
be able to perform OVB, this is often not the case – multiple studies report lack of ability of 
SBAs (including non-certified attendants, midwives and doctors) to perform OVB as the 
main reason behind an inability to perform OVB in Latin American (57,58), sub-Saharan 
Africa (53,54) and Papua New Guinea (36).  
 
1.4.1.4.2 Lack of awareness of indications for OVB 
Given the low rates of utilisation of OVB within LMICs, it is unsurprising that some 
accoucheurs are unaware of the potential benefit. It is logical that such accoucheurs will not 
develop awareness of OVB themselves if they are trained in a setting where there are 
relatively few, if any experts who practice OVB. This is reflected in the literature - Bailey et 
al. found that six countries reported that the most common reason that a plurality of their 
health centres did not perform OVB was due to having no women in whom it was indicated 
(Laos, Cambodia, Bangladesh, Zambia, Benin & Haiti) (50).  
Earlier surveys of practitioners in LMICs has demonstrated rates of non-awareness of 
ventouse delivery as high as 15% (27). 
While this lack of awareness may be related to a lack of training in the utility of OVB, it may 
also reflect an informed reluctance to undertake a procedure which associated with 
substantially greater risk in LMICs than in HICs. For example, the relative risk of maternal 
death following OVB in all LMICs analysed as part of the WHO Global Survey on Maternal 
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and Perinatal Heath (2004 to 2008) was 2.9 (95% CI 1.84 to 4.56), significantly higher than 
intrapartum Caesarean section performed with indications (RR 1.7, 95% CI 1.24 to 2.33) 
(26). Although this latter pool will include some women in the first stage of labour, 
generating results which are not directly comparable, the difference between the two may 
still be considered a useful marker for the significant morbidity and mortality associated 
with OVB in LMICs. This possible increase in risk of OVB in LMICs may be caused by multiple 
factors unrelated to the training level of the SBAs, such as poorer condition of women and 
babies at the time of presentation, poorer quality of available instruments and lack of 
appropriate aftercare. 
 
1.4.1.4.3 Utility of instruments in LMICs 
Instruments are required to perform OVB, and these require procurement, maintenance, 
sterilisation and training for practitioners to be able to use them effectively. At present, 
there is no device which has achieved a recognised superiority in any of these factors.  
Reusable ventouse devices, such as Malström cups and silastic ventouse, are prone to 
failure of the component parts, particularly leaking tubes or broken vacuum bottles, and 
require electricity to create a vacuum which can limit utility in LMICs (27). Forceps, while 
easy to maintain and effective in trained hands, are associated with higher rates of maternal 
trauma (11) and are regarded (perhaps erroneously) as requiring higher levels of training 
and expertise for use (49). The disposable single-use Kiwi ventouse (Clinical Innovations, Salt 
Lake City, Utah, USA) theoretically overcomes these challenges by not requiring the use of 
an electric pump, tubes or other vacuum equipment, not being associated with the higher 
rates of maternal trauma found with forceps. Moreover it is perceived as not requiring the 
levels of experience and training required in the use of forceps. However, despite these 
advantages, the provision of Kiwi ventouse alone has not been sufficient to increase OVB in 
LMICs to a level commensurate with likely demand.  
 
The varying levels of utilisation of OVB between national settings suggests that, regardless 
of the material and personal issues which may restrict use, different maternal populations 
present with different clinical characteristics in labour, and this may partially explain some 
(but not all) of the variation in OVB rates. The clinical factors that may impact on the success 
or failure of OVB also need to be considered. 




1.5 Characteristics of beneficial or harmful OVB 
Relative to Caesarean section, operative vaginal birth can be beneficial or harmful to the 
woman and her baby depending on the clinical presentation, the setting, the skill of the 
operator, and the number of instruments used. More complex procedures, performed by 
less experienced members of staff and using a second instrument are in general more likely 
to be associated with poorer maternal and neonatal outcomes.  
 
1.5.1 UK specific performance of OVB versus Caesarean section 
In UK settings, OVB is likely to be beneficial compared to Caesarean section – Murphy et al. 
in 2001 found that in two UK units which modelled best practice at the time, and with 
skilled accoucheurs, immediate recourse to Caesarean section and the use of either forceps 
or ventouse dependent on operator choice, following Caesarean section women were more 
likely to have a major haemorrhage (>IL, RR 2.8) and extended hospital stay (>6 days, RR 
3.5) and babies were more likely to be admitted to Neonatal Intensive Care (NICU) (RR 2.6) 
but less likely to sustain trauma (RR 0.4). 
However, the characteristics of the settings of these studies are not universal and will have 
a real impact on maternal and neonatal outcomes following OVB. 
 
1.5.2 Clinical factors 
1.5.2.1 Position of the fetal head 
Malposition of the fetal head in the second stage of labour was demonstrated by Senecal et 
al. to be associated with an increased risk of multiple adverse maternal and neonatal 
outcomes, including higher risks of postpartum haemorrhage (PPH), severe perineal tearing, 
need for oxytocin augmentation of labour, longer second stage of labour and Caesarean 
section, as well specifically higher rates of OVB (36.5% OVB rate for OA, 50.8% of OP) (55).  
In addition Palatnik et al., in a retrospective cohort study of all attempted OVBs in one unit 
in the USA over 9 years (n = 4423), found that persistent malposition of the fetal head (any 
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position other than direct OA, left occipito-anterior (LOA) or right occipito-anterior (ROA) is 
more likely to be associated with a failed OVB (RR 3.73) (56). 
 
1.5.2.2 Progress of labour 
OVB performed in a clinical setting with features of obstructed labour appears to be more 
likely to be associated with poorer maternal and neonatal outcomes than either OVB 
performed without these features present or Caesarean section. In a retrospective cohort 
study of all attempted mid-pelvic OVBs in British Columbia between 2004 to 2014 (n = 
10901), OVBs births performed for a diagnosis of ‘dystocia’ were significantly more likely to 
be associated with severe maternal and neonatal morbidity compared to Caesarean section 
(severe maternal morbidity: CS RR 1.0, forceps RR 1.57, ventouse RR 2.29, severe neonatal 
morbidity: CS RR 1.0, forceps RR 2.11, ventouse RR 2.17). By comparison, rates of adverse 
maternal and neonatal outcomes were greater following attempted OVB when a diagnosis 
of dystocia was not present relative to CS, but these differences were either smaller or in 
favour of OVB (severe maternal morbidity: CS RR 1.0, forceps RR 2.34, ventouse RR 0.79, 
severe neonatal morbidity: CS RR 1.0, forceps 1.15, ventouse RR 1.28) (57).  
Conversely, Ducarme et al., in a prospective study of 2138 women who underwent OVB, did 
not find any differences in outcomes for women or babies when stratified by station of the 
fetus in the pelvis (58). This would suggest that the negative predictive effect of obstruction 
cannot be determined solely through vertical progress through the pelvis, but rather is 
related to other factors which reflect the prospect of successful vaginal birth, such as 
oedema, haematuria, caput or moulding. 
 
1.5.3 Accoucheur-dependent characteristics and associated outcomes 
In addition to the clinical prognostic markers such as malposition and progress of labour, 
there are several operator-dependent factors that may influence the maternal and neonatal 
outcomes following an attempted OVB. These factors have the potential to be modified and 
therefore are of significance when considering strategies to improve outcomes following 
OVB. 
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1.5.3.1 Experience of the accoucheur 
While several commentaries have suggested that better trained and more experienced 
accoucheurs are more likely to generate better maternal and neonatal outcomes following 
OVB (17,26), this has not been conclusively demonstrated in the literature. Recent reviews 
have examined the role of senior presence on labour ward on outcomes of all women (not 
specific to OVB). A recent systematic review of by Henderson et al. found that OVB was 
undertaken more frequently when consultants were present (RR 1.14), but was unable to 
comment on the maternal and neonatal outcomes of these births due to lack of consistent 
data (59). Furthermore, a separate systematic review and meta-analysis by Reid et al. of 
outcomes did not find any such difference, nor did it demonstrate any difference in clinical 
outcomes (although it examined outcomes of all women who passed through the units, not 
solely outcomes following OVB) (60). Therefore, although potentially desirable for other 
reasons, it has been recognised that senior presence alone does not necessarily improve 
outcomes for women and babies within the wider context of all maternity care. Although 
not examined in detail, this seems likely to be the same within OVB. Despite some small 
studies demonstrating differences in indirect markers of patient outcomes (superior rates of 
diagnosis of fetal position among more experienced accoucheurs (61), increased risk of 
junior accoucheurs attempting more than three pulls and use of multiple instruments (62), 
or better placement of forceps blades in simulated OVBs (63)) larger studies specifically 
looking at the effects of presence vs non-presence of senior clinicians at OVB have not 
shown a difference in maternal or neonatal outcomes (71,72). Moreover, other studies 
looking at the effect on outcomes of different techniques for OVB (not explicitly looking for 
the effect of senior presence) have found no difference in outcomes when outcomes are 
not adjusted for the presence of a senior clinician (21,64). 
However, in most settings, junior accoucheurs are directly supervised during all attempted 
deliveries for at least the first two years of practice, as well as during more complicated 
procedures thereafter – this may (rightly) limit the exposure of true novices to situations 
where a lack of skill could result in a failed procedure, and thus be detected in any study. 
Moreover, experienced maternity practitioners (senior midwives) acknowledge that 
significant differences in skill between senior accoucheurs exist, and that some accoucheurs 
are more skilled at OVB than others, although the differences are hard to specify in a 
detailed manner (65,66). Therefore, it seems likely that there are differences in outcomes 
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following OVB between skilled and non-skilled accoucheurs, but these have not yet been 
detected as no studies have stratified participants in this manner. 
 
1.5.3.2 Number of instruments used 
The use of more than one instrument in an attempt to perform OVB is associated with 
poorer maternal and neonatal outcomes. In a retrospective cohort study of 1360 OVBs 
performed in two hospitals in the UK in 2005 and 2006, Murphy et al. demonstrated that 
sequential use of instruments was associated with greater maternal and neonatal morbidity 
when compared to use of a single instrument (anal sphincter tear OR 2.1 (95% CI 1.2 to 3.3); 
umbilical artery pH <7.10 OR 3.3 (95% CI 1.7 to 6.2)). Furthermore, sequential instrument 
use had greater morbidity than use of forceps alone (anal sphincter tear OR 1.8 (95% CI 1.1 
to 2.9); umbilical artery pH <7.10 OR 3.0 (95% CI 1.7 to 5.5)) (67). This finding has been 
replicated in studies examining different clinical presentations. A retrospective cohort study 
of all attempted mid-pelvic OVBs in British Columbia between 2004 to 2014 (n = 10901) 
found that rates of severe neonatal morbidity were higher following an attempted OVB 
using sequential instruments in a setting of dystocia than those following either Caesarean 
birth, forceps or ventouse alone (CS RR = 1, forceps RR = 2.11, ventouse RR = 2.17, 
sequential RR = 4.68) (57). 
 
1.5.3.3 Placement of instruments 
Instruments are designed to exert traction over a specific area of the fetal head to facilitate 
delivery (over the zygomatic arches in the case of forceps, and over the flexion point in the 
case of ventouse). Exertion of force over areas other than those intended is more likely to 
lead to fetal injury and/or failure to deliver. This is demonstrated in the only study 
examining maternal and neonatal outcomes relative to placement of instruments. In a 
prospective sample of 478 sequential attempted OVBs (both forceps and ventouse) in two 
units in Ireland, stratified into optimal and suboptimal placement, Ramphul et al. found that 
suboptimal placement was associated with prolonged hospital stay (OR 2.28, 95% CI 1.30 to 
4.02), greater neonatal trauma (OR 4.25, 95% CI 1.85 to 9.72), a greater use of sequential 
instruments (OR 3.99, 95% CI 1.94 to 8.23) and caesarean section for failed instrumental 
delivery (OR 3.81, 95% CI 1.10 to 13.16) (64). While this supports the general notion that 
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misplacement is associated with poorer outcomes, each instrument has specific adverse 
outcomes which may be more common following misplacement. 
 
1.5.3.3.1 Misplacement of forceps 
Obstetric forceps are capable of exerting a great deal of pressure directly onto the fetal skull 
(up to 309 Newtons (N)), dependent on the strength and size of the operator (68). 
Misplacement of forceps blades has been postulated as contributing to the significantly 
higher rates of depressed skull fracture found in a cohort of 68 French babies with 
depressed skull fractures delivered with forceps versus spontaneous births (69).  
Furthermore, placement of forceps blades over specific sensitive fetal structures can cause 
significant injury – placement over the eyes may lead to long-term corneal scarring (70). 
 
1.5.3.3.2 Misplacement of ventouse 
When correctly placed over the flexion point and traction is applied, the ventouse works by 
generating flexion of the fetal head. This causes the narrowest possible diameter of the fetal 
head (the suboccipito-bregmatic diameter) to present to the pelvic canal, facilitating an 
easier birth (36). Therefore, misplacement of a ventouse is more likely to be associated with 
a failed attempted OVB, as well as potentially requiring greater traction force to be applied. 
This was demonstrated in a sub-analysis of a small observational cohort study of outcomes 
associated with the use of the Kiwi ventouse in 119 sequential attempted OVBs in two units 
in Brisbane between 2001 and 2002. The most severe neonatal outcome observed was a 
subgaleal haemorrhage, and was sustained by a baby in which cup placement was both 
deflexing and paramedial, requiring a relatively high level of traction force to be applied 
over a longer than usual period of time (130 N over 17 minutes) (71). 
 
1.5.3.4 Traction force applied with instruments 
It is axiomatic that less traction force exerted upon a fetus will result in less potential 
trauma as a result of this force. Both forceps and ventouse demonstrate this relationship. 
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1.5.3.4.1 Traction force exerted with forceps 
Forceps are capable of transmitting a great deal of traction. The transmission of a lower 
total force (by either the exertion of less traction or exerting traction over a shorter period 
of time) is likely to reduce the level of adverse maternal and neonatal outcomes generated. 
This is demonstrated in several studies which have examined the number of pulls used to 
deliver the baby. Although these have not measured the force applied, it is reasonable to 
assume that if the baby descends significantly with the first pull, the operator is likely to 
exert less force on subsequent pulls. Whereas if the baby advances slowly, the operator is 
likely to use equivalent or greater force on subsequent pulls, creating a situation in which as 
an operator uses an increasing number of pulls they also apply an increasing amount of 
force. 
Murphy et al. demonstrated, in a retrospective cohort study of 390 women undergoing 
attempted OVB in theatre in two UK units between 1999 and 2000, that more than three 
pulls at attempted OVB was associated with increased neonatal trauma for both completed 
(OR 4.2, 95% CI 1.6 to 9.5) and failed deliveries (OR 7.2, 95% CI 2.1 to 24) (62). Similarly, in a 
small retrospective cohort study of 87 women who underwent sequential attempted OVB 
with forceps in one unit in Japan between 2012 and 2014, Matsumoto et al. demonstrated a 
statistically significant increased risk of neonatal facial injury after three pulls relative to one 
pull (OR 16, 95% CI 2.1 to 123.3, p < 0.01). There was no difference between one and two 
pulls (72). 
 
1.5.3.4.2 Traction force exerted with ventouse 
A similarly proportional relationship as that observed with forceps may exist with ventouse. 
This has been examined in two small, limited studies studying the correlation between the 
amount of traction force exerted with ventouse and subsequent maternal and neonatal 
outcomes. Vacca et al., in their cohort study of 119 sequential attempted OVBs using the 
Kiwi ventouse, found that deliveries completed with a traction force that never exceeded 
115 N tended to be less likely to be associated with both neonatal scalp abrasion (RR 0.38, 
95% CI 0.12 to 1.24) and cephalohaematoma (RR 0.34, 95% CI 0.08 to 1.41) relative to those 
that did not. However, neither of these associations were statistically significant. As all 
attempted OVBs were successful, no difference in success rate could be determined (71). 
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While this evidence is intuitive, the 100% success rate does not reflect rates found in recent  
UK-based studies (73,74). 
In contrast, Hofmeyer et al. in a small, unblinded randomised controlled trial (RCT) of 31 
women in Johannesburg in 1989 demonstrated that the rate of failure following the use of 
rigid mushroom cups (Bird’s and O’Neil) was significantly lower than that found during the 
use of soft cups (OR 12.9, CIs 12.2 to 138). In this study, rigid cups were able to generate 
significantly higher levels of maximum traction force than soft cups (Silc and Silastic) (158 N 
vs 110 N). No differences were found in any of the markers of neonatal outcome, although 
these were limited to 1-minute Apgar < 8 and the appearance of the scalp 5 minutes after 
delivery (75). 
Neither of these studies was sufficiently powered a priori to demonstrate a difference in 
maternal or neonatal outcomes. However, taken together the studies suggest that a more 
rigid cup (able to transmit greater traction force), is likely to increase the rate of injuries 
(cephalohaematoma and scalp abrasions) that are associated with the negative pressure 
generated by the ventouse. The corollary of this increased level of transmitted traction 
force may be a higher rate of successful delivery. What cannot be determined is to what 
extent the potential increased rate of vaginal birth outweighs the increased potential rate of 
neonatal complications. 
 
1.5.3.5 Pressure exerted by instruments 
Both forceps and ventouse exert pressure (forceps exerting positive pressure, ventouse 
exerting negative pressure) on the fetal head. Again, it is axiomatic that less pressure 
exerted will result in lower rates of complications. While no studies have prospectively 
quantified the pressures exerted by either forceps and ventouse and compared these to 
clinical outcomes, there is strong evidence that pressure exerted on the fetal head is the 
proximate cause of several significant adverse outcomes. 
 
1.5.3.5.1 Positive pressure 
Positive pressure (applied by forceps) can result in crush injuries to fragile facial structures. 
The following adverse outcomes are associated with forceps birth to a significantly greater 
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degree than ventouse, suggesting that positive pressure plays an important role in their 
aetiology: 
(i) Scalp/skin injuries (11) 
(ii) Facial nerve palsy (76) 
(iii) Ocular injury (77) 
(iv) Skull fracture (69,78) 
 
1.5.3.5.2 Negative pressure 
Negative pressure over the fetal head can result in two separate types of injury – scalp 
injury and cerebral vascular injury. Scalp injuries result from where the cup adheres to the 
scalp and torsional force results in tearing or shearing of the fetal skin, or in severe cases, 
avulsion of the scalp (79). 
Cerebral vascular injuries result from negative pressure exerted on the vascular network of 
the fetal skull, causing tearing of vessels and extravasation of blood. Cephalohaematoma, 
the most common form of injury, is usually mild and self-limiting (80,81). However negative 
pressure is more likely to be associated with subgaleal haemorrhage (SGA) than positive 
pressure. Estimates of absolute risk suggest rates of 0.44/1000 following spontaneous 
births, 1/1000 following forceps births and 5.9/1000 following ventouse (82,83). SGA occurs 
due to rupture of the emissary veins, and can result in up to 260ml of blood being 
extravasated into the subgaleal space, causing significant hypovolaemia, hypotension and, 
in extremis, coagulopathy and multi-organ failure (82,84). Mortality from SGA can be as high 
as of 25% of babies that are admitted to NICU due to SGA alone (85). 
While there is speculation that softer and larger cups (capable of applying less traction and 
less pressure) may result in lower levels of SGA, no studies have assessed this theory 
directly, and the latest Cochrane review was unable to comment given the absence of any 
applicable data (11). 
 
1.5.4 Instrument-dependent characteristics and associated outcomes 
1.5.4.1 Diameter of instrument and fetal head 
Greater diameters of the presenting fetal head/instrument may increase the rate of 
obstetric anal sphincter injury (OASI). This is demonstrated in differences in rate of OASI 
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following ventouse and forceps (6.4% vs 22.7% respectively , without episiotomy) (86). This 
theory is supported by studies demonstrating that additional risk factors for OASI include 
greater fetal head diameter and birthweight (87). 
 
1.6 Improving outcomes of OVB 
Individual clinical and practitioner factors can be modified by patient selection and 
accoucheur training. These include placement of instruments, availability of supervision, 
communication and team working. Improvements in the performance of these skills by 
individual accoucheurs may facilitate better maternal and neonatal outcomes following 
attempted vaginal birth.  
 
1.6.1 Placement of instruments 
As previously discussed, correct placement of instruments will tend to reduce adverse 
events and increase success rates in OVB (73,78). Although several attempts have been 
made to design training programs to improve placement, none have so far been shown to 
impact on clinical outcomes. While computer simulation-based programs that track the 
movement of forceps blades and provide real-time feedback have been shown to improve 
the placement of forceps by junior accoucheurs in simulated OVBs (88), and 5-step Vacca 
technique of measuring and applying the Kiwi ventouse has been promoted by the RCOG 
(36), neither of these measures have been definitively associated with improvements in 
patient-level outcomes. 
While it is reasonable to assume that thorough simulation training in OVB may improve 
instrument placement and thus clinical outcomes, more robust evaluation is required until 
this statement can be said to be evidence-based. 
 
1.6.2 Availability of training, teaching and supervision 
The presence of accoucheurs who are both clinically experienced in OVB and committed 
teachers can increase rates of OVB within individual settings (89). These improvements have 
been observed in a variety of settings. Solt et al. in one unit in the USA demonstrated that 
the addition of a dedicated OVB-positive senior accoucheur led to an increase in the rate of 
forceps birth by 59% over 2 years (2008 to 2010) (89). This has also been shown in a large 
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UK unit where the arrival of one experienced user of rotational forceps reduced the rate of 
Caesarean section at full dilatation by 20% over a four year period (2009 to 2013) (42). 
Significant improvements have also been seen in LMICs, where, following intensive training 
in the use of ventouse, rates of OVB increased substantially in settings as diverse as Ecuador 
(90) and rural Malawi (54). 
Patterns of use of instruments for OVB have been modified by structuring routine training 
for junior obstetricians in a manner designed to prevent failure to acquire skills in methods 
of OVB that may be perceived as more challenging. This can be achieved by teaching junior 
accoucheurs the use of forceps prior to the use of ventouse. One such programme over four 
years in a large tertiary centre in Australia from 2010 to 2014 demonstrated an increase in 
the use of forceps (OR 1.5, 95% CIs 1.03 to 1.96) and a matching reduction in ventouse. 
However there was no significant change in maternal or neonatal clinical outcomes (91).   
While these case studies demonstrate that localised changes and in some cases 
improvements in OVB rates are possible, improvements often depend on the arrival of 
expert users who have already been trained in other units. While this is inevitably the only 
recourse individual units have at present, a more generalised increase in OVB rates 
(particularly in LMICs) is unlikely to be achieved in this manner alone (8,17,96). Local 
leadership may be more able to deliver sustainable improvements in outcomes – this 
approach has been demonstrated in previous studies implementing obstetric emergency 
skills training (92-94). 
 
1.6.3 Communication with the patient and wider team 
Women who have had an OVB are more likely to be dissatisfied with their birth experience 
compared to women who have had a spontaneous vaginal birth (95,96). This can lead to 
increased sexual dysfunction (97), aversion to subsequent pregnancies (98), and complaints 
and litigation (99,100). Cross-sectional surveys of women who have undergone OVB have 
identified the factors that promote a more positive experience by the woman undergoing 
OVB as: 
• Communication “I felt well informed due to good communication” 
• Respect “I felt I was treated with respect at all times” 
• Safety “I felt safe at all times” (101) 
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While these factors have been identified, and are promoted through the current ROBuST 
simulation training package (36), there has not as yet been any evaluation as to how these 
factors can be promoted either within individual accoucheur-patient or wider team-patient 
interactions. At present best practice states that women should have the indication and 
purpose of any OVB clearly explained, be told what to expect both during and after the OVB, 
and thoroughly debriefed after the event (36). While this is likely to help promote good 
maternal perception, the impact of these recommendations has not been evaluated and so 
it is not possible to definitively say how the factors which could engender positive maternal 
perception can be promoted. 
 
1.7 Promoting better management of complications in the second stage of 
labour 
In light of the heavy burden of maternal and neonatal morbidity and mortality generated by 
complications in the second stage of labour, current management of these complications is 
axiomatically not satisfactory (3,5).  
Complications in the second stage of labour will continue to occur and are likely to increase. 
Factors associated with a prolonged or complicated second stage of labour, such as 
nulliparity, maternal obesity, diabetes, increasing maternal age, use of regional analgesia 
and augmentation of labour with oxytocin are all increasing worldwide (102,103). 
Moreover, despite significant initiatives among professional and international bodies to 
reduce the rate of Caesarean section over the past 30 years (104,105), little progress has 
been made (106). This combination of rising complications, often poor availability of OVB 
and increased willingness to resort to Caesarean section represents a significant challenge 
to promoting the best possible maternal and neonatal outcomes in the second stage of 
labour. 
In this context, increased provision of safe OVB has been identified as a possible solution to 
the problem of rising short and long-term complications (107). How to do so remains a 
matter of debate within the obstetric community. Any solution (particularly to be effective 
in LMICs) must overcome the challenges of potentially damaging instruments, the poor 
availability of expert teaching and the resource requirements of sterilisation and additional 
equipment (8,61). 
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1.7.1 Key features of any proposed new device 
Any new device for OVB should incorporate features that improve its performance relative 
to current instruments for OVB. Specifically, it should be: 
• Able to apply greater levels of traction than ventouse before failure 
• Less potentially damaging to fetal and maternal tissues than forceps 
• Require minimal or no ongoing support, such as electricity or sterilisation 
• Able to be used by accoucheurs with both high and low familiarity with OVB (108) 
 
1.7.2 The BD Odon Device 
The BD Odon Device is a new device for OVB. It has been designed by a multi-professional 
team of engineers, doctors and midwives.  
The design team believes that the device incorporates features that meet the challenges to 
any new device for OVB within the overall mechanism of the device. 
 
1.7.2.1 Mechanism of the BD Odon Device 
The device functions by placing an air cuff around the fetal head which is then used as a 
traction point to assist birth. The BD Odon Device consists of an applicator, sleeve and cuff, 
and fastening band (Figure 1-4). 
Figure 1-4. BD Odon Device components 
 
The applicator (four flexible spatulas emerging from an applicator handle) enables the 
operator to position the air cuff over the fetal head, past its widest point. The cup at the tip 
of the applicator facilitates the initial sliding motion of the cuff around the fetal head. The 
applicator is equipped with a progress indicator with markings allowing the user to check 
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when the intended depth of insertion has been reached. The operator then inflates the air 
cuff using the hand pump. The cuff is equipped with a rapid deflation button enabling the 
operator to release the pressure at any point. The pump also includes a pressure valve, 
which prevents over-inflation of the air cuff.  
Once the sleeve is situated over the fetal head, and the air cuff inflated, the applicator is 
removed by the operator. The air cuff is then re-inflated twice to compensate for a possible 
reduction in pressure. 
The operator now grasps the handles of the sleeve and, following the J-shaped curve of the 
pelvis, applies traction with contractions to assist the birth of the fetal head. Just prior to 
crowning a blue “deflation line” will be visible past the introitus. At this point the operator 
deflates the cuff and continues to apply traction. Once the fetal head is born the cuff will 
spontaneously detach allowing the operator to continue to assist the birth of the baby. 
This process is illustrated in Figure 1-5. 
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Figure 1-5. Visualisation of the use of the BD Odon Device 
 
 
1.8 Evaluation of new devices 
The aforementioned design features may, or may not, increase the clinical effectiveness of 
the BD Odon Device and reduce the burden of adverse outcomes on women and their 
babies. However, this can only be conclusively shown in a clinical evaluation of the device in 
the context of a randomised controlled trial comparing the device to the current most 
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commonly used instrument. It is no longer acceptable to proceed directly to a clinical study 
for any new medical device without first undertaking a process where the design team seek 
to evaluate and improve the potential effectiveness and risk burden of the new device. The 
current relevant regulations form the European Union (Regulation (EU) 2017/757 – on 
medical devices, Annex I) states that manufacturers of medical devices should: 
a) establish and document a risk management plan for each device; 
b) identify and analyse the known and foreseeable hazards associated with each 
device; 
c) estimate and evaluate the risks associated with, and occurring during, the 
intended use and during reasonably foreseeable misuse; 
d) eliminate or control the risks … as far as possible through safe design and 
manufacture; 
e) where appropriate, take adequate protection measures, including alarms if 
necessary, in relation to risks that cannot be eliminated; and 
f) provide information for safety (warnings/precautions/contra-indications) and, 
where appropriate, training to users. 
Moreover, “in eliminating or reducing risks related to use error, the manufacturer shall: 
reduce as far as possible the risks related to the ergonomic features of the device and the 
environment in which the device is intended to be used (design for patient safety), and 
give consideration to the technical knowledge, experience, education, training and use 
environment, where applicable, and the medical and physical conditions of intended users 
(design for lay, professional, disabled or other users)” (109). 
 
Therefore, it is incumbent upon all design teams responsible for new medical devices to 
develop and utilise a methodology to identify, evaluate, quantify and enable, if possible, a 
reduction in risks through both design of the device and appropriate training of the 
intended users.  
To date there have been no attempts to systematically evaluate and reduce the risks of a 
new medical device in operative vaginal birth.  
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1.8.1 Proposed methodology for evaluating risks of the BD Odon Device 
Simulation has been established as a robust means of driving improvements within the 
wider field of obstetrics. Numerous studies have used simulation to teach and consolidate 
the practical and team-working skills of birth attendants, and have been associated with 
improvements in maternal and neonatal outcomes (92,110). Moreover, previous studies 
have used simulation methodology to improve operator performance at specific skills 
relevant to OVB, such as examination (111) or placement of forceps (88). While not yet 
demonstrated in literature, it is therefore reasonable to assume that information generated 
or operator behaviours learnt or refined during OVB simulations can be applied to in-vivo 
situations.  
This thesis therefore sought to develop a methodological simulation-based approach to 
evaluating, and therefore reducing, the risks associated with OVB using a new device.  
 
1.9 Primary objective of thesis 
The primary objective of this thesis was to develop a simulation-based methodology for 
evaluating the risks of a new instrument (the BD Odon Device) for operative vaginal birth.  
 
1.9.1 Hypothesis 
It is possible to use simulation technology to prospectively quantify the likely characteristics 
of a new instrument for operative vaginal birth.  
 
The specific aims of this thesis are to develop simulation methodologies for quantitatively 
describing the following characteristics: 
1. Position of an instrument 
2. Likely perineal trauma 
3. Force generated by the instrument 
4. Pressure generated by the instrument 
5. Usability of the instrument by the intended operators 
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Chapter 2 Position of the BD Odon Device on a model fetal head 
2.1 Abstract 
Objective 
To investigate the placement of the BD Odon Device on the model fetal head 
Design 
Observational simulation study 
Setting 
North Bristol NHS Trust, UK 
Population or Sample 
490 simulated operative vaginal births 
Methods 
Three bespoke fetal mannequins were developed to represent (i) bi-parietal diameter of the 
50th centile at term (ii) bi-parietal diameter at the 5th centile at term and (iii) 50th centile 
head with 2 cm of caput. Siting of the BD Odon Device on model heads was determined 
before and after 490 simulated operative vaginal births. Variables were analysed to 
determine their effect on device siting and movement during birth.  
The fetal mannequins were placed inside a maternal mannequin (PROMPT Flex, Limbs & 
Things, Bristol, UK) and the BD Odon Device was placed around the fetal head as per the 
instructions for use. The location of the air cuff was determined before and after the head 
was delivered. 
Main Outcome Measures  
Site and displacement during birth of the BD Odon Device on a model head. 
Results  
The BD Odon Device was reliably sited in a standard over the fetal head position 
(approximately 40mm above the fetal chin) for all stations, head sizes and positions with no 
significant displacement. In occipito-posterior births, compared to occipito-anterior or 
transverse, the BD Odon Device routinely sited further down the fetal head (toward the 
chin). 
Conclusions 
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The BD Odon Device behaves in a repeatable and reliable way in citing over the fetal head in 
490 simulated births representative of clinical practice. 
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2.2 Introduction 
Any potential new instrument for operative vaginal birth must be carefully evaluated for 
safety and efficacy.  An ideal instrument should be associated with minimal risks to the 
mother and her baby, have a low failure rate, be simple to use and finally, be acceptable to 
both women and medical practitioners.  
Instruments should be able to be reliably sited over the intended area of the fetal head. 
Instruments are designed to transmit mechanical force to the fetal head in order to 
expedite the passage of the fetus through the birth canal, and the application of this force 
onto the fetal head should be carefully controlled. Sub-optimal placement of instruments, 
either forceps or ventouse, is associated with both increased levels of harm and injury, as 
well as lower levels of successful birth (64,71). The drivers of suboptimal placement are; i) 
incorrect diagnosis of position and ii) inaccurate placement of instrument even when the 
position has been correctly diagnosed. Both of these causes and subsequently poor 
placement, are common. 
Incorrect diagnosis of position has been found to occur in 20 to 44% of cases in reported UK-
based studies (61,112). In addition, sub-optimal placement has been found in as many as 
40% of retrospectively analysed ventouse deliveries (113) and 62% of simulated forceps 
deliveries (63). 
Given that sub-optimal placement is both harmful and relatively common, it is important 
that any new instrument has a high degree of internal placement reliability. This means that 
it will, due to its inherent design features, reliably sit over the intended area of the fetal 
head if used correctly. While misplacement due to factors such as incorrect position 
diagnosis or insufficient training can be mitigated by improving the clinical skills of the user 
population, any device should be able to be used repeatable and reliably in well-trained 
hands. There should be as little variation as possible in device performance due to the 
device itself, given the wide spectrum of placement possible due to user error. Moreover, 
the behaviour of the device in various expected clinical circumstances (OT or OP position, 
high or low station, presence of caput, variation in head size) should be properly understood 
and described. This may ensure that the device behaves as expected, and can therefore be 
used, in almost any clinical situation. Furthermore, should it be found that the device is 
ineffective or behaves in a manner likely to result in harm in any particular clinical 
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circumstance (i.e. face presentation, on a small head etc.), this should be formally recorded 
and incorporated into the instructions for the device. 
  
The BD Odon Device is presently in development and offers a potential alternative to 
obstetric forceps and ventouse.  The BD Odon Device consists of an inflatable circular air 
cuff attached to a thin circumferential polyethylene sleeve.  A semi-rigid plastic applicator is 
used to place the air cuff and sleeve into the birth canal, past the widest diameter of the 
fetal head. The air cuff is inflated around the fetal head, and the applicator is removed. 
During maternal contractions the accoucheur applies traction to the polyethylene sleeve, to 
assist birth of the baby.  
The air cuff provides the traction anchor point of the BD Odon Device, and is intended to sit 
in a ‘safe zone’, between the fetal chin and nose anteriorly, and at the nape of the neck 
posteriorly. We sought to determine where the cuff sits in relation to sensitive fetal 
anatomy (neck, nose and eyes) in simulated births.  In particular, this study investigated the 
effect on the position of the air cuff in relation to: (i) fetal position, (ii) fetal station, (iii) fetal 
head size, (iv) presence of caput succedaneum, and (v) the inflation pressure of the air cuff.  
2.3 Methods 
2.3.1 Development of fetal mannequins 
The PROMPT birthing simulator (Limbs & Things, Bristol, UK) fetal mannequin was used. This 
mannequin has an average size head for a term fetus with a bi-parietal diameter (BPD) of 
96mm, comparable to the 50th centile of 97mm at 39 to 40 weeks gestation (12) (Figure 
2-1).   
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Figure 2-1. Model fetal head with biparietal diameter of 96mm 
 
 
Two additional fetal mannequins were developed for use in this study. A new fetal model 
was manufactured with a BPD of 89mm, equivalent to a fetal head on the 5th centile (12) 
(Figure 2-2) to assess the risk of the device slipping onto and constricting the fetal neck in 
cases of a small head size. A second fetal mannequin was developed to simulate a 50th 
centile term fetus with a 2cm depth of caput succedaneum (situated in the midline between 
the anterior fontanelle and 2cm posterior of the posterior fontanelle) (Figure 2-3) to assess 
how the presence of caput succedaneum could affect the application and use of the BD 
Odon Device.  
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Figure 2-2. Model fetal head with biparietal diameter of 89mm 
 
Figure 2-3. Model fetal head with 2cm of caput 
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2.3.2 Simulation of operative vaginal births 
The pre-existing PROMPT birthing simulator fetal mannequin together with the two 
bespoke fetal mannequins were used with a PROMPT Flex maternal mannequin birthing 
simulator for the simulated operative vaginal births.  All simulated OVBs were conducted by 
a single operator (SO’B).  
Four hundred and ninety simulated OVBs were performed to investigate the placement of 
the BD Odon Device and the effect of key variables on the position and movement of the BD 
Odon Device air cuff during simulated birth, namely:   
1. fetal head size: 50th centile, 5th centile 
2. presence of caput succedaneum 
3. fetal position (occipito-anterior (OA), occipito-posterior (OP), right occipito-
transverse (ROT), face presentation) 
4. fetal station: vertex at the ischial spines, vertex 1cm below the ischial spines, vertex 
2cm below the ischial spines 
5. BD Odon device air cuff inflation pressure: 40kPa, 60kPa, 80kPa. 
 
The range of BD Odon Device cuff inflation pressures tested (40 to 80kPa) is the range 
envisaged to be used in vivo. The behaviour of the device at pressures over 80kPa were not 
investigated. The device incorporates a pressure limiter which prevents the generation of 
inflation pressures greater than 80kPa. 
During each simulated OVB, a modified procedure for using the BD Odon Device was 
employed. The air cuff was inflated and the applicator was removed. The distance of the 
inferior edge of the air cuff from four reference points on the fetal head ((i) mental 
protuberance (ii) right angle of mandible (iii) left angle of mandible and (iv) C7 posteriorly) 
was then measured in mm using a manual ruler (see Figure 2-4). Routine traction was 
applied in the standard manner to the BD Odon device sleeve to assist the birth of the fetal 
head. After crowning of the head, the air cuff should be deflated. However, in our modified 
procedure to ensure the position of the air cuff after traction had been applied to deliver 
the fetal head, the air cuff was left inflated and measurement of the distance between the 
air cuff from the fixed reference points on the fetal head was repeated. 
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Figure 2-4. reference locations for measurement of device position 
 
Device placement data were collected: site of the device on a model head before birth, 
distance moved by the device over the model head during the simulated birth (mm), and 
site of the device on the fetal head post birth. All positions were determined relative to four 
reference points: the fetal mental protuberance, right angle of mandible (RAoM), left angle 
of mandible (LAoM) and C7 posteriorly. The data measuring distance from the mental 
protuberance and C7 were analysed as separate outcomes, whilst data from RAoM and 
LAoM were pooled to give a composite measure of device movement around the lateral 
aspects of the fetal head. Distances and displacement are reported as positive if the air cuff 
was sited or moved cephalad relative to the reference point (i.e. closer to the fetal vertex), 
and negative if the air cuff was sited or moved caudal relative to the reference point (i.e. 
closer to the fetal chin).  
Results are provided for the location of the device on the model fetal head relative to fetal 
mental protuberance (Table 2-2) and relative to C7 (Table 2-4) before and after birth in 
scenarios where only one variable has changed (i.e. inflation pressure or head size or 
position or station).   
Statistical analyses of the significance of degree of change in position of the device before 
and after birth relative to the mentum between all variable groups relative to a baseline 
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group (BD Odon Device, 40kPa inflation pressure, OA, station +2, 50th centile head size, no 
caput) are presented in Table 2-3. 
 
Data describing differences in degree of movement of the device over the model fetal face 
from before to after birth between variable groups were analysed using a Kruskal-Wallis 
test. Bonferroni corrected p-values were derived to account for test-multiplicity.  A p-value 
≤0.05 was considered as evidence of group difference. 




Four hundred and ninety simulated OVBs were performed. The number of births for each 
combination of variables is provided in Table 2-1. Selected results demonstrating the 
relative effect of the alteration of a single variable are presented in Table 2-2, Table 2-3 and 
Table 2-4. Data are presented as medians with quartiles, as they were not normally 
distributed (assessed using simultaneously Kurtosis statistics and the coefficient of skewness 
of the variable distribution as well as the qq plot and pp plot of this distribution). Full results 
of all 490 simulated births are given in Appendix 1.  
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Table 2-1. Numbers of births for each combination of variables 
OA 
Number of simulated births 
Total 
births 












Normal 10 10 10 10 10 10 60 
Small 10  10  10  30 
Spines 
+1 
Normal 10  10    20 
Small 10      10 
At 
spines 
Normal 10 10 10 10 10 10 60 




Normal 10 10 10  10  40 
Small 10      10 
Spines 
+1 
Normal 10  10    20 
Small 10      10 
At 
spines 
Normal 10  10  10  30 




Normal 10 10 10  10  40 
Small 10      10 
Spines 
+1 
Normal 10  10    20 
Small 10      10 
At 
spines 
Normal 10  10  10  30 




Normal 10  10  10  30 
Small 10      10 
Spines 
+1 
Normal        
Small        
At 
spines 
Normal        
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2.4.1 Location of air cuff in relation of the fetal chin 
Prior to the application of traction, the inferior edge of the BD Odon Device air cuff was 
positioned on, or above, the fetal mental protuberance (i.e. between the fetal chin and 
nose) in all simulations.  In all 490 simulations performed prior to the application of traction 
to the BD Odon Device the median distance between the inferior edge of the BD Odon 
Device air cuff and the fetal mental protuberance was 40mm (1st and 3rd quartiles [Q1, Q3], 
21mm & 45mm).  
The inflation pressure within the air cuff had little effect on the initial position of the device 
from the fetal chin: 43mm [40 to 44.5], 46mm [43.5 to 46.5] and 44.5mm [41 to 46] for 
inflation pressures of 40, 60 and 80kPa respectively.  
The ROT position, presence of caput, 5th centile head size and vertex at station +1cm below 
ischial spines had little effect on the position of the device relative to the fetal chin: 44mm 
[41.7 to 48], 44.5mm [42 to 50.5], 37mm [33 to 38.5] and 44mm [42 to 44.5] respectively. 
On average the air cuff moved less than 10mm in either direction during birth. 
However, the air cuff was located lower on the fetal face (nearer the chin) when the fetus 
was in the OP position (median distance to chin 31mm [25 to 36.5] before birth, and was 
noted to be beneath the fetal chin after birth in the majority of cases (median distance to 
chin -10mm [-12 to -6]). The air cuff moved by a greater margin in these OP simulations, on 
average moving down the fetal face (toward the chin) by 36mm during birth [-47.5 to 30.5]. 
In births where the model fetus was at the level of the ischial spines, the air cuff moved by 
9.5mm during birth. This is due to the air cuff being placed higher (toward the vertex) on the 
fetal head before birth than in any other scenario, 49.5mm [45.7 to 74] above the fetal chin. 
In these scenarios the air cuff was located in a similar site on the fetal head to procedures in 
OA or OT positions after birth, 42mm [39 to 44.5] above the fetal chin. 
These results are shown in Table 2-2. 
Ten attempts were made to apply the BD Odon Device in a mento-anterior face 
presentation, although this would be an unlikely circumstance in clinical practice. The BD 
Odon Device spontaneously slipped off the face during inflation in three (30%) of these 
attempts. These findings confirm that it is inappropriate to use the BD Odon Device for face 
presentations. 
Chapter 2 - Position of the BD Odon Device on a model fetal head 
 41 
Testing for statistically significant differences revealed that each chosen variable (inflation 
pressure, position, station) was not sufficient in itself to generate significant difference in 
the distance of the cuff from the mentum, relative to the reference group (OA, +2 spines, 
50th centile head, 40 kPa inflation pressure, no caput), with the exception of the addition of 
caput and the use of a small head. This is shown in Table 2-3. 
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 Variable  
Fetal head size (term 
BPD centile) 
50th 50th 50th 50th 50th 50th 5th 50th 50th 
Position OA OA OA ROT OP OA OA OA OA 
Caput present No No No No No Yes No No No 
Inflation pressure of 
BD Odon Device cuff 
(kPa) 
40 60 80 40 40 40 40 40 40 
Station (cm below 
ischial spines) 
+2 +2 +2 +2 +2 +2 +2 +1 0 
Number of births (n) 10 10 10 10 10 10 10 10 10 
Before birth median 
distance from mental 
protuberance in mm 
(Q1, Q3) 
43 
(40 to 45) 
46 
(44 to 47) 
45 
(41 to 46) 
44 
(42 to 48) 
31 
(25 to 37) 
45 
(42 to 51) 
37 
(33 to 39) 
44 
(42 to 45) 
50 
(46 to 74) 
After birth median 
distance from mental 
protuberance in mm 
(Q1, Q3) 
42 
(40 to 43) 
43 
(42 to 44) 
41.5 
(-23 to 44) 
40 
(36 to 43) 
-10 
(-12 to -6) 
40 
(40 to 45) 
39 
(26 to 40) 
44 
(42 to 44) 
42 
(39 to 45) 
Before-after birth 
median change in mm 
(Q1, Q3) 
-5 
(-8 to -2) 
-4 
(-5 to 0) 
-3 
(-60 to 0) 
-5 
(-23 to -2) 
-36 
(-48 to -31) 
-5 
(-8 to -2) 
0 
(-8 to 4) 
-1 
(-4 to 1) 
-10 
(-29 to -3) 
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Table 2-3. Degree of movement of BD Odon Device in relation to mentum from before to after birth between single variable 
groups across all births 



















Number of births (n) 30 80 80 90 90 80 130 
Before birth median 
distance from 
mentum in mm (Q1, 
Q3) 
44 
(42 to 48) 
44 
(19 to 46) 
42 
(5 to 45) 
44 
(40 to 48) 
16 
(0 to 28) 
46 
(42 to 48) 
20 
(4 to 35) 
After birth median 
distance from 
mentum in mm (Q1, 
Q3) 
42 
(40 to 44) 
40 
(-16 to 44) 
40 
(-20 to 44) 
42 










median change  
(Q1, Q3) 
-4 
(-9 to 0) 
-6 
(-17 to -1) 
-4 
(-20 to 0) 
0 
(-4 to 0) 
-25 
(-38 to -2) 
-3 
(-6 to 0) 
-16 




reference group (p) 
 0.47 0.47 0.23 0.01 0.96 0.03 
*Baseline group: 50th centile head, OA, no caput, 40kPa inflation pressure, +2 station 
 
2.4.2 Location of air cuff in relation to the fetal 7th cervical vertebrae (C7):   
All variables, except the OP position, had little effect on the position of the BD Odon Device 
air cuff relative to the 7th cervical vertebrae (C7): for all variables except OP position, the air 
cuff was located within 15mm of C7, and moved less than 10mm from before to after birth. 
In the OP positions, the air cuff was consistently sited higher up the fetal head, towards the 
vertex (26mm, [15 to 29]). During birth it moved down the fetal head by 23mm [-29.5 to -
17.5] so that it was located just below C7, with a median distance from C7 of -2mm [-2.5 to 
0.5] 
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These data are presented in Table 2-4. 
 
Table 2-4. Placement of the BD Odon Device in relation to C7 
 
  
 Variable (s) 
Fetal head size (term 
BPD centile) 
50th 50th 50th 50th 50th 50th 5th 50th 50th 
Position OA OA OA ROT OP OA OA OA OA 
Caput present No No No No No Yes No No No 
Inflation pressure of 
BD Odon Device cuff 
(kPa) 
40 60 80 40 40 40 40 40 40 
Station (cm below 
ischial spines) 
+2 +2 +2 +2 +2 +2 +2 +1 0 
Number of births (n) 10 10 10 10 10 10 10 10 10 
Before birth median 
distance from C7 in 
mm (Q1, Q3) 
-1 
(-2 to 1) 
5.5 
(4 to 11) 
4 
(2 to 7) 
14.5 
(10 to 19) 
26 
(15 to 29) 
10 
(9 to 12) 
9.5 
(6 to 11) 
0 
(-1 to 0.8) 
7 
(4 to 18) 
After birth median 
distance from C7 in 
mm (Q1, Q3) 
0 
(-12 to 1) 
2.5 
(0 to 5) 
1 
(-1 to 3) 
8 
(5 to 9) 
-2 
(-3 to 1) 
13 
(9 to 15) 
9 
(7 to 15) 
0 
(0 to 2) 
7 
(2 to 10) 
Before-after birth 
median change in mm 
(Q1, Q3) 
2 
(-2 to 5) 
-4 
(-6 to -2) 
-4 
(-6 to 0) 
-7 
(-15 to -3) 
-23 
(-30 to -18) 
2 
(-2 to 5) 
1.5 
(-2 to 6) 
0 
(1 to 2) 
-4 
(-9 to 3) 
Chapter 2 - Position of the BD Odon Device on a model fetal head 
 45 
2.5 Discussion  
2.5.1 Main Findings 
Using the standard operating procedure for placement, the BD Odon Device was 
consistently sited over the same area of the fetal head for all fetal head sizes, stations and 
positions, except OP and when the vertex was at the level of the ischial spines. For all other 
scenarios tested, the BD Odon Device was sited around the fetal head within 15mm of the 
level of C7 posteriorly, and between 37mm and 46mm above the fetal chin anteriorly 
(Figure 2-5). This is the same level as the tips of correctly applied forceps blades. 
Furthermore, the device was stable with minimal movement of the device (<10 mm) during 
simulated birth.  
 
 
In OP positions, the placement of the air cuff of the BD Odon Device was further down the 
fetal head, typically sited more cephalad (toward the vertex) over the posterior aspect of 
the neck, and more caudal (toward the chin) over the chin anteriorly when compared with 
births in an OA position. This may be a desirable feature, as deflexion of the fetal head is 
frequently associated with OP positions, and during inflation the BD Odon Device air cuff 
generated flexion of the fetal head. Increased flexion of the fetal head was observed in all 
positions, which may partially explain the mechanism of action of the device. 
Figure 2-5. Typical location of the BD Odon Device on a model fetal head - 40mm above the fetal chin and 10mm above C7 
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A significant hypothetical risk of the BD Odon Device was the possibility of the device 
slipping onto, and subsequently constricting the fetal neck. However, we observed that 
even when the device appeared to slip below the fetal chin, the downward traction on the 
device caused the cuff to only exert pressure on the inferior aspect of the mandibles, rather 
than on the anterior aspect of the fetal neck. 
The location of the BD Odon Device was different in births performed with the vertex at the 
level of the ischial spines. In these births, the device was initially sited further cephalad 
(toward the vertex) than usual (49.5mm from the mental protubence, Table 2-2). After 
traction, the device was sited at the same level as other procedures, (42mm above the fetal 
chin). After the application of traction the BD Odon Device moves to the same site 
irrespective of the initial fetal station. 
The BD Odon Device consists of an air cuff which, once inflated, is relatively incompressible. 
If the air cuff is further compressed (by an external force or by an increase in the intrinsic air 
pressure using the hand pump), the cuff will move to an area of lower external pressure. 
Because the fetal head progressively narrows between the widest point at the parietal ridge 
and the chin, an increase in pressure will result in the cuff to moving caudally (toward the 
chin).  However, the anterior surface of the face between the nose and the chin is relatively 
flat, meaning that the cuff is likely to come to rest here rather than continue to travel 
caudally down the face. This observation was most pronounced in the births conducted with 
the vertex at the level of the ischial spines. The cuff initially is located higher towards the 
vertex. However, as traction force is applied, the air cuff moves caudally down the fetal 
head, coming to rest on the relatively flat portion of the face between the nose and chin.  
The BD Odon Device was reliably sited in a “safe area” between the fetal chin and nose, for 
all the investigated fetal positions and stations.  
 
2.5.2 Strengths and Limitations 
This is the first study to prospectively investigate the performance of a novel device for 
operative vaginal birth using simulation. We employed a simulation methodology previously 
used to investigate and improve management of other areas of intra-partum care (110,114-
116).  
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All simulations were performed by a single operator, which assisted internal consistency of 
measurement and eliminated inter-operator variability. However, we recognise the inherent 
limitations of this strategy, in particular the possibility of repeated systematic error. 
We looked at the behaviour of the BD Odon Device with an average-sized head, a small 
head and a head with 2cm of caput. We did not analyse the behaviour of the BD Odon 
Device when used with a large head (i.e. >95th centile). As this was a ‘worst-case scenario’ 
simulation, we sought to evaluate the greatest perceived risk, the risk of the deice slipping 
over and constricting the neck. Due to the wider presenting part of a large head, we felt this 
risk to be less with a large head compared to a small head. Therefore, given the limited 
resources of the study, we only analysed the behaviour of the device with a small head. 
Lubrication was used in our simulations – this would reflect real-world practice and we do 
not consider it to be a weakness of the study. 
A further potential criticism of this study is the uncertainty whether our findings are 
generalisable to actual use of the device in clinical practice – while we acknowledge that this 
may be eventually discovered to be the case, the use of simulation models to predict 
instrument placement is already widely used and validated in teaching practice (63,88), and 
so it seems unlikely that utilisation of a similar model would not be consistent with clinical 
reality. 
 
2.5.3 Interpretation (in light of other evidence) 
Studies of ventouse and forceps have demonstrated that poor device positioning increases 
the risk of adverse outcomes (64,71). While correct positioning can be successfully taught 
(88), an instrument that can be reliably sited is an important safety feature. Our study 
demonstrates a high degree of concordance in the siting of the BD Odon Device across a 
wide range of fetal positions and stations.  
 
2.6 Conclusions 
In 490 simulations, using a robust and validated model, the BD Odon Device is consistently 
and reliably sited over the fetal head, and the location of the air cuff on the fetal head is 
likely to be safe in clinical practice. The device does not appear to slip or move significantly 
during simulated births, and generates a degree of head flexion. 
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Inflation of the air chamber results in flexion of the fetal head which may be associated with 
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Appendix 1 Full results of all simulated births 
 
2.7 Results not presented here 
10 assisted births were attempted using the small head in FMA position, +2 at 40 kPa and 
FMA, +2 at 80 kPa. However, during this series of assisted births, it was not possible to apply 
the device in a manner that would allow the device to remain on the fetal head during and 
after inflation on 8 occasions in each presentation. Therefore no numeric results are 
presented for this series of births.  
 
2.8 Results of simulations performed with 50th centile head 
 
Table 2-5. OA, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 43.0 (40 to 48) [2.7] 40.4 (24 to 47) [6.1] 
RAoM -15.6 (-20 to -5) [5.2] -17.0 (-20 to -10) [3.0] 
LAoM -16.3 (-22 to -6) [4.9] -16.1 (-20 to 3) [6.8] 
C7 -0.7 (-4 to 2) [2.1] 0.5 (-3 to 10) [3.6] 
 
 
Table 2-6. OA, +2, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 45.5 (40 to 52) [3.2] 42.6 (40 to 45) [1.7] 
RAoM -11.9 (-18 to -4) [4.9] -15.2 (-20 to -6) [4.1] 
LAoM -11.3 (-19 to -4) [4.4] -12.7 (-19 to -4) [3.9] 
C7 6.6 (3 to 11) [3.2] 2.7 (0 to 6) [2.4] 
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Table 2-7. OA, +2, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 43.1 (36 to 46) [3.5] 22.5 (-28 to 46) [32.6] 
RAoM -19.4 (-30 to -9) [6.4] -28.4 (-38 to -16) [7.5] 
LAoM -15.8 (-24 to -8) [6.2] -28.7 (-40 to -9) [9.9] 
C7 4.4 (2 to 8) [2.5] 1.0 (-4 to 6) [2.9] 
 
 
Table 2-8. OA, +1, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 45.8 (42 to 66) [7.2] 42.9 (38 to 46) [2.4] 
RAoM -11.9 (-17 to 10) [8.3] -14.1 (-18 to -2) [4.7] 
LAoM -14.9 (-20 to 5) [7.3] -15 (-18 to -6) [3.7] 
C7 1.6 (-2 to 18) [5.9] 1.2 (0 to 7) [2.4] 
 
 
Table 2-9. OA, +1, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 37.8 (4 to 48) [12.3] 43.4 (40 to 46) [1.6] 
RAoM -18.6 (-20 to -16) [1.3] -15.8 (-28 to 16) [11.7] 
LAoM -21.6 (-28 to -18) [3.4] -20.7 (-26 to -16) [3.8] 
C7 -0.1 (-4 to 4) [2.1] -0.5 (-4 to 2) [1.6] 
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Table 2-10. OA, at spines, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 59 (44 to 90) [17] 43.5 (32 to 71) [10.4] 
RAoM -0.3 (-12 to 16) [9.9] -3.1 (-12 to 13) [7.6] 
LAoM 0.9 (-14 to 18) [11.8] -2.4 (-12 to 14) [7.2] 
C7 9.5 (2 to 20) [6.8] 6.3 (0 to 14) [4.5] 
 
Table 2-11. OA, at spines, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 43.7 (39 to 49) [3.0] 43.1 (39 to 45) [2.2] 
RAoM -13.9 (-18 to -6) [4.0] -15.4 (-20 to -10) [3.2] 
LAoM -14.8 (-19 to -8) [4.3] -14.1 (-20 to -6) [4.6] 
C7 4.8 (1 to 11) [3.6] 1.5 (0 to 5) [1.6] 
 
During this series of births there was one instance of detachment of air tube from the cuff 
after inflation. 
 
Table 2-12. OA, at spines, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 38.9 (29 to 47) [6.0] 29.9 (-20 to 44) [23.8] 
RAoM -19.3 (-28 to -9) [5.2] -22.8 (-45 to -8) [12.0] 
LAoM -16.1 (-24 to -2) [6.7] -21.3 (-48 to -2) [14.4] 
C7 6.6 (-2 to 14) [6.1] 2.0 (-4 to 12) [4.8] 
Table 2-13. OP, +2, 40 kPa 
Mean distance from reference point (mm) 




(range) [standard deviation] 




Mentum 30.5 (16 to 42) [7.8] -5.4 (-20 to 36) [15.3] 
RAoM -9.0 (-26 to 4) [9.1] -28.0 (-36 to -14) [6.0] 
LAoM -5.8 (-18 to 2) [6.3] -25.4 (-34 to 14) [5.4] 
C7 -22.6 (10 to 32) [8.0] -1.2 (-6 to 4) [2.9] 
 
 
Table 2-14. OP, +2, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 25.2 (18 to 32) [5.9] -14.8 (-18 to 26) [14.6] 
RAoM -18.2 (-24 to -10) [4.6] -39.8 (-44 to -28) [4.5] 
LAoM -17 (-24 to -10) [4.1] -33.1 (-45 to -24) [6.5] 
C7 20 (16 to 26) [3.5] -6.6 (-12 to 4) [4.4] 
 
 
Table 2-15. OP, +2, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 20.3 (8 to 30) [6.9] -24 (-30 to -12) [5.4] 
RAoM -26 (-30 to -18) [5.5] -42.9 (-55 to -30) [7.4] 
LAoM -24.6 (-32 to -14) [5.3] -38 (-50 to -28) [6.2] 
C7 9 (4 to 16) [4.1] -6.6 (-10 to 0) [3.1] 
 
  
Chapter 2 - Position of the BD Odon Device on a model fetal head 
 53 
Table 2-16. OP, +1, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 18.1 (8 to 28) [5.9] 11.2 (-1 to 24) [9.1] 
RAoM -18.7 (-25 to -14) [4.3] -20.6 (-26 to -15) [4.0] 
LAoM -17.7 (-24 to -9) [5.5] -18.6 (-25 to -10) [4.8] 
C7 22.2 (14 to 27) [3.6] 8.4 (0 to 20) [5.9] 
 
 
Table 2-17. OP, +1, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 14.1 (8 to 26) [5.3] -12.5 (-24 to -4) [7.4] 
RAoM -22.4 (-30 to -14) [5.9] -31.6 (-38 to -26) [4.1] 
LAoM -28 (-36 to -20) [5.1] -29.8 (-38 to -2) [10.3] 
C7 3.2 (-8 to 12) [5.8] -6.8 (-10 to -4) [2.1] 
 
 
Table 2-18. OP, at spines, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 27.7 (20 to 35) [4.7] 16.3 (-4 to 36) [16.8] 
RAoM -10.1 (-18 to 3) [5.3] -18.5 (-30 to 0) [10.5] 
LAoM -14.1 (-22 to -4) [5.8] -18.4 (-30 to -3) [9.8] 
C7 25.8 (20 to 36) [4.8] 5.4 (-4 to 26) [9.4] 
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Table 2-19. OP, at spines, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 22 (12 to 38) [8.2] -1.3 (-15 to 40) [19.9] 
RAoM -20.7 (-26 to -15) [3.6] -33.3 (-40 to -18) [6.8] 
LAoM -24.7 (-42 to -18) [7] -33.6 (-40 to -20) [7.6] 
C7 -1.8 (-4 to 2) [2.2] -7.7 (-12 to 0) [3.7] 
 
 
Table 2-20. OP, at spines, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 8 (-8 to 20) [7.2] -18 (-26 to -10) [5.5] 
RAoM -30.8 (-40 to -18) [7.6] -32.2 (-36 to -24) [3.5] 
LAoM -30.8 (-36 to -26) [2.9] -35 (-38 to -32) [2.4] 
C7 -1 (-14 to 10) [7.8] -11.4 (-14 to -8) [2.1] 
 
 
Table 2-21. ROT, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 43.8 (36 to 54) [5.1] 34.2 (-13 to 44) [17.9] 
RAoM -2.2 (-14 to 18) [11.0] -6.4 (-42 to 5) [13.6] 
LAoM -6 (-22 to 6) [9.2] -11.6 (-40 to 0) [11.9] 
C7 13.5 (6 to 22) [4.8] 6.1 (-4 to 10) [4.3] 
 
During this series of births there was one instance of the cuff being applied too high on the 
model head, causing the cuff to slide off the head during inflation. 
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Table 2-22. ROT, +1, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 47.5 (42 to 54) [3.0] 44.6 (38 to 48) [3.2] 
RAoM -7.4 (-16 to 8) [7.9] -11.7 (-18 to -6) [3.5] 
LAoM -8 (-18 to 4) [10.0] -9.7 (-18 to 16) [10.1] 
C7 12.3 (5 to 26) [5.9] 8 (4 to 16) [4.0] 
 
 
Table 2-23. ROT, +1, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 37.8 (10 to 48) [12.7] 34.8 (-28 to 46) [22.2] 
RAoM -23.2 (-40 to -18) [8.5] -26.8 (-44 to -16) [7.7] 
LAoM -23.6 (-36 to -12) [7.5] 26.6 (-46 to -14) [9.7] 
C7 5.4 (-2 to 14) [4.6] 7.6 (-6 to 14) [5.6] 
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Table 2-24. ROT, at spines, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 48.5 (44 to 52) [2.5] 43.3 (40 to 46) [1.9] 
RAoM -10 (-16 to 2) [5.1] -10.8 (-16 to -4) [3.3] 
LAoM -14.7 (-20 to -5) [4.4] -14.7 (-18 to -10) [2.6] 
C7 7.8 (2 to 14) [3.6] 9.6 (3 to 12) [3.0] 
 
During this series of births there was one instance of detachment of air tube from the cuff 
after inflation. 
 
Table 2-25. ROT, at spines, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 42.8 (38 to 48) [3.2] 41.2 (40 to 46) [1.9] 
RAoM -19.2 (-28 to -14) [3.8] -25.6 (-30 to -16) [3.7] 
LAoM -19.8 (-38 to -20) [15.2] -25 (-30 to -18) [3.8] 
C7 -1.8 (-10 to 4) [4.8] 6.4 (2 to 10) [2.6] 
 
 
Table 2-26. ROT, at spines, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 34.2 (-8 to 46) [15.9] 26.6 (-34 to 44) [30.4] 
RAoM -24.2 (-42 to -18) [7.5] -29 (-50 to -14) [12] 
LAoM -26.6 (-40 to -18) [6.9] -27.3 (-55 to -16) [11.7] 
C7 -1.2 (-8 to 8) [4.6] -6.8 (-20 to 10) [7.9] 
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Table 2-27. ROT, +2, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 44 (42 to 46) [1.6] 44.1 (42 to 48) [1.9] 
RAoM -13 (-20 to 12) [9.2] -15.2 (-18 to -12) [1.9] 
LAoM -19 (-28 to -10) [5.2] -17.6 (-22 to -14) [2.8] 
C7 6.4 (0 to 10) [3.1] 8.4 (2 to 14) [3.5] 
 
 
Table 2-28. ROT, +2, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 45.7 (44 to 50) [2.4] 45.7 (42 to 50) [2.4] 
RAoM -14.7 (-22 to 0) [6.8] -18 (-22 to -10) [3.6] 
LAoM -19 (-24 to -14) [3.2] -19.7 (-22 to -18) [1.2] 
C7 2.2 (0 to 4) [1.6] 4.5 (2 to 10) [2.4] 
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Table 2-29. FMA, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 






18.2 (10 to 30) [6.4] 15.2 (9 to 24) [4.8] 
Right pinna -12.5 (-23 to 4) [9.2] -15.1 (-22 to -2) [7.4] 




32.1 (14 to 68) [14.8] 22.1 (13 to 38) [9.5] 
 




Table 2-30. FMA, +2, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 






-85 (-92 to -78) [36.1] -76 (-80 to -68) [27.2] 
Right 
pinna 
-9.5 (-18 to 0) [6] -31.7 (-36 to -24) [4.1] 




92.3 (82 to 110) [8.4] 81.2 (68 to 92) [9.7] 
 
During this series of births the cuff slid off the model fetal face after inflation on three 
occasions. 
 
Chapter 2 - Position of the BD Odon Device on a model fetal head 
 59 
When performed on a FMA presentation, +2 spines and using an 80 kPa inflation pressure, 
the cuff slid off the model fetal face on eight occasions – therefore no results are presented 
for this attempt. 
2.9  Results of simulations with caput head 
 
Table 2-31. Caput head, OA, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 45.9 (40 to 52) [4.3] 41.4 (36 to 48) [3.7] 
RAoM -10.7 (-16 to -6) [3.4] -13 (-16 to -10) [2.3] 
LAoM -15.9 (-70 to -8) [19.3] -11.4 (-16 to -8) [2.3] 
C7 10.6 (4 to 17) [3.3] 11.9 (6 to 17) [3.5] 
 
 
Table 2-32. Caput head, OA, +2, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 46.6 (40 to 50) [3.1] 43.1 (40 to 46) [2.2] 
RAoM -15.8 (-12 to -10) [2.7] -21.4 (-24 to -18) [2.5] 
LAoM -16.6 (-18 to -14) [1.9] -22.1 (-25 to -18) [2.9] 
C7 16.3 (14 to 21) [2.5] 9 (7 to 10) [1.2] 
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Table 2-33. Caput head, OA, +2, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 47 (42 to 52) [3.1] 45.7 (42 to 48) [1.8] 
RAoM -14.4 (-18 to -10) [2.5] -19.1 (-25 to -17) [2.4] 
LAoM -14 (-20 to -6) [4.2] -16 (-14 to -18) [1.6] 
C7 9.5 (6 to 14) [2.9] 6.5 (4 to 13) [3.2] 
 
 
Table 2-34. Caput head, OA, at spines, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 42.6 (34 to 50) [5.1] 41 (38 to 50) [3.7] 
RAoM -16.7 (-20 to -14) [2.0] -16.2 (-18 to -14) [1.4] 
LAoM -18.2 (-24 to -15) [2.7] -17.1 (-20 to -15) [2.4] 
C7 17.5 (7 to 24) [4.8] 14.5 (10 to 20) [2.9] 
 
 
Table 2-35. Caput head, OA, at spines, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 45.8 (44 to 48) [1.5] 40.7 (35 to 44) [2.4] 
RAoM -15.5 (-20 to -12) [2.6] -21.8 (-28 to -16) [3.7] 
LAoM -16.5 (-14 to -24) [3.2] -23.1 (-26 to -16) [3.3] 
C7 19.6 (14 to 24) [3.8] 9.9 (8 to 12) [1.5] 
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Table 2-36. Caput head, OA, at spines, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 45.2 (40 to 48) [2.5] 43.2 (40 to 46) [2.5] 
RAoM -20.9 (-24 to -15) [2.9 -29.7 (-33 to -24) [3.3] 
LAoM -23.1 (-28 to -18) [3.8] -31.7 (-35 to -25) [3.9] 
C7 12.6 (10 to 16) [1.8] 6.6 (6 to 9) [1.0] 
 
 
Table 2-37. Caput head, OP, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 37 (26 to 46) [5.8] 30.6 (-10 to 45) [15.6] 
RAoM -7 (-14 to -2) [3.6] -13.7 (-34 to -8) [7.7] 
LAoM -8.4 (-16 to -4) [3.9] -12.8 (-20 to -6) [4.5] 
C7 40.1 (32 to 46) [4.0] 17.4 (10 to 28) [5.7] 
 
 
Table 2-38. Caput head, ROT, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 48 (44 to 50) [3.4] 43.5 (40 to 46) [2.4] 
RAoM -9.6 (-16 to 0) [4.5] -10.5 (-15 to -6) [3.4] 
LAoM -10 (-16 to -6) [3.5] -11.4 (-18 to -4) [3.5] 
C7 21.9 (10 to 30) [5.7] 19.4 (16 to 24) [2.8] 
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2.10 Results of simulations with small head 
Table 2-39. Small head, OA, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 35.3 (22 to 42) [5.7] 28.1 (-27 to 40) [23.6] 
RAoM -21 (-25 to -14) [3.3] -18.9 (-30 to -9) [6.8] 
LAoM -20.8 (-42 to -12) [8.1] -17.5 (-34 to -8) [8.7] 
C7 8.1 (-1 to 12) [3.8] 10.1 (0 to 18) [5.9] 
 
Table 2-40. Small head, OA, +2, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 6.6 (-4 to 26) [9.0] -11.6 (-28 to 40) [19.8] 
RAoM -34.8 (-40 to -26) [4.1] -36 (-46 to -22) [6.4] 
LAoM -37.7 (-44 to -13) [9.2] -38.4 (-46 to -18) [8.0] 
C7 5.1 (2 to 14) [3.4] 2.4 (-2 to 18) [6.1] 
 
During this series of births there was once instance of bag failure during traction 
 
Table 2-41. Small head, OA, +2, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 17 (0 to 30) [11.3] -19 (-32 to -10) [9.0] 
RAoM -26.6 (-30 to -22) [3.4] -30.4 (-34 to -24) [3.5] 
LAoM -26.4 (-36 to -20) [5.4] -30.2 (-34 to -24) [3.2] 
C7 3.6 (0 to 8) [2.5] 5 (-2 to 14) [5.5] 
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Table 2-42. Small head, OA, +1, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 26.8 (20 to 38) [4.1] 6.1 (-20 to 40) [26.9] 
RAoM -28.2 (-36 to -24) [4.2] -27.4 (-35 to -19) [5.8] 
LAoM -24 (-30 to 0) [9.2] -28.1 (-40 to -18) [7.5] 
C7 6.2 (3 to 8) [1.8] 7.7 (-2 to 16) [6.2] 
 
Table 2-43. Small head, OA, at spines, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 35.9 (22 to 44) [7.2] 35 (4 to 42) [11.3] 
RAoM -20.5 (-26 to -15) [3.7] -14.7 (-24 to -4) [5.8] 
LAoM -21 (-15 to -24) [3.7] -15 (-30 to -5) [6.6] 
C7 10.6 (0 to 24) [7.0] 14.8 (2 to 25) [6.2] 
 
 
Table 2-44. Small head, OA, at spines, 60 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 2.4 (-10 to 35) [12.2] -13.8 (-20 to -15) [12.0] 
RAoM -37.1 (-44 to -30) [4.3] -40.3 (-45 to -36) [2.9] 
LAoM -37.4 (-42 to -34) [5.3] -39.2 (-42 to -34) [2.7] 
C7 3.2 (-2 to 10) [4.1] 0.2 (-2 to 2) [1.8] 
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Table 2-45. Small head, OA, at spines, 80 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 3 (-2 to 6) [2.5] -17.7 (-24 to -14) [3.3] 
RAoM -39.8 (-46 to -38) [2.4] -39.6 (-44 to -36) [2.5] 
LAoM -41 (-48 to -38) [3.0] -38.8 (-42 to -35) [1.9] 
C7 4.6 (0 to 14) [3.7] 2.6 (0 to 4) [1.6] 
 
Table 2-46. Small head, OP, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 9.6 (-4 to 20) [7.3] -20.7 (-35 to 0) [10.3] 
RAoM -24.2 (-54 to -10) [14.3] -27.4 (-40 to -20) [5.9] 
LAoM -27 (-54 to -14) [11.8] -29.4 (-40 to -22) [5.7] 
C7 19.2 (-20 to 30) [14.8] 2.2 (-2 to 12) [4.8] 
 
 
Table 2-47. Small head, OP, +1, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 8.8 (-2 to 30) [9.8] -12.7 (-32 to 36) [26.1] 
RAoM -25 (-42 to -12) [11.4] -31.4 (-45 to -18) [8.1] 
LAoM -25.4 (-36 to -18) [6.1] -27.9 (-38 to -9) [8.5] 
C7 12.4 (2 to 28) [9.3] 0.4 (-6 to 8) [4.0] 
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Table 2-48. Small head, OP, at spines, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 10.7 (0 to 28) [8.0] -22.4 (-36 to 36) [21.0] 
RAoM -26.4 (-34 to -18) [6.1] -34.2 (-40 to -18) [6.4] 
LAoM -28.8 (-44 to -20) [8.1] -30.8 (-36 to -14) [6.5] 




Table 2-49. Small head, ROT, +2, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 35.9 (20 to 44) [7.4] 40.2 (36 to 44) [2.0] 
RAoM -21.5 (-25 to -18) [2.5] -13.4 (-18 to -10) [2.3] 
LAoM -25 (-30 to -20) [3.8] -10.6 (-13 to -8) [1.7] 
C7 11.7 (2 to 18) [4.3] 17.5 (-10 to 25) [10.2] 
 
 
Table 2-50. Small head, ROT, +1, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 37 (20 to 40) [6.3] 29.8 (-30 to 40) [21.8] 
RAoM -29.6 (-36 to -20) [5.3] -17.5 (-46 to -10) [10.4] 
LAoM -33.7 (-40 to -22) [6.0] -17 (-36 to -10) [7.3] 
C7 6 (2 to 10) [3.1] 20.9 (2 to 26) [7.1] 
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Table 2-51. Small head, ROT, at spines, 40 kPa 
Reference 
point 
Mean distance from reference point (mm) 
(range) [standard deviation] 




Mentum 35.2 (24 to 42) [5.8] 37 (34 to 40) [1.9] 
RAoM -26 (-35 to -15) [5.2] -14.2 (-16 to -12) [1.5] 
LAoM -25.9 (-34 to -18) [5.7] -14.2 (-16 to -10) [1.7] 
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Chapter 3 Perineal distension associated with the use of forceps, 
Kiwi ventouse and BD Odon Device 
3.1 Abstract 
Objective 
To investigate the perineal distention during simulated operative vaginal births conducted 
with forceps, Kiwi and the BD Odon Device 
Design 
Observational simulation study 
Setting 
North Bristol NHS Trust, UK 
Population or Sample 
40 simulated operative vaginal births 
Methods 
A PROMPT Flex maternal/fetal mannequin was used. Perineal distension was determined by 
recording maximum perineal distention during a simulated operative vaginal birth in a 
scenario employing an inappropriately non-deflated air cuff and an appropriately deflated 
air cuff (for the BD Odon Device), the Kiwi ventouse and non-rotational forceps. 
Main Outcome Measures  
Maximal perineal distension during birth. 
Results  
The BD Odon Device was not associated with more perineal distension than forceps or Kiwi 
ventouse (21mm vs 26mm vs 21mm respectively at posterior fourchette) when deflated 
correctly.  
Conclusions 
The BD Odon Device generates similar levels of perineal distension compared to Kiwi 
ventouse when used correctly. 
  




Operative vaginal birth, while a beneficial intervention for both mother and baby in well-
trained hands (6), is associated with adverse maternal and neonatal outcomes. Specifically, 
OVB is associated with a greater degree of maternal perineal trauma than unassisted vaginal 
birth (117,118). 
Maternal perineal trauma causes both short and long-term problems for women – in the 
short term, women can sustain obstetric anal sphincter injuries (OASI), and feacal 
incontinence (FI), anal incontinence (AI), urinary incontinence (UI) and pelvic organ prolapse 
(POP) in the medium or long term.  
These outcomes have significant impacts on maternal quality of life and future reproductive 
career. Taken together, women sustaining some degree of perineal trauma are more likely 
to report bothersome symptoms of UI, AI, FI or POP from one year after birth (119) to 20 
years after birth (120,121). Moreover, women who sustained an OASI, compared to women 
who had a vaginal birth without OASI, are specifically more likely to report higher rates of FI 
and AI (122), poorer sexual function (123), as well as poorer overall quality of life (124) 
overall. 
In view of these common, severe adverse events, the development of any new device for 
OVB should consider how best to predict and reduce these outcomes. Given the short time-
span of any outcome data gathering, and the need to clearly classify any reported 
outcomes, it is reasonable that this effort focuses primarily on predicting and reducing the 
risk of OASI, both as a negative outcome in itself and as a predictor of longer term negative 
outcomes. 
The BD Odon Device consists of an inflatable circular air cuff attached to a thin 
circumferential polyethylene sleeve.  A semi-rigid plastic applicator is used to place the air 
cuff and sleeve into the birth canal, past the widest diameter of the fetal head. The air cuff 
is inflated around the fetal head, and the applicator is removed. During maternal 
contractions the accoucheur applies traction to the polyethylene sleeve, to assist birth of 
the baby.  
The air cuff provides the traction anchor point of the BD Odon Device, and is the part of the 
device most likely to contribute to severe maternal trauma – however, the expected rate of 
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this trauma/OASI is unknown, and there are no tools currently in existence that allow for a 
reasoned estimate to be made. 
 
3.2.1 Predicting OASI 
Multiple risk factors for OASI have been identified, such as advancing maternal age 
(129,130), nulliparity (122,131,132), high birthweight (>4000g) (122,129,132), ethnicity 
(women of Asian origin are more at risk of OASI than Caucasian women) (129,133,134), 
greater fetal head circumference (135,136), and persistent OP position (55,125,126).  
In addition, OVB has been clearly identified as a predictive of increased risk of sustaining an 
OASI by individual studies (122,129,132), systematic reviews (127,128) and professional 
body guidance (12,129). 
Within this, there are marked differences in the rate of OASI between forceps and ventouse, 
with the most recent Cochrane meta-analysis reporting OASI rates for all types of pooled 
forceps births of 14%, compared to 7.5% for all ventouse (11). This is supported by 
retrospective studies of national registries in the UK and Netherlands, which have 
demonstrated 2 to 3-fold higher rates of OASI among women delivered with forceps versus 
women delivered with ventouse (86,130). 
 
3.2.2 Mechanism of OASI 
While there remains debate about the relative importance of different contributory factors, 
the underlying mechanism of OASI is generally agreed to be displacement of the anal 
sphincter past its point of maximal elastic stretch during crowning of the fetal head 
(127,131,132). This suggests that any clinical circumstance which widens the presenting 
diameter of the fetal head is likely to increase the rate of OASI, and would account for the 
higher rate of OASI found with increased head circumference, OP position and forceps. 
While the absolute circumference of a fetal head +/- any instrument may be the proximate 
cause of a tear, simply measuring the circumference of any fetal head/instrument complex 
is not sufficient alone to predict the likelihood of a significant tear, as any clinical scenario 
will entail individual (and often small) variations in fetal head position and instrument 
placement - the risk of tearing will not be identical from one clinical scenario to the next. 
Therefore, any attempt to quantify the risk of tearing between instruments should take 
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these variations in placement and fetal head position into account – this may be best done 
by measuring the effect that any particular fetal head and instrument position has on the 
maternal tissues themselves, rather than simply the dimensions of the head and instrument 
together. 
It has already been established that the degree of stretch that can be accommodated by 
maternal tissues has a predictive value for a significant tear. Women whose perineums are 
either unable to stretch sufficiently or which stretch significantly more than average are 
more likely to sustain a significant tear - Lai et al. found that nulliparous women who 
stretched less had a higher chance of sustaining a significant tear (percentage of perineal 
stretch from baseline in group with 1st degree tear versus those with 2nd degree tear = 
30.9% vs 20.2%, p=0.02) (133), while Walfisch et al. found that excessive stretching (women 
whose perineum stretched more than 150% from resting were significantly more likely to 
require suturing (OR 2.11, p<0.01)) (134).  
Therefore, while it is generally agreed that a greater presenting part circumference at 
crowning results in a higher likelihood of significant perineal trauma, the potential 
displacement effect of such a presenting part on maternal tissues may be a more sensitive 
predictor of the likelihood of perineal trauma.  
 
3.2.3 Quantifying the risk of OASI in simulation 
At present there are no validated simulation tools to assess the likelihood of perineal 
trauma during birth. Given the predictive role of potential displacement of maternal tissues 
in perineal trauma, we chose to develop a tool for measuring perineal displacement at 
crowning, as a pragmatic means of estimating likelihood of trauma. We sought to determine 
the perineal distension during simulated births with the BD Odon Device, using an 
appropriately deflated cuff, non-rotational forceps and Kiwi ventouse. Misuse of the BD 
Odon Device, where the air cuff remains inflated during crowning contrary to Instructions 
For Use, was also simulated using a modified procedure, to evaluate the degree of perineal 
distention provided by the inflated air cuff if the practitioner inadvertently failed to deflate 
the air cuff prior to crowning of the fetal head. 
 




3.3.1 Simulation of operative vaginal births 
The PROMPT birthing simulator fetal mannequin was used. This mannequin has, an average 
size head for a term fetus with a bi-parietal diameter (BPD) of 96mm, comparable to the 
50th centile of 97mm at 39 to 40 weeks gestation (12) (Figure 3-1).  
Figure 3-1. Model fetal head with BPD of 96mm 
 
  
All simulated OVBs were conducted by a single operator (SO’B).  
Forty simulated OVBs were performed to investigate the placement of the BD Odon Device.  
The 50th centile head diameter fetal mannequin was used to measure the perineal 
distension during birth in four separate clinical scenarios (10 births per scenario):  
(i) BD Odon Device, OA position, vertex 2cm below the ischial spines (station +2cm), 
air cuff inflation pressure of 40kPa, cuff appropriately deflated at crowning of the 
fetal head 
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(ii) BD Odon Device, OA position, vertex 2cm below the ischial spines (station +2cm), 
air cuff inflation pressure of 40kPa, cuff inappropriately not deflated at crowning 
of the fetal head 
(iii) Kiwi ventouse, OA position, station +2cm 
(iv) Non-rotational forceps, OA position, station +2cm  
 
Perineal distension with the vertex at 2 cm below the ischial spines (the baseline) was 
measured for each simulation prior to the application of an instrument (BD Odon Device, 
Kiwi or non-rotational forceps).  Measurements were taken from three fixed points on the 
maternal mannequin; (i) posterior fourchette (PF), (ii) left mid-vestibular edge (LMVE) and 
(iii) right mid-vestibular edge (RMVE) (Figure 3-2). 
Figure 3-2. Perineal displacement measurement points 
 
 Measurements were repeated at the point of maximum perineal distension (either laterally 
for LMVE and RMVE or directly inferiorly for PF) during the simulated birth (Figure 3-3).   
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Figure 3-3. Maximal perineal distention 
 
The difference between the baseline and maximum distension measurements of each 
reference point (LMVE, RMVE, PF) in mm were calculated to determine the maximum 
perineal distension in each of the four scenarios described above. The scenario where the 
BD Odon Device cuff was left intentionally inflated during crowning (contrary to instructions 
for use) was included to simulate a worst-case scenario where the operator neglects to 
deflate the cuff. 
Data from the posterior fourchette were analysed as a single outcome, while data from 
LMVE and RMVEs were pooled to give a composite measure of lateral perineal distension.  
Results are presented using descriptive statistics for distention data in each scenario. As 
data was not used for inferential comparisons it has not been transformed into a normal 
distribution. Therefore, the mean and range is given for all data.  
 
3.4 Results 
Data are presented as means with ranges, as they were normally distributed (assessed using 
simultaneously Kurtosis statistics and the coefficient of skewness of the variable distribution 
as well as the qq plot and pp plot of this distribution). 
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3.4.1 Perineal distension 
During birth, when used correctly, there was no difference between the means of posterior 
fourchette distension using the BD Odon Device and Kiwi ventouse. When the BD Odon 
Device was used with the air cuff purposefully left inflated at crowning (simulating a user 
error) to investigate perineal distension in a worst-case scenario, greater perineal distension 
was observed at the posterior fourchette than with obstetric forceps or Kiwi ventouse 
(Table 3-1). 
 
Table 3-1. Perineal distension associated with the use of BD Odon Device, non-rotational forceps and Kiwi in OA, 2cm below 
the ischial spines 
Instrument BD Odon Device 
(cuff correctly 
deflated prior to 
crowning)  
n = 10 
BD Odon Device 
(cuff incorrectly 









Mean maximal perineal 
distension at the posterior 
fourchette during birth 
(mm) (range) 
21 
(13 to 33) 
36 
(28 to 42) 
21 
(18 to 24) 
26 
(18 to 28) 
Mean maximal lateral 
perineal distension during 
birth (mm) (range) 
18 
(11 to 28) 
27 
(14 to 34) 
19 
(7 to 25) 
25 




3.5.1 Main Findings 
When correctly used, the BD Odon Device did not generate greater perineal distention than 
Kiwi ventouse or forceps. However, in ‘worst case’ simulations in which the air cuff was not 
deflated, the BD Odon Device generated greater distention at the posterior fourchette than 
either forceps or Kiwi. These findings suggest that incorrect use of the BD Odon Device, by 
not deflating the air cuff prior to crowning, may generate similar or higher rates of perineal 
tears than forceps, whereas correct use of the BD Odon Device produced similar perineal 
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distention to the Kiwi. This finding highlights the importance of training accoucheurs to use 
the BD Odon Device correctly. 
 
3.5.2 Strengths and Limitations 
This is the first study to prospectively investigate the performance of a novel device for 
operative vaginal birth using simulation. 
All simulations were performed by a single operator, which assisted internal consistency of 
measurement and eliminated inter-operator variability. However, we recognise the inherent 
limitations of this strategy, in particular the possibility of repeated systematic error. 
No assessment was made of the behaviour of any instrument with the model fetal head in 
an OP position. While perineal distention is likely to be greater that that generated in an OA 
position, our lack of quantification is a limitation of the study. 
A further potential criticism of this study is the uncertainty whether the findings are 
generalisable to actual use of any device in clinical practice. We also acknowledge that there 
are no anatomical measurements with sufficient predictive validity to accurately assess the 
risk of perineal tears. However, our comparison of perineal distension during Kiwi ventouse, 
forceps and the BD Odon Device is a pragmatic proxy for prediction of perineal tears. We 
also believe that while the chosen methodology may not be externally valid and able to 
predict the absolute rates of tears experienced in vivo, the findings should be internally 
consistent – i.e. the rate of OASI is likely to be similar between deflated BD Odon Device and 
Kiwi ventouse, and less than forceps. 
 
3.5.3 Interpretation (in light of other evidence) 
A wider presenting part is more likely to cause maternal trauma during birth (62,129,133-
137). Simulated perineal displacement may be a usable direct measurement that will predict 
the expected rate of perineal trauma during birth. 
 
3.6 Conclusions 
In 40 simulations, using a robust and validated anatomical model, the perineal distension 
associated with the use of the BD Odon Device was similar to the Kiwi ventouse when the 
air cuff was deflated appropriately just prior to birth of the fetal head, and greater than 
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forceps when the cuff was not deflated. These findings should be correlated with outcomes 
form a clinical trial, which will either validate or reject our methodological model. 
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Chapter 4 Traction over a model fetal head and neck associated 
with the use of forceps, Kiwi ventouse and the BD Odon Device 
4.1 Abstract 
Objective 
To determine the pressure and traction forces exerted on a model fetal head by the BD 




Simulated operative vaginal birth. 
Population or Sample 
20 simulated operative vaginal births. 
Methods 
A bespoke fetal mannequin with a strain gauge across the neck was used to investigate 
traction across the neck during 20 simulated births using the BD Odon Device, non-
rotational forceps and Kiwi ventouse. 
Main Outcome Measures  
Peak traction force generated until instrument failure using the BD Odon Device, forceps 
and Kiwi ventouse. 
Results  
In cases of true cephalic disproportion the BD Odon Device ‘popped-off’ at a lower traction 
force than forceps (208N vs 270N). 
Conclusions 
 In cases in which delivery of the fetal head is not possible due to cephalo-pelvic 
disproportion, lower traction forces could be applied using the BD Odon Device than with 
forceps before the procedure was abandoned due to device failure.  
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4.2 Introduction  
Some complications of OVB are related to the traction force required to complete the birth.   
Specifically, trauma is more likely to occur if greater levels of traction are transmitted to the 
baby during application and traction. This has been shown in the case of both forceps and 
ventouse. 
In the case of forceps, there is a well-demonstrated relationship between the number of 
pulls and adverse neonatal outcomes – as direct levels of traction have never been 
measured (such as with the use of a Newton meter or other device), the number of pulls 
serves as a pragmatic proxy for the overall amount of traction force transmitted to the baby 
by the accoucheur via the instrument. Murphy et al. reported significantly increased rates of 
adverse neonatal outcomes following more than three pulls (6), while Matsumo et al. 
demonstrated a statistically significant increased risk of neonatal facial injury after three 
pulls relative to one pull (OR 16, CIs 2.1 to 123.3, p < 0.01) (72). This recognition of the 
causal link between number of pulls and neonatal adverse outcomes has been widely 
recognised within the profession – limiting the number of pulls to three has been adopted 
by the RCOG and is clearly stated in both the RCOG OVB Green-top guideline and the RCOG 
official OVB training guide (ROBuST Manual) (13,40). Guidelines form other national 
professional bodies (American College of Obstetricians & Gynecologists, Canadian Society of 
Obstetricians and Gynecologists, Royal Australian and New Zealand College of Obstetricians 
and Gynaecologists and Collège National des Gynécologues et Obstétriciens Français) have 
also recommended a limited number of pulls, but have not specified an exact number (135-
138). 
 
In the case of ventouse, although the absolute level of traction that can be transmitted is 
lower than with those of forceps, the association between traction and adverse outcomes 
has again been demonstrated. Vacca et al. showed that deliveries completed with a traction 
force that never exceeded 115 N versus those that did, were less likely to be associated with 
both neonatal scalp abrasion (RR 0.38, CI 0.12 to 1.24) and cephalohaematoma (RR 0.34, CI 
0.08 to 1.41), although neither of these were deemed to be statistically significant (71).   
In addition to studies looking directly at the amount of traction applied (including via the 
proxy of the number of pulls) and adverse maternal and neonatal outcomes, there is further 
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supporting evidence from studies which have stratified attempted OVBs by indication. In 
their retrospective cohort study of all attempted mid-pelvic OVBs within British Columbia 
between 2004 and 2014, Muraca et al. found that OVBs performed for the indication of 
‘dystocia’ were more likely to be associated with severe maternal and neonatal morbidity 
than those performed for ‘fetal distress’ alone (dystocia vs fetal distress respectively - 
severe maternal morbidity: forceps RR 1.57 vs 2.34, ventouse RR 2.29 vs RR 0.79, severe 
neonatal morbidity: forceps RR 2.11 vs 1.15, ventouse RR 2.17 vs 1.28) (57). While it is not 
documented that practitioners used more force or a greater number of pulls to expedite the 
births conducted for dystocia, it is likely that greater traction was used in these births 
overall. 
 
While this evidence for the association between the rate of adverse outcomes and traction 
force applied is intuitive, it does not take into account the risk of failure, itself a major 
source of morbidity for both mothers and their babies. Failure to achieve birth is likely to 
have some association with the ability to correctly apply traction to the baby, and an 
inability to apply a sufficient amount of traction is likely to be responsible for at least some 
failures to achieve a vaginal delivery. This is supported by the general superiority of forceps 
over ventouse at achieving vaginal delivery (11) (as forceps are able to apply more traction 
than ventouse), as well as a small study showing that ventouse cups that are able to apply 
more traction to the fetal head have lower failure rates. Hofmeyer et al., in a small, 
unblinded RCT of 31 women showed that the rate of failure during the use of rigid 
mushroom cups (Bird’s and O’Neil), which were able to generate significantly higher levels 
of maximum traction force than soft cups (Silc and Silastic) (158 N vs 110 N), was 
significantly lower than that found during the use of soft cups (OR 12.9, CIs 12.2 to 138).  
While it is desirable to prevent accoucheurs from applying an excessive amount of traction 
which could result in harm, this should not come at the expense of being able to apply the 
amount of traction required to achieve birth if used correctly – this could be established by 
measuring the pop-off point. The pop-off point is the point at which the addition of 
additional traction force results in the instrument either coming off the fetal head (as in 
ventouse) or being deformed so that it is unable to apply further traction (forceps). As the 
pop-off point represents the juncture at which no further traction force can be applied, it 
should act as a useful marker for the potential adverse outcomes that would be associated 
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with that particular point – if the pop-off point is low, the instrument is unlikely to cause 
harm due to excessive traction, but may fail more than is acceptable, whereas if it is too 
high, the instrument may rarely fail but could be associated with unacceptably high levels of 
trauma in unskilled hands.  
The BD Odon Device consists of an inflatable circular air cuff attached to a thin 
circumferential polyethylene sleeve.  A plastic applicator places the air cuff and sleeve into 
the birth canal, past the widest diameter of the fetal head. The air cuff is inflated, and the 
applicator removed. During maternal contractions the accoucheur applies traction to the 
sleeve, to expedite the birth.  
The use of an air cuff positioned circumferentially around the fetal head acts as the ‘anchor 
point’ for traction, compared to the zygomatic arches in the case of forceps or the cup 
position in the case of ventouse.  
We sought to determine the pop-off point for currently used instruments as well as the BD 
Odon Device in order to determine the likely potential for both failure and harm in clinical 
practice due to under or over-application of traction.  
We developed a simulation model to study the force applied across the fetal head and neck 
during attempted OVB in a situation of true cephalo-pelvic disproportion where the head is 
not deliverable vaginally. The model head was used to compare forces on the fetal head in 
births using (i) non-rotational forceps, (ii) Kiwi ventouse and (iii) the BD Odon Device.  
 
4.3 Simulation of operative vaginal births 
A PROMPT Flex Force Monitoring fetal mannequin was used with a standard PROMPT Flex® 
maternal mannequin and associated software to enable the simulation of operative vaginal 
births.  
A series of simulated OVBs using the BD Odon Device, Kiwi ventouse and non-rotational 
forceps were performed by a single operator (SO’B).  The air cuff of the BD Odon Device was 
inflated to 60kPa and 80kPa. This is the expected pressure range that will be used in-vivo.  
Twenty scenarios were performed to evaluate the force at which a device would detach or 
‘pop-off' the fetal head when the head was not deliverable. A bespoke ‘pelvic shelf’ was 
produced to prevent decent and birth of the fetus in order to simulate cephalo-pelvic 
disproportion. The pelvic shelf consisted of two steel bars inserted through non-deformable 
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attachments at the fetal shoulders, which were then laid across the upper brim of the model 
pelvis. This prevented any downward movement of the model fetus. The traction force (N) 
exerted during attempted non-rotational forceps (n=5), kiwi ventouse (n=5) and BD Odon 
Device with cuff inflated to 60kPa (n = 5) and BD Odon Device with cuff inflated to 80kPa 
birth (n=5) on a cephalic presentation, direct OA position with the vertex at the ischial 
spines was measured using the integrated force monitoring device within the PROMPT Flex 
fetal mannequin.   
Traction force data was captured by the PROMPT Flex® birthing simulator software (Limbs 
&Things, Bristol, UK) at 20Hz and subsequently exported for analysis. Failure was considered 
to have occurred when the device pop-off the fetal head. Forceps failure was diagnosed 
when, due to the force of traction, the forceps blades came apart such that they also slipped 
off the fetal head.  
Results are presented using descriptive statistical data due to the limited number of 
repetitions within each scenario. Data are reported as mean values for each dataset with 
full ranges of all values.  
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4.4 Results  
Twenty simulated operative vaginal births were performed (Table 4-1).  
Table 4-1. Summary of simulations performed 







OA 60 5 
OA 80 5 








Data are presented as means with ranges, as they were normally distributed (assessed using 
simultaneously Kurtosis statistics and the coefficient of skewness of the variable distribution 
as well as the qq plot and pp plot of this distribution). 
 
4.4.1 Evaluation of the force at which a device detaches from the model fetal 
head when the head is not deliverable  
The maximum traction force applied before the device disengaged from the fetal head 
during an obstructed OVB (in which it was not possible for the fetal head to be delivered) 
was greater in non-rotational forceps (270N) compared to attempts using the BD Odon 
Device at 80kPa inflation pressure (208N), 60kPa inflation pressure (167N) and Kiwi 
ventouse (70N) (Table 4-2). At disengagement, the BD Odon Device and Kiwi ventouse 
‘popped-off’ the fetal head. At disengagement point, the traction on the forceps was 
sufficient to force the blades apart around the fetal head resulting in disengagement of the 
forceps. Therefore the force transmitted by forceps was limited by the material resistance 
of the fetal head, and not traction force applied by the operator. 
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Table 4-2. Traction force generated across fetal neck at pop-off of instrument 
Mean pop-off force (N) 
[range] 
BD Odon Device, 
80kPa inflation 
pressure 
n = 5 
BD Odon Device, 
60kPa inflation 
pressure 
n = 5 
Non-rotational 
forceps 
n = 5 
Kiwi ventouse 
n = 5 
208 
[192 to 283] 
167 
[159 to 183] 
270 
[251 to 309] 
 
70 




4.5.1 Main Findings 
When used inappropriately in an obstructed birth and used forcefully until device failure, 
the BD Odon Device generates substantially less traction than forceps but more than Kiwi 
ventouse. However, as our simulator was unable to generate a chignon, the true pop-
off/failure force for a Kiwi ventouse is likely to be higher in clinical practice – previous 
studies have demonstrated pop-off forces of between 110N to 130N (71). This is still 
however lower than the traction forceps reported here for the BD Odon Device.  
 
4.5.2 Interpretation  
Greater traction forces used in OVBs correlate with higher rates of neonatal injury and 
maternal anal sphincter damage (71).   The BD Odon Device generates less traction force 
before device failure than forceps. The incidence of adverse outcomes related to 
inappropriate traction force applied using an BD Odon Device is therefore likely to be less 
than those associated with forceps. Previous research has demonstrated that traction forces 
of 110 to 130N are routine using Kiwi (71), suggesting that rates of adverse outcomes due to 
high traction may be comparable between the BD Odon Device and the Kiwi ventouse. The 
BD Odon Device does not generate negative pressure on the fetal head, reducing the 
likelihood of adverse outcomes such as subgaleal or retinal haemorrhage and 
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cephalohaematoma being associated with the use of a BD Odon Device when compared to 
vacuum assisted births. 
If the assumption that there is a correlation between the amount of traction that can be 
applied and the chance of failure is correct, then we would expect the BD Odon Device to be 
associated with a higher level of failure than forceps, but lower than Kiwi ventouse.  
 
4.5.3 Strengths and Limitations 
We have not been able to quantify negative pressures, or replicate the chignon associated 
with ventouse births.  However, due to its mechanism of action we are confident that the 
BD Odon Device does not generate any negative pressure on the fetal head and therefore 
will not cause a chignon.  It is therefore unlikely that the most serious outcomes generated 
by negative pressure (such as subgaleal haemorrhage), or those associated with movement 
of the cup over an established chignon (scalp abrasion/avulsion) will occur following births 
conducted using the BD Odon Device. 
4.6 Conclusion  
The BD Odon Device generates lower peak pressure than non-rotational forceps during 
simulated birth and does not exert a negative pressure required to perform a vacuum 
assisted birth.  It is therefore likely that the BD Odon Device will be associated with lower 
adverse outcomes related to both peak pressure (bruising, facial nerve palsy, skull fracture) 
and negative pressure (subgaleal or retinal haemorrhage and cephalohaematoma, scalp 
abrasion/avulsion) compared to currently available instruments (forceps and ventouse). 
This study has generated sufficient data to suggest that, in this regard, the BD Odon Device 
is likely to be as safe, if not safer, than forceps and ventouse in clinical practice. A clinical 
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Chapter 5 Simulation of pressure on a model fetal head and neck 





To determine the pressure exerted on a model fetal head by the BD Odon Device, forceps 




Simulated operative vaginal birth. 
Population or Sample 
64 simulated operative vaginal births. 
Methods 
A bespoke fetal mannequin with pressure sensors around the head and neck was used to 
investigate pressure applied over the head during 64 simulated births using the BD Odon 
Device, non-rotational forceps and the Kiwi ventouse. 
Main Outcome Measures  
Peak pressure on the fetal face and lateral aspects of the head during correct use of the BD 
Odon Device and forceps.  Peak pressure on orbits and neck during misplacement of the BD 
Odon Device and forceps.   
Results  
When correctly sited and using 80kPa inflation pressure on the cuff, the BD Odon Device 
generated a lower peak pressure on the fetal head than forceps (83kPa vs 146kPa). 
When instruments were purposefully misplaced over the orbits the BD Odon Device 
generated a lower peak pressure on the orbits than forceps (70kPa vs 123kPa).  When 
purposefully misplaced over the neck the BD Odon Device, compared to forceps, generated 
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a greater peak pressure on the anterio-lateral aspect of the neck (56kPa vs 17kPa) and a 
lower peak pressure on the posterior aspect of the neck (76kPa vs 93kPa) than forceps.  
 
Conclusions 
In simulated assisted vaginal birth with correctly placed instruments the peak pressure 
exerted on the fetal head by a BD Odon Device is lower than pressure exerted by non-
rotational forceps.  
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5.2 Introduction  
Neonatal complications of OVB can be related to pressure exerted by the instrument on the 
fetal head required to complete the birth. While the pressure exerted on a fetal head is 
often related to the amount of traction applied by the accoucheur,  
Specific adverse events that are established as being likely to be directly correlated to the 
amount of pressure exerted are those that relate to compression of sensitive fetal 
structures including the skin, facial nerve, cranial bones and eye. In addition, although no 
studies have attempted to specify the exact mechanism of injury, it is reasonable to assume 
that the amount of pressure experienced by the fetal skull is likely to contribute to extra and 
intracranial bleeds. 
The incidence, severity and contributing factors of these events are briefly discussed below. 
 
5.2.1 Soft tissue and bony injuries 
5.2.1.1 Scalp/facial skin injuries 
Bruises, lacerations, cuts and breaks to the skin can occur after both forceps and ventouse 
births – the most recent Cochrane review found a rate of 17% in all forceps births, and 11% 
in all pooled ventouse births – within this there was substantial variation based on the 
characteristics of the cups used – for example, the rate was higher for metal cup ventouse 
(Bird’s, Malstrom) than soft cups (Silastic) (41% vs 29%) (11). 
 
5.2.1.2 Facial nerve palsy 
Facial nerve palsy is caused by compression of the facial nerve as it passes over the 
relatively incompressible temporal or zygomatic bones of the skull. Facial nerve palsy can 
occour after forceps birth (rates of 2.9 to 5/1000 forceps births have been reported) (76), 
although most case series report the substantial majority of facial nerve palsies occurring 
following spontaneous delivery (139). Moreover, almost all cases resolve within 24 days, 
with no lasting effects (140). 
 
5.2.1.3 Ocular injury 
Damage to the eye from OVB is usually described as compression of the eye by a mis-placed 
forceps blade, causing a rupture in Descemet’s membrane on the posterior aspect of the 
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cornea. Although relatively uncommon (one series of 11 cases over 17 years at one tertiary 
center described a rate of 2.4/1000 forceps birth) (77), the majority of cases are minor and 
self-limiting with no impact on long-term vision. However, more serious damage can occur – 
a significant rupture of the Descemet’s membrane can cause immediate loss of sight (141), 
as well as long-term astigmatism and corneal scarring, and may require corneal 
transplantation (70,142,143). 
 
5.2.1.4 Cranial fracture 
Rates of cranial fracture are difficult to determine as most fractures are linear fractures and 
are minor and not diagnosed unless purposefully screened for (144). Moreover, treatment 
of linear fractures is often not required (144,145), with surgical intervention only being 
required if neurological deficit is present (81). 
However, robust data does exist on the frequency of death secondary to significant skull 
fracture in the UK – in their 2005 review of all UK births from 1994 to 1995, O’Mahoney et 
al. found an absolute rate of 0.031/1000 births (78). All cases of significant skull fracture 
leading to death were associated with difficult operative births, using both ventouse and 
forceps. 
 
5.2.2 Cranial vascular injuries 
Cranial vascular injuries in the peripartum period can take the form of cephalohaematoma, 
subgaleal, subdural, subarachnoid, intraparenchymal and intraventricular heamorrhage. Of 
these, cephalohaematoma and subgaleal haemorrhage are thought to be related to 
pressure on the fetal skull, while subdural, subarachnoid, intraparenchymal and 
intraventricular haemorrhage are generally not. 
 
5.2.2.1 Cephalohaematoma 
Cephalohaematoma is a collection of blood underneath the periosteum of the cranial 
bones, caused by rupture of the bridging blood vessels, due to the application of direct 
traction and sheering forces to the scalp. The collected blood is restricted by the suture lines 
of the cranial bones, and so potential volume is limited. This self-tamponadeing mechanism 
means that clinically significant hypovolaemia or hypotension are rare (80), and almost 
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always resolves with three weeks (81). Cephalohaematoma occurs in one to two percent of 
spontaneous vaginal births, four percent of forceps births and six to ten percent of ventouse 
births (81). 
 
5.2.2.2 Subgaleal haemorrhage 
Subgaleal haemorrhage (SGH) is caused by rupture of the emissary veins between the 
cranial periosteum and the scalp aponeuroses. This occurs when direct (either positive or 
negative) pressure on the scalp pulls the scalp aponeurosis from the cranial periosteum. As 
there are no anatomical constrictions on the potential subgaleal space, significant volumes 
of blood (up to 260ml) can extravasate into this space, resulting in hypovolaemia, 
hypotension, encephalopathy and coagulopathy (84,146) – of note, while some previous 
studies suggested that coagulopathy may be a causative factor in SGH (85), more recent 
case reviews have supported the notion that the coagulopathy found in some cases of SGH 
is a response to the pre-existing bleed, rather than its proximate cause (82,84) . Although 
population-level incidence estimates are lacking, rates of 0.44/1000 following spontaneous 
births, 1/1000 following forceps births and 5.9/1000 following ventouse births are widely 
agreed (82,83). While absolute mortality is hard to determine, some case reviews have 
reported death rates of 25% of those babies that are admitted to NICU due to SGH alone 
(85). National bodies continue to regard SGH as a major risk to neonates - it was in response 
to a significant 5-fold rise in deaths in the previous 15 years from SGH that the FDA issued 
its Public Health Advisory notice calling for caution when using ventouse devices in 1998 
(34). 
While there is speculation that softer cups (capable of applying less traction and less 
pressure) may result in lower levels of SGH, no studies have assessed this question directly, 
and the latest Cochrane review was unable to comment given the absence of any applicable 
data (11). 
 
5.2.2.3 Intracranial bleeds 
Intracranial bleeds (subarachnoid, subdural, intraparenchymal and intraventricular 
haemorrhage) are not thought to be due to physical pressure on the fetal head (in the 
absence of significant skull fracture) (80). Although this is intuitive given the presence of the 
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fetal skull bones between any instrument that may compress the structures in question, it is 
also supported by population-level data from Werner et al., who examined all births within 
New York City over eight years from 1995 to 2003, and found no significant differences in 
rates of intraventricular haemorrhage between forceps, ventouse and Caesarean births 
(147). Furthermore, in their examination of all births in California between 1992 and 1994, 
Towner et al. found no difference in the rate of subdural haemorrhage between forceps, 
ventouse and Caesarean sections performed in labour (148).  
 
Taken together, many of these complications (soft tissue, bony and vascular) are likely to be 
due to excess pressure exerted either directly or tangentially (as a sheering force) on the 
fetal head. It is axiomatic that any attempt to reduce the amount of pressure will reduce the 
likelihood of these complications. While this could be achieved through the application of 
less traction force using existing instruments, this poses the risk of reducing the 
effectiveness of the instruments for delivery and increasing the failure rate. A contrary 
strategy would be to increase the contact surface area of an instrument while keeping the 
traction force the same, thus reducing the contact pressure but not the likelihood of 
successful birth. Although this approach is intuitive, any new such instrument should be 
studied in simulation to determine the actual pressure experienced by the fetal head, and 
compared to that exerted by existing instruments.   
 
The BD Odon Device is a new device being developed for OVB. The BD Odon Device consists 
of an inflatable circular air cuff attached to a thin circumferential polyethylene sleeve.  A 
plastic applicator places the air cuff and sleeve into the birth canal, past the widest diameter 
of the fetal head. The air cuff is inflated, and the applicator removed. During maternal 
contractions the accoucheur applies traction to the sleeve, to expedite the birth.  
The use of an air cuff positioned circumferentially around the fetal head as the ‘anchor 
point’ for traction has the potential to reduce fetal injury when compared to forceps.  
Pressure applied to the fetal head during birth may be more evenly distributed than 
pressure by forceps and therefore a lower risk of injury might be expected.  Similarly, the 
wider distribution of pressure, and lack of negative pressure, may also reduce the risk of 
adverse outcomes such as subgaleal haemorrhage and cephalohaematoma associated with 
the use of ventouse. However, the possibility of the air cuff slipping down around the fetal 
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neck and occluding the carotid arteries needs to be evaluated, and a determination of the 
pressure over the anterio-lateral aspect of the neck should be made in order to evaluate the 
risk of the BD Odon Device causing a clinically significant compression of the carotids.  
 
We developed a simulation model to study the pressure and force applied across the fetal 
head and neck during OVB. The model head was used to compare pressures on the fetal 
head in births using (i) non-rotational forceps, (ii) Kiwi ventouse and (iii) the BD Odon 
Device.   
5.3 Methods 
5.3.1 Development of a fetal mannequin to measure dynamic pressure changes 
during simulated operative vaginal birth 
A bespoke fetal mannequin was designed and manufactured by a multi-professional team of 
obstetricians, midwives, engineers and model makers.  A PROMPT Flex® fetal mannequin 
was adapted.  Pressure sensors (Tekscan®, Boston, Massachusetts, USA) were mounted 
against a bespoke modelled fetal skull and neck.  Three pressure sensors (Tekscan Pressure 
Mapping Sensor 5101: sensor pad dimensions = 111.8mm x 1118mm, thickness 0.102mm; 
1,936 sensels; sensel density = 15.5 sensels/cm2) covered the majority of the fetal skull 
including the entirety of the face and the lateral aspects of the head. These locations are 
shown in Figure 5-1. 
Figure 5-1. Cloation of pressure sensors over model fetal head 
 
 An additional pressure sensor (Tekscan Pressure Mapping Sensor 6300: sensor pad 
dimensions = 33.5mm x 264.2mm, thickness 0.102mm; 2,288 sensels; sensel density = 25.8 
Chapter 5 - Simulation of pressure on a model fetal head and neck associated with the use 
of forceps, Kiwi ventouse and the BD Odon Device 
 92 
sensels/cm2) was placed around the fetal neck.  The fetal neck was modified with the 
addition of a silicone ‘collar’ to an anterio-posterior diameter of 58mm, equivalent to the 
50th centile of fetal neck diameters at 40 weeks gestation (149).  Moulded silicone 
representing features of the fetal face (nose, mouth, orbits and ears) and scalp skin (5mm 
thick) was positioned over the pressure sensors to simulate a fetal head.  The fetal 
mannequin had a bi-parietal diameter (BPD) of 96mm, to simulate an average-sized term 
baby (BPD on 50th centile of 97mm) (150).  A calibration device (Tekscan PB15C) was used to 
equilibrate, calibrate and zero all pressure sensors prior to each use. An example of the 
model fetal head with pressure sensors under the silicone skin (but not the neck) is shown 
in Figure 5-2. 




5.3.2 Simulation of operative vaginal births 
The bespoke pressure monitoring fetal mannequin was used with a standard PROMPT Flex® 
maternal mannequin to enable the simulation of operative vaginal births.  
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A series of simulated OVBs using the BD Odon Device, Kiwi ventouse and non-rotational 
forceps were performed by a single operator (SO’B).  The air cuff of the BD Odon Device was 
inflated to 60kPa and 80kPa. This is the expected pressure range that will be used in-vivo.  
The peak pressure over the face (right orbit, left orbit, nose and chin) and lateral aspects of 
head were measured in 40 simulated births (cephalic presentation, direct occipito-anterior, 
vertex 2cm below the ischial spines) in which either a BD Odon Device (cuff inflation 
pressure 60kPa n = 10 or 80kPa n =10), non-rotational forceps (n=10) or Kiwi ventouse 
(vacuum pressure 70N) (n=10) were correctly applied and used to complete the birth of the 
fetal model in the standard manner.   
Peak pressure exerted on sensitive fetal structures (orbits and neck) were measured 
throughout birth in an OA position at station 2cm below the ischial spines in 24 non-
standard scenarios: (i) with the BD Odon Device cuff placed purposefully over the orbit and 
inflated to 60kPa (n = 3) (ii) with the BD Odon Device cuff placed purposefully over the orbit 
and inflated to 80kPa (n = 3) (iii) with non-rotational forceps placed purposefully over the 
orbit (n = 3) (iv) with the BD Odon Device cuff placed purposefully around the neck and 
inflated to 60kPa (n = 5) (v) with the BD Odon Device cuff placed purposefully around the 
neck and inflated to 80kPa (n = 5) and with non-rotational forceps placed correctly on the 
fetal head (n = 5). Pressure data was initially captured and analysed using the proprietary 
iScan® program (Tekscan, Boston, Massachusetts, USA). Results are presented using 
descriptive statistics only. As sample sizes were small for each group (maximum n = 10), no 
inferential statistics were used. Results are presented with a mean value and the complete 
range of data.  
 
5.4 Results  
Sixty-four simulated operative vaginal births were performed (Table 5-1).  
Table 5-1. Summary of simulations performed 











OA 60 Correct Face 10 
OA 80 Correct Face 10 
OA 60 Orbit Face 3 
OA 80 Orbit Face 3 
OA 60 Neck Neck 5 
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OA 80 Neck Neck 5 
Forceps OA  Correct Face 10 
OA Orbit Face 3 
OA Correct Neck 5 
Kiwi 
ventouse 
OA Correct Face 10 
    Total births 64 
 
Data are presented as means with ranges, as they were normally distributed (assessed using 
simultaneously Kurtosis statistics and the coefficient of skewness of the variable distribution 
as well as the qq plot and pp plot of this distribution). 
 
5.4.1 Pressure over fetal face, lateral aspects of head, orbits, nose and mentum 
Mean peak pressures over fetal face and lateral aspects of the head are shown in Table 5-2. 
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Table 5-2. Mean peak pressure generated during correct placement of instruments 











n = 10 
Non-rotational 
forceps 
n = 10 
Kiwi ventouse 




[62 to 111] 
109 
[82 to 148] 
146 
[108 to 154] 
79 
[66 to 90] 
Face 106 
[85 to 140] 
99 
[80 to 113] 
108 
[90 to 123] 
96 
[83 to 105] 
Orbits 67 
[27 to 109] 
47 
[8 to 94] 
24 
[9 to 45] 
19.2 
[9 to 30] 
Nose 43 
[2 to 115] 
81 
[49 to 129] 
78 
[56 to 109] 
88 
[69 to 105] 
Mentum 30 
[3 to 74] 
60 
[36 to 92] 
38 
[18 to 50] 
44 
[20 to 104] 
 
The mean peak pressure over the lateral aspects of the fetal head was greater using non-
rotational forceps (146kPa) compared to the BD Odon Device (109kPa at 60kPa air cuff 
pressure and 83kPa at 80kPa air cuff pressure) and Kiwi ventouse (79kPa). The difference in 
magnitude of these applied pressures over the lateral aspects of the head is illustrated in 
Figure 5-3. 
Figure 5-3. Illustrative example of pressure differences generated over model fetal face between Odon Device and forceps 
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Mean peak pressures over the fetal face was comparable between the simulated births 
performed with non-rotational forceps (108kPa), Kiwi ventouse (96kPa) and BD Odon Device 
with cuff inflation pressure of 60kPa (99kPa) and 80kPa (106kPa). 
Mean peak pressures over the orbits were greater using the BD Odon Device at both 60kPa 
and 80kPa cuff inflation pressures (47kPa and 67kPa respectively) than non-rotational 
forceps and Kiwi ventouse (24kPa and 19kPa respectively). 
Mean peak pressures over the nose were lower using the BD Odon Device at 80kPa 
compared to all other scenarios, where the mean peak pressures were broadly comparable 
(Table 2).  
Mean peak pressures over the mentum were comparable using the BD Odon Device at 
80kPa inflation pressure (30kPa), non-rotational forceps (38kPa) and Kiwi ventouse (44kPa) 
and higher in scenarios using the BD Odon Device at 60kPa inflation pressure (60kPa). 
 
5.4.2 Pressures exerted when devices are incorrectly sited   
Three simulated births were performed with the BD Odon Device air cuff purposefully 
incorrectly sited over the left orbit and inflated to 60kPa, and a further three simulated 
births with the air cuff inflated to 80kPa. Peak pressures over the left fetal orbit were 
compared to three simulated births in which the non-rotational forceps were also 
incorrectly sited to lie over the left fetal orbit. It was only possible to perform three births 
for each scenario due to sensor degradation during these tests, so robust statistical 
comparison is not possible. However, the measurements suggest that incorrectly placed 
forceps generate substantially greater mean peak pressure over the fetal orbit (123kPa) 
than an incorrectly positioned BD Odon Device inflated to 60kPa or 80kPa (60kPa and 70kPa 
respectively) (Table 5-3).  
 
Table 5-3. Mean peak pressure generated during incorrect placement over orbit 
 Mean peak pressure generated (kPa) 
[range] 
BD Odon Device, 80kPa 
inflation pressure 
n = 3 
BD Odon Device, 60kPa 
inflation pressure 
n = 3 
Non-rotational 
forceps 




[47 to 79] 
70 
[68 to 72] 
123 
[121 to 123] 
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The air cuff of the BD Odon Device was purposefully placed around the fetal neck (50mm 
below the fetal chin) and inflated to 60kPa and 80kPa. Five OVBs were performed with the 
fetus in a direct OA position at each inflation pressure.  A comparison of applied peak 
pressure was made with five non-rotational forceps births (Table 5-4).  Forceps tended to 
exert a higher median peak pressure on the posterior aspect of the fetal neck (94kPa) when 
compared to BD Odon Device with the cuff inflated to 60kPa (87kPa) and 80kPa (76kPa). 
However, the median peak pressure applied to the anterio-lateral aspects of the fetal neck 
(the likely location of the fetal carotid arteries) by an BD Odon Device at 60kPa (59kPa) and 
80kPa (56kPa) inflation was greater than that generated with non-rotational forceps 
(17kPa). 
 
Table 5-4. Mean peak pressure generated during incorrect placement of instruments over neck 
 Mean peak pressure generated (kPa) 
[range] 
BD Odon Device, 
80kPa inflation 
pressure 
n = 5 
BD Odon Device, 
60kPa inflation 
pressure 
n = 5 
Non-rotational 
forceps 
n = 5 
Antero-lateral 
aspects of neck 
56 
[19 to 89] 
59 
[32 to 97] 
17 
[5 to 32] 
Anterior aspect of 
neck 
44 
[33 to 76] 
38 
[27 to 51] 
20 
[6 to 38] 
Posterior aspect of 
neck 
76 
[48 to 106] 
87 
[63 to 101] 
93 
[77 to 109] 
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5.5.1 Main Findings 
The BD Odon Device, when correctly sited, generates less peak pressure on a model fetal 
face than correctly sited forceps, but higher peak pressure than Kiwi ventouse. The 
mechanism of action of the Kiwi ventouse, whereby there is no instrument in contact with 
the face or lateral aspect of the head, clearly explains the lower pressures for this 
instrument. When incorrectly sited, the BD Odon Device generates less pressure on 
vulnerable facial structures (the orbit) than forceps.  
When the BD Odon Device was purposefully placed around the neck (previous simulation 
work has demonstrated that this is unlikely to occour), it generates more pressure over the 
anterior and antero-lateral aspects, but less pressure over the posterior aspect of the neck 
than forceps.  
 
5.5.2 Interpretation  
The BD Odon Device generated lower levels of peak pressure over the lateral aspects of the 
fetal head than forceps, but higher levels than Kiwi ventouse. This is biologically plausible.   
Forceps have a much lower instrument surface area in contact with the fetal head (the 
blades) than the BD Odon Device (the circumferential air cuff) hence identical traction 
forces will result in lower pressure peak pressure exerted by the Odon Device when 
compared to forceps.  It is therefore plausible that the risk of neonatal injuries specifically 
associated with high peak pressures, such as facial nerve palsy, scalp injury, skull fracture 
and bruising (11) are likely to be lower in OVBs using the BD Odon Device than those 
conducted using forceps. The low pressure detected on the lateral aspects of the head 
during a Kiwi ventouse birth is in-keeping with the birthing mechanism and lack of contact 
of the instrument with the lateral aspects of the fetal head.  
 
Direct pressure to the orbit during birth can result in serious and permanent ophthalmic 
injuries (70). The peak pressure generated by the BD Odon Device, at both inflation 
pressures of 60kPa and 80kPa, when placed directly over the orbit was substantially lower 
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than that generated by forceps – this is likely to correlate to lower rates of trauma to the 
face during birth if the BD Odon Device is incorrectly sited compared to incorrectly sited 
forceps.  
 
The BD Odon Device generated lower peak pressure over the posterior aspect of the neck 
compared to forceps. This may reflect the mechanism in which a baby in the OA position 
extends its neck as it negotiates the pelvic curve.  Pressure is exerted on the posterior 
aspect of the neck as the fetus lies directly beneath the pubic symphysis, acting as a locus 
around which the fetal head extends.  However, when a baby is delivered with the 
assistance of a BD Odon Device that has been purposefully misplaced around the fetal neck 
the air cuff rests between the posterior aspect of the neck and the pubic symphysis and 
appears to act as a cushion, redistributing pressure around the circumference of the neck.  
 
We acknowledge that the simulated pressure readings cannot be a true reflection of the 
exact pressures exerted in clinical practice.  However, the relative degree and distribution of 
pressures in vivo are likely to be similar to those we have observed in simulation.  This 
simulation study suggests that the BD Odon Device generates approximately half the peak 
pressure generated by the forceps, with pressure distributed across a wider area i.e. there is 
less point pressure.  
 
The clinical significance of the observed pressure on the anterior portion of the neck when 
the BD Odon Device is purposefully misplaced is unclear.  Animal studies and clinical 
observation of 48 births in healthy volunteers in Argentina suggest the BD Odon Device is 
extremely unlikely to be placed around the fetal neck.  Reported mean systolic blood 
pressure of term neonates is 72.6 (SD 9.0) mmHg (151)  therefore if a pressure of 59kPa was 
exerted on the fetal neck by a misplaced BD Odon Device the systolic circulation through the 
carotid arteries could be occluded. While this pressure is sufficient to be able to 
theoretically occlude the carotid arteries, studies of complete carotid arterial occlusion in 
animals did not demonstrate a significantly reduced and sustained reduction in cerebral 
perfusion (152). 
The BD Odon Device does not generate negative pressure on the fetal head, reducing the 
likelihood of adverse outcomes such as subgaleal haemorrhage or cephalohaematoma 
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being associated with the use of a BD Odon Device when compared to vacuum assisted 
births. 
 
5.5.3 Strengths and Limitations 
This is the first study to attempt to quantify the pressures exerted on a baby’s head and face 
during OVB and the methodology is necessarily pragmatic. 
No statistical inferences were made between scenarios. As low numbers of individual 
observations were made within each group (maximum n = 10), statistical comparison would 
not be useful or allow for further interpretation that could not be gained from the raw data.  
We used a modified version of the PROMPT Flex® Force Monitoring birthing simulator with 
bespoke fetal heads incorporating pressure sensors. The pressure sensors have previously 
been employed to quantify pressures generated using forceps made from novel materials 
(153). We acknowledge that given the complexities of the birthing process, and the inherent 
limitations of any simulation-based modeling, our results are unlikely to be quantifiably 
reproducible in-vivo. However, the results are likely to be internally consistent and reflect 
the location and broad relationships in the pressures exerted by the BD Odon Device, 
forceps and Kiwi ventouse.  
 
We have not been able to quantify negative pressures, or replicate the chignon associated 
with ventouse births.  However, due to its mechanism of action we are confident that the 
BD Odon Device will not generate any negative pressure on the fetal head and therefore will 
not cause a chignon.  It is therefore unlikely that the most serious outcomes generated by 
negative pressure (subgaleal haemorrhage or cephalohaematoma), or those associated with 
movement of the cup over an established chignon (scalp abrasion/avulsion) will occur 
following births conducted using the BD Odon Device. 
5.6 Conclusion  
The BD Odon Device generates lower peak pressure than non-rotational forceps during 
simulated birth and does not exert a negative pressure required to perform a vacuum 
assisted birth.  It is therefore likely that the BD Odon Device will be associated with lower 
adverse outcomes related to both peak pressure (bruising, facial nerve palsy, skull fracture) 
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and negative pressure (subgaleal or retinal haemorrhage and cephalohaematoma, scalp 
abrasion/avulsion) compared to currently available instruments (forceps and ventouse). 
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Chapter 6 Development of the design and training of the BD Odon 




To (i) determine how intended users interact with and use the BD Odon Device in 
simulation, (ii) use these findings to progressively alter the design of the BD Odon Device 
and (iii) validate that these changes have improved the ability of practitioners to use the BD 
Odon Device 
Design 
Human Factors evaluation study 
Setting 
Simulation suite designed to mimic delivery room. 
Population or Sample 
390 simulated operative births, performed by 100 practicing clinicians. 
Methods 
Simulated operative vaginal births performed using the BD Odon Device and Instructions For 
Use were subjected to four human factors evaluations. Following each evaluation, findings 
were reviewed and the design of the BD Odon Device and Instructions For Use were 
modified. 
Main Outcome Measures  
Successful performance of steps required to perform an operative vaginal birth using the BD 
Odon Device in accordance with provided training and Instructions For Use. 
Results  
Using version one of the BD Odon Device, and following exposure to face-to-face training 
and written instructions, 25% of accoucheurs were able to successfully perform a simulated 
operative vaginal birth. In the final evaluation, following device design and training material 
alterations, all accoucheurs were able to successfully perform a simulated operative vaginal 
birth using version four of the BD Odon Device.  
Conclusions 
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Human factors evaluations have enabled a multi-professional device and training materials 
design team to alter the design of the BD Odon Device and the Instructions for Use in an 
evidence-based fashion. This process has resulted in a device which has a predictable and 
likely safe pattern of use. 
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6.2 Introduction 
Operative vaginal birth  is an important skill that can improve outcomes for mothers and 
their babies (6).  However, performing an operative vaginal delivery is a complex, time 
critical technical skill and the misuse of forceps or vacuum can lead to significant injury to 
the mother and/or her baby (154).  Such concerns led to the FDA in the USA to releasing a 
Public Health Advisory Paper explaining the need for caution when using vacuum assisted 
delivery devices (34). Similar concerns have been expressed about the use of forceps (16).  
While forceps and vacuum are not inherently dangerous, inappropriate patient selection, 
level of technical skill or poor team working in using the instrument can all interact and have 
a significant effect on their safety, and therefore on poor uptake around the world, 
especially in LMICs (49,107). Within this context, the introduction of a new device for OVB is 
a reasonable strategy to try and promote better outcomes for women and babies who 
encounter complications in the second stage of labour (8,50). 
The introduction into clinical practice of a new medical device to expedite vaginal birth is 
complex and requires detailed investigation to identify and mitigate potential risks. 
Specific questions that should be answered by any design team include; how is the device 
used, how is the device best used and how do clinicians train to use the device?  The unique 
features of the BD Odon Device (e.g. air chamber and sleeve) seem to offer advantages in 
clinical practice but the novelty of the design means that the technique required for the BD 
Odon Device is markedly different from those employed during a forceps or vacuum 
assisted delivery. Therefore, before it is introduced into clinical practice it is crucial to 
ensure that accoucheurs use the BD Odon Device in a safe and effective manner. Ideally, the 
use of the BD Odon Device should be understandable, intuitive and reproducible. Moreover, 
the BD Odon Device and IFU should demonstrate that they can be used by representative 
users without producing patterns of failures that could result in poor clinical outcomes or 
harm to clinicians. 
Human Factors Engineering (HFE) focuses on the interactions between people and devices 
and is used to ensure that medical devices are as safe, reliable and effective as possible 
(155).  Human factors evaluations are used to refine and improve the user-device interface. 
This interface includes all components with which users interact with the device; preparing 
the device for use (e.g. unpacking and set up) and using the device (e.g. how users perceive 
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and interpret the information from the device, make decisions about what to do, and 
manipulate the device during use).  Human factors evaluations provide evidence to ensure 
that a device does not lead to failures and that the risk controls made by the design team, 
by altering the device or the supporting training materials are effective.  The most 
important goal of the human factors engineering process is to minimize use-related hazards 
and risks and thus improve safety (155).  
 Notably, since the commencement of this thesis project, the relevant regulatory body 
within the UK, the Medicines and Healthcare products Regulatory Agency (MHRA), has 
issued new guidance which specifically states that new medical devices should be analysed 
within the context in which they are intended to be used. This is in order to “reduc(e), as far 
as possible, the risk of use error due to the ergonomic features of the device and the 
environment in which the device is intended to be used (design for patient safety), 
and (include) consideration of the technical knowledge, experience, education and training 
and where applicable the medical and physical conditions of intended users (design for lay, 
professional, disabled or other users)”. This need can be met by the utilisation of HFE 
studies (156). 
 
6.2.1 Human factors engineering 
Human factors is the scientific discipline concerned with the understanding of interactions 
among humans and other elements of a system, and the activity that applies theory, 
principles, data and methods to design in order to optimize human well-being and overall 
system performance (157). Within this, human factors engineering is human factors 
application of knowledge about human behaviour, abilities, limitations, and other 
characteristics to the design of medical devices systems and tasks to achieve adequate 
usability (156).  
Human factors engineering examines the outcome following the use of the device, taking 
into account all potential drivers, including how users behave, their environment and the 
device itself. This process is illustrated in Figure 6-1. 
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Figure 6-1. Human factors affect outcomes of using medical devices 
 
* Adapted from FDA’s ‘Applying Human Factors and Usability Engineering to Medical 
Devices’ guidance February 2016 (158)  
 
Design teams can utilise human factors engineering to systematically identify risks 
inherent within the design or training provided with any new device – this then affords 
the design team the opportunity to put in place mitigations or alterations to an existing 
design or training package to reduce these risks.  
Human factors engineering should ideally be an iterative process with multiple stages of 
formative evaluations, with identified risks mitigated by purposeful changes to the device 
design and/or training provided. Following each formative round, risks should be analysed 
and a determination made as to whether or not they have been reduced to an acceptable 
level. 
Following a formative round that has demonstrated no outstanding critical risks, a 
summative validation evaluation should take place. The summative validation evaluation 
should have a pre-specified level of acceptable performance for all domains of the use of 
the device, and should only be deemed as successful if all thresholds are met. 
This process is illustrated in Figure 6-2. 
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Figure 6-2. The human factors engineering process 
 
* Adapted from MHRA’s Human Factors and Usability Engineering – Guidance for 
Medical Devices Including Drug-device Combination Products, September 2017 (156) 
A significant benefit of using human factors engineering is that, because the process analyses 
outcomes following the use of the device after training has been provided, it enables analysis 
of the training rather than just the device alone. This avoids the problem of having to adjust 
for different devices or technology that may be introduced during later attempts to analyse 
the effect of training alone in clinical practice. This process also provides an evidence base for 
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any training programme developed in this way – this does not currently exist for some of the 
highest profile obstetrics practical skills training packages, from device-specific packages such 
as the ‘Vacca 5-step technique’ for the Kiwi ventouse to the all types of OVB RCOG-endorsed 
ROBuST course (36). 
 
6.2.1.1 Participants 
Participants in human factors engineering cycles should be representative of the likely user 
groups. Groups can be assigned by levels of experience, profession or other identifiable 
characteristic, but this division must be of relevance to the later user groups once the device 
is in clinical practice. Greater numbers of participants from a specific group will increase the 
likelihood of identifying all possible user errors that may occur – previous work has found that 
a sample size of 15 participants per group is likely to identify 97% of all use errors, and since 
the commencement of this thesis, this has been adopted as an industry standard (156,158). 
While smaller sample sizes are acceptable for formative rounds of HFE, a summative HFE 
validation test should contain at least 15 participants per group of interest (158). The 
percentage of user errors detected in various group sizes is shown in Table 6-1. 
 
Table 6-1. Percentage of Total Known Usability Problems Found in 100 Analysis Samples 
No. of users Min. % found Mean % found SD SE 
5 55 85.55 9.2 0.92 
10 82 94.69 3.2 0.32 
15 90 97.05 2.1 0.21 
20 95 98.4 1.6 0.16 
30 97 99.0 1.1 0.10 
* Adapted from Faulkner L. Beyond the five-user assumption: Benefits of increased 
sample sizes in usability testing. Behaviour Research Methods, Instruments, & 
Computers. Springer-Verlag; 2003;35(3):379–83 (159).  
 
6.2.1.2 Current use 
HFE has been used in the development of other medical devices relevant to a new device 
for OVB. Studies have been carried out on new devices which are designed to be used by 
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users of the current standard device, of all levels of experience. HFE have been used in, for 
example, the development of a new model of naloxone auto-injecting pen, for use by 
experienced emergency medicine doctors, emergency department nurses, paramedics and 
patients, and the development of a new form of laparoscopic port, for use by novice, 
intermediate and expert surgeons (160,161). 
Despite the clear need to structured, formal evaluation of devices for OVB and their 
associated training, HFE has not been used in the development of any devices within the 
field of OVB. This is likely to change in the future in light of recent guidance from the 
regulatory bodies in the US (FDA, September 2016), the UK (MHRA, September 2017) and 
the EU (EU, July 2017) - conducting HFE studies on new medical devices is now mandatory 
for manufacturers within these jurisdictions (109,156,158) – however, this was not the case 
at the design stage of this project, and as such this thesis represents the first use of HFE in 
the design and development of any device or training package within OVB. 
 
This chapter describes the human factors evaluations conducted to determine the usability 
of the BD Odon Device and describes the iterative modifications to the design of device (and 
associated Instructions For Use (IFU) and training materials) in response to user feedback.  
 
6.2.2 General methods 
Three formative evaluations and one Human Factors Validation Test (HFVT) were conducted.  
Participants in the formative evaluations were practicing midwives and obstetricians from 
South West of England and all testing was conducted in Southmead Hospital, Bristol, UK. 
Participants in the validation test were recruited from 14 countries (UK, Ireland, Germany, 
Spain, Italy, Denmark, Egypt, Nigeria, South Africa, Kenya, Jordan, India, Nepal and Australia). 
Testing was conducted in Southmead Hospital, Bristol, UK, the Pump Rooms, Bath, UK, and 
the RCOG Annual Congress 2017, Cape Town, South Africa. Each participant performed a 
series of structured simulations of an operative vaginal birth using the BD Odon Device to 
deliver a fetal mannequin from an anatomical accurate maternal mannequin (PROMPT Flex, 
Limbs and Things Ltd, Bristol, UK) (Figure 6-3) (162).  
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Figure 6-3. A PROMPT Flex maternal and fetal mannequin 
 
 
Participants were able to participate in the study if they fulfilled all of the criteria below: 
(i) At least 18 years of age. 
(ii) Currently employed in a clinical setting. 
(iii) Able and willing to provide a signed Participant Agreement. 
(iv) Able and willing to complete all study assessments. 
(v) Able to read, write and follow instruction in English. 
(vi) Agree to the being videoed, recorded and/or photographed.  
 
Participants were excluded from the study and unable to take part if they did not fulfil all of 
the inclusion criteria listed above or if they fulfilled any of the following: 
(i) Have physical conditions which would make them unable to perform study 
procedures. 
(ii) Have discussed the details of this study or test products with BD staff or other study 
participants outside of the study. 
(iii) Work for a medical device company. 
 
In each simulation, the fetal mannequin was placed in a cephalic presentation, in the occipito-
anterior (OA) position, with the vertex 2cm below the ischial spines.  To increase the 
environmental validity of the simulations, all assisted births were performed in a setting 
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design to mimic a delivery room, with the maternal mannequin lying on a delivery bed or 
table.  All simulations and interviews were recorded on a stationary video camera (GoPro 
Hero4 Session, GoPro, San Mateo, California, USA) and observed by an Obstetrician (SOB), 
Human Factors Expert (AM), Design Engineer (DA, TS or WLL). The inventor of the BD Odon 
Device (JO) was present for the majority of simulations. 
Participants were provided with a prototype BD Odon Device and asked to attempt to 
deliver the fetus using the device.  Expediting birth using the BD Odon Device requires three 
distinct stages to be completed by the operator: (i) preparation of the device, (ii) application 
of the device into the correct position around the fetal head, and (iii) use of traction to 
deliver the fetal head. These three stages, together with the individual steps required in 
each stage, are outlined in Table 6-2.   
  
Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 112 
 








Assess patient and determine suitability for OVB – not assessed in this study 
Open BD Odon Device packaging while maintaining sterility 
With the fastening band still intact, generously lubricate the inside and outside of the sleeve and 
the cup 
Lubricate birth canal 







Fold the cup and gently insert it into the vulva and check it has regained its circular shape 
Check that there is no maternal tissue trapped between the cup and the fetal head 
While gently pushing, continue inserting the sleeve and applicator into the vulva until the top of 
the fastening band is inside the vulva 
Open and remove the fastening band while the sleeve and applicator remains inside the vulva 
Between contractions, continue to gently insert the applicator, starting at 45º below the 
horizontal and following the curvature of the birth canal. Monitor progress by looking through 
the viewing window 
Continue to insert the device and stop when “0” appears in the viewing window 
Inflate the cuff by fully squeezing the bulb pump at least 8 times 
While protecting the perineum with one hand, use the other hand to completely withdraw the 
applicator and cup, leaving only the sleeve in place 
To compensate for possible reduction in cuff pressure after removing the applicator, squeeze 





Grasp the sleeve handle, and during contractions pull gently and progressively following the J-
shape of the birth canal 
While continue to pull gently along the J-shape of the birth canal. Confirm the fetal head is 
descending with pulling efforts 
Once you see the blue deflation line completely (approximately at crowning) deflate the cuff by 
pushing on the deflation button. Pull the sleeve handle continuing to press the deflation button 
following the J-shape of the birth canal 
Continue to pull the sleeve handle while pressing the deflation button to pull the fetal head until 
the sleeve detaches from the head 
Proceed to assist the birth of the baby as per normal procedure 
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At the start of rounds one, two and three (formative rounds) each participant was 
randomized to one of four groups: (i) using the device with no instructions for use (IFU), (ii) 
using the device after reading a copy of the current IFU, (iii) using the device after face-to-
face training, and (iv) watching a training video. During the final validation evaluation, all 
participants were exposed to one-to-one training and the IFU before attempting to use the 
device. The individual objectives of each study varied based on the findings of the previous 
study and subsequent design changes made by the study team to the device and IFU, while 
the overall objective (to determine how participants interacted with the BD Odon Device 
and IFU, and to mitigate any patterns of use which would compromise the safety and 
efficacy of the device) remained the same. 
The ability of participants to perform each phase and step was recorded after their exposure 
to different training materials (IFU, video and one-to-one training).  A step was defined as 
being successfully completed if it was performed safely, correctly and in the correct 
sequence.   
Following the simulations participants were questioned on the design of the device and 
their understanding of (i) the BD Odon Device, (ii) the IFU, (iii) the face-to-face training 
module and (iv) training video.   
Following each Human Factors Evaluation, the multi-professional device development team 
comprising Obstetricians, Midwives, Human Factor Specialists and R&D Engineers used the 
study findings to iteratively modify the device and associated IFU and training materials to 
address any user difficulties and/or risks observed during simulations.  These evidence-
based changes were evaluated in the subsequent round of testing to ensure the previously 
uncovered user errors had been mitigated and no new risks or problems had been created. 
Simulations and interviews were structured in accordance with Human Factor Evaluation 
guidance from the FDA and the Medicines and Healthcare products Regulatory Agency 
(MHRA) (155,158).  The study was approved by the North Bristol NHS Trust Research & 
Innovation Department (Study Number 3671) on 29th February 2016. As per the UK Health 
Departments’ Governance Arrangements for Research Ethics Committees (GAfREC) this 
study did not require ethical approval. 
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6.2.3 General results  
Three formative studies and a Human Factors Validation Study were undertaken. Three 
hundred and ninety simulated births were conducted using the BD Odon Device. In total 100 
naïve participants who had not previously been exposed to the BD Odon Device 
participated.  The demographics of the four cohorts are summarised in Table 6-3.  
 
Table 6-3. Demographics of participants in HFE Rounds 1, 2, 3 & 4 
Characteristic Formative 
round 1 
(n = 35) 
Formative 
round 2 







Age      
 Mean 41.2 35.9 37.1 44.8 
 Std Dev 10.8 8.1 8.7 9.9 
 Range 25 to 59 26 to 52 25 to 52 32 to 69 
Gender      
 Male 6 (17%) 0 (0%) 1 (6%) 11 (30%) 
 Female 29 (83%) 11 (100%) 17 (94%) 25 (70%) 
Handedness      










Profession      
 Midwife 15 (43%) 7 (64%) 8 (44%) 18 (50%) 
 Obstetrician 20 (57%) 4 (36%) 10 (56%) 18 (50%) 
Years of experience      
 4 or less 12 (34%) 6 (55%) 4 (22%) 3 (8%) 
 ≥5 23 (66%) 5 (45%) 14 (78%) 33 (92%) 
Number of OVBs 
observed/performed per 
month 
     
 Mean 13.8 7 11.6 8.1 
 Stan Dev 11.5 5.2 7.5 5.8 
 Range 1 to 50 2 to 18 2 to 30 1 to 20 
Instrument of choice 
(If obstetrician) 
     
 Forceps 10 (50%) 0 (0%) 4 (40%) 7 (39%) 
 Vacuum 6 (30%) 0 (0%) 4 (40%) 8 (44%) 
 No preference 4 (20%) 4 (100%) 2 (20%) 3 (17%) 
 
 
The percentage of participants able to correctly perform at least 50% and 75% of the steps 
required in each phase (preparation, application and delivery) of the use of the BD Odon 
Device are provided in Table 6-4.  These data are further classified by device version 
(version two, three or four) and type of training (no IFU, IFU alone, IFU and one-to-one 
training, IFU and video) and the attempt number.  
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Table 6-4. Ability of participants to successfully perform steps in stages of OVB using the BD Odon Device 
 Percentage of participants correctly performing ≥50% and ≥75% 
of required steps  
Preparation Application Delivery 











 V2 device 
(n=11) 







 V2 device & IFU 
(n=28) 







 V2 device & IFU & 
training 
(n=35) 











 V2 device & IFU 
(n=5) 







 V2 device & IFU & 
video & training 
(n=11) 











 V3 device & IFU 
(n=9) 







 V3 device & video 
(n=9) 







 V3 device & IFU & 
video & training 
(n=18) 







 V3 device, 
exposed to all 
training materials 
(n=18) 











 V4 device & 
training  
(n=36) 
100 100 100 97 97 97 
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 V4 device & 
training & IFU 
(n=36) 







 V4 device & 
training & IFU 
(n=36) 
100 100 100 100 100 100 
 
 
There was no significant difference between the ability of midwives and obstetricians to 
perform an operative vaginal birth using the BD Odon Device (Table 6-5). 
 
Table 6-5. Ability of participants to perform steps in stages of OVB using the BD Odon Device by profession 
 Proportion of participants correctly performing ≥50% and ≥75% of 
required steps  
Preparation Application Delivery 
≥50% ≥75% ≥50% ≥75% ≥50% ≥75% 
V2 Device 
& IFU & 
training  
Midwives 
(n=15) 93 27 100 87 93 93 
Doctors 







(n=18) 89 89 100 100 100 100 
Doctors 
(n=18) 100 100 100 100 100 100 
 
A detailed breakdown of participant behaviours and responses to all observed categories, 
questions and interviews in all rounds of HFE is set out in the Additional Data supplied with 
this thesis.  
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6.3  Formative round one (March 2016) 
6.3.1 Objectives 
Using simulation, the objectives of this HFE round were: 
• to identify potential risks from how users interact with the BD Odon Device version two 
(Figure 6-4) 
• to evaluate the utility of the current Instructions For Use (IFUv1, Appendix 1) to inform any 
necessary changes and ensure that the product has an evidence-base  
 
Figure 6-4. BD Odon Device, version two 
 
 
6.3.2 Primary outcomes 
• To assess if users are comfortable using the BD Odon Device in simulated circumstances 
after exposure to the IFU and a brief training session 
• To assess if users feel confident to use the BD Odon Device after exposure to IFU and brief 
training 
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• To assess the extent to which users are able to demonstrate the correct technique in using 
the BD Odon Device before and after exposure to IFU and brief training 
 
6.3.3 Secondary outcomes 
To identify: 
• The steps within the procedure which are most and least likely to contribute to the 
successful use of the BD Odon Device 
• The usefulness of an IFU to users when performing an OVB using the BD Odon Device 
• How well users can recall and demonstrate individual steps for performing an OVB using the 
BD Odon Device after exposure to the IFU and brief training 
• What level of difficulty users rate individual steps for performing an OVB using the BD Odon 
Device 
• What level of acceptability and intuitiveness the users rate for all parts of the design of the 
BD Odon Device  
• Any modifications to the device that may help users feel more confident in performing 
previously identified problematic tasks 
 
6.3.4 Methods 
This was a human factors engineering study. All participants were asked to attempt a number of 
simulated deliveries with the BD Odon Device on a maternal/fetal dyad (PROMPT Flex), with the 
baby in an OA position and station +2 spines. Participants were asked to undertake their first 
attempted simulated OVB in the conditions above with either no training, access to the IFU alone, or 
following access to the IFU and training. The steps required in this round to perform an OVB using 
the BD Odon Device are shown in Table 6-6. Following this first attempted birth, participants were 
granted access to the IFU and full training (if not given already), and undertook a second attempted 
OVB. Following this, participants were fully trained again, and undertook a third attempted OVB. 
Participants were also questioned about how comfortable and intuitive they found the device, and 
were tested on how well they recalled the contents of the IFU. These procedures are laid out in the 
study flow chart (Figure 6-5). 
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(with and w/o IFU)
1. To assess the impact of the task in the IFU as well as the intuitiveness (for non-IFU users) to ensure 
success of the procedure.
2. To identify (IFU and non-IFU users) risks/recurring user patterns/errors that may influence future study 
designs change and IFU improvement
Part II
IFU compliance/training (with IFU)
1. To understand user training needs in conjunction with IFU
2. To assess IFU compliance with regards to rates of success or deviations leading to risks or artifacts
Part III
IFU content and comprehensibility (w/o IFU)
1. To assess the ability of the end user to understand the steps needed to perform application for a safe 
birth
2. To assess if the IFU content is perceived as sufficient by the user
Part IV
Design assessment
1. To identify potential design changes to ensure the device can be used safely and efficiently
2. To assess device acceptability, comfort and confidence
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Table 6-6. Steps of performing an OVB with the BD Odon Device in HFE Round 1 
Step Description 
1 Remove BD Odon Device from packaging without compromising the sterility of the device 
2 With the fastening band still intact, generously lubricate the inside and outside of the sleeve 
and the cup 
3 Lubricate birth canal 
4 While holding the sleeve handle gently slide the fastening band to the top of the sleeve 
5 Fold the cup and gently insert it into the vulva and check it has regained it’s circular shape 
6 Check that there is no maternal tissue trapped between the cup and the fetal head 
7 While gently pushing, continue inserting the sleeve and applicator into the vulva until the top 
of the fastening band is inside the vulva 
8 Open and remove the fastening band while the sleeve and applicator remains inside the vulva 
9 Between contractions, continue to gently insert the applicator, starting at 45º below the 
horizontal and following the curvature of the birth canal. Monitor progress by looking through 
the viewing window 
10 Continue to insert the device and stop when “0” appears in the viewing window 
11 Confirm stop pushing when “0” appears in viewing window 
12 Inflate the cuff by fully squeezing the bulb pump at least 8 times 
13 Confirm pumps at least 8 times 
14 While protecting the perineum with one hand, use the other hand to completely withdraw the 
applicator and cup, leaving only the sleeve in place 
15 To compensate for possible reduction in cuff pressure after removing the applicator, squeeze 
the bulb pump 2 more times 
16 Grasp the sleeve handle, and during contractions pull gently and progressively following the J-
shape of the birth canal 
17 While continue to pull gently along the J-shape of the birth canal. Confirm the fetal head is 
descending with pulling efforts 
18 Once you see the blue deflation line completely (approximately at crowning) deflate the cuff 
by pushing on the deflation button. Pull the sleeve handle continuing to press the deflation 
button following the J-shape of the birth canal 
19 Continue to pull the sleeve handle while pressing the deflation button to pull the fetal head 
until the sleeve detaches from the head 
20 Proceed to assist the birth of the baby as per normal procedure 
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All procedures took place in a dedicated research space in The Chilterns, Southmead Hospital, 
Bristol. Observations from each attempted OVB using the BD Odon Device were recorded directly 
onto paper proformas. Each attempted birth was recorded on video by one stationary camera.  
 
6.3.4.1 Sample 
Participants were selected from four groups of maternity staff representative of the future user 




• Obstetricians/gynaecologists or midwives of 5 or more years continuous experience 
• Obstetricians/gynaecologists or midwives of 4 or less years continuous experience 
 
Thirty-five participants were recruited, satisfying guidance on the minimum required in each user 
group to achieve saturation of adverse events in FDA guidance on human factors studies (158). 
 
Participants were recruited from a single maternity unit in Bristol, UK. This is a busy tertiary-level 
centre with >6,500 births/year with a 12% instrumental birth rate.  The Principal Investigator (SOB) 
approached participants by email and direct personal contact. Participants took part in the study 
outside of their employed hours.  To compensate for their time participants were offered a £20 
voucher for a department store, a level of compensation in line with guidance from the National 
Institute of Health Research (NIHR) (163). 
 
 
6.3.4.2 Statistical analysis 
Frequency data for outcomes is presented using descriptive statistics. No further inferential statistics 
were undertaken as this was a complete sample. 
 
6.3.5 Results 
Thirty-five participants undertook the study procedure. Demographics of study participants are 
described below in Table 6-7. 
Table 6-7. Participant demographic details 
Characteristic  Results  
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(n = 35) 
Age   
 Mean 41.2 
 Stan Dev 10.8 
 Range 25 to 59 
Gender   
 Male 6  (17%) 
 Female 29 (83%) 
Handedness   
 Right 33 (94%) 
 Left 2 (6%) 
Professions   
 Midwife 15 (43%) 
 Obstetrician 20 (57%) 
Years of experience   
 4 or less 12 (34%) 
 ≥5 23 (66%) 
 
Number of operative vaginal births 
observed/performed per month 
  
 Mean 13.8 
 Stan Dev 11.5 
 Range 1 to 50 
(If obstetrician)  
What is your instrument of choice? 
(n = 20) 
  
 Forceps 10 (50%) 
 Ventouse 6 (30%) 





The experience levels of participants in each study group are described in Table 6-8. 
Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 123 





Midwife (n=15) 11 4 
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6.3.6 Primary Outcomes 
6.3.6.1 Comfort/confidence 
The majority of both midwives and obstetricians reported feeling confident/comfortable or very 
confident/comfortable using the BD Odon Device in simulated circumstances after exposure to the 
IFU and brief training (Table 6-9).  Only 8% participants felt somewhat not, or not at all, 
confident/comfortable using the BD Odon Device after exposure to the IFU and a brief one-to-one 
practical training session. 
 
Table 6-9. Participant responses concerning comfort/confidence (after exposure to IFU and brief one-to-one practical 
instruction) 
 Response 









Pooled M/w Obs Pooled M/w Obs 
How confident 
do you feel using 
the device? 
(n = 34) 









do you feel using 
the device? 
(n = 34) 











6.3.6.2 Encountering difficulty – before and after IFU and training 
Participants encountered progressively fewer difficulties in using the BD Odon Device in simulated 
circumstances after exposure to the IFU and even fewer difficulties were encountered after a brief 
one-to-one practical training session (Figure 6-6). Ninety-two percent of participants reported 
difficulties with applying the device before exposure to the IFU and training, 66% reported 
difficulties after exposure to the IFU alone, whereas only 45% of participants reporting difficulties 
after exposure to the IFU together with practical training. 
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Figure 6-6. Percentage of participants reporting difficulties in using device after IFU and training 
 
6.3.6.3 Ability to demonstrate use of device 
Following exposure to both IFU and training 32 of the 34 (94%) participants were able to successfully 
demonstrate the correct usage of the device.  The remaining two (6%) participants were able to 
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6.3.7 Secondary outcomes 
6.3.7.1 Steps of procedure most likely to succeed or fail by training 
level 
Participants were significantly more likely to be able to progress with using the 
device in simulated circumstances (that is, not have to cease the procedure due 
to a lack of understanding/knowledge of next steps) after being exposed to the 
IFU.  This effect was even greater after exposure to training. Following training 
almost all participants were able to successfully complete all 20 steps to 
perform a simulated OVB (Figure 6-7). 
 




The specific steps that participants were most likely to succeed or fail at for 







1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Step in performing OVB
























9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 
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9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 






likely to be 
successful 
  
 Lubricating sleeve  8 
 Lubricating birth canal  6 
 Removing device from packaging 5  
Steps most 
likely to fail 
  
 Ensure spatula tips fully inserted 14  
 Insert along J-shaped curve 
Stop pushing once “0” in window 









 Check for maternal tissue after inserting 
cup 
9 
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            Table 6-11. Success/failure for participants with IFU 
 Step(s) Number of participants 
succeed/fail at this 
step 
Steps most likely 
to be successful 
  
 Lubricate sleeve, lubricate 
birth canal 
12 
 Grip handle with viewing 
window uppermost 
Fold cup and place inside 
vulva 






 Ensure fastening band is in 
place 
10 
Steps most likely 
to fail 
  
 Re-inflate cuff after 
applicator removal 
9 
 Stop pushing once “0” in 































9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 
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Table 6-12. Success/failure for participants following brief training 
 Step(s) Number of 
participants 
succeed/fail at this 
step 
Steps most 
likely to be 
successful 
  
 Deliver baby as per usual 
procedure 
32 
 Detach sleeve from fetal 
head 
31 
 Stop pushing once “0” 




likely to fail 
  
 Push applicator until tips 
are inside vulva and 
detach fastening band 
3 
 No other steps had more 
than one participant 



























9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 
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6.3.7.2 Participant reported usefulness of IFU in performing 
simulated OVB with BD Odon Device 
All participants (100%) felt that an IFU was necessary to perform a simulated 
OVB with the BD Odon Device. However, some participants were either not 
satisfied with the current IFU (30%) or did not feel that the current IFU was 
sufficient (25%). 
Whilst all participants felt the current IFU was comprehensible, there was 
variation around the comprehensibility of some of the instructions (Figure 
6-8).   
 
Figure 6-8. Percentage of participants describing ease of understanding of IFU 
 
 
6.3.7.3 Recollection of steps for performing OVB after exposure to 
IFU and training 
The package of IFU and one-to one training appeared very successful at helping 
participants recall the 20 steps necessary to perform a simulated OVB using the 
BD Odon Device. Almost all users were able to correctly describe the majority 
of the steps (Figure 6-9). However, the steps required at the beginning of the 
procedure, were the steps that the least number of participants were able to 




















































































9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 
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BD Odon Device are the most-novel and are unique to the BD Odon Device; it is 
therefore not surprising that these are the steps that participants had the most 
trouble achieving and recalling. Note that step 20 (deliver baby) was not 
assessed for recall as it was felt that it would be apparent in clinical practice 
that this would be required and is not dependent on the quality of the IFU. 
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9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 
 Step(s) Number of participants 
fail this step (n = 34) 
Steps most likely to be 
incorrectly described 
  
 Ensure fastening band 
is in place 
18 
 Ensure spatula tips 
fully inserted 
15 




Table 6-13. Steps most likely to be incorrectly described by participants 
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6.3.7.4 Difficulty of individual steps 
While Table 6-13 and Figure 6-9 describe the steps where participants are 
more likely to fail, they do not capture when steps were difficult or awkward to 
execute. Figure 6-10 and Table 6-14 demonstrate the difficulties that some 
participants experienced with each individual step. Of note, 26% of participants 
found the step of pushing the applicator up into the birth canal in a J-shaped 
curve and confirm that it is at ‘0’ (step 11) to be ‘easy’ or ‘very easy’, and 32% 
of participants described this step as ‘difficult’. There was also the previously 
noted difficulty with the earlier steps, such as orientation, ensuring the 
applicator was fully inside the sleeve, and removing the fastening band. 
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9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 
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Table 6-14. Steps most likely to be described as “difficult” or “very difficult” by participants 




(n = 34) 
Steps most likely 
to be described 
as “difficult” or 
“very difficult” 
  
 Pushing the applicator 
following the J-shaped 
curvature of the birth canal 
while monitoring progress 
in the viewing window 
11 (32%) 
 Ensure tips of the 
applicator are fully inserted 
10 (29%) 
 Push the applicator so the 
tips of the applicator are 
inside the vulva and 





 View “0” in the window as 



























9 Insert device 
10 Stop at “0” 
11 Confirm stop 












18 Deflate cuff 
19 Detach cuff 
20 Assist birth 
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6.3.7.5 Device acceptability/intuitiveness 
Most participants rate most aspects of the device as acceptable, comfortable or intuitive (Figure 
6-11 and Table 6-15).  However, participants struggled with removing the device from the 
packaging, 56% of participants did not find it easy to take the device out of the packet without 
compromising the integrity of the device, whilst 38% did not find it easy to take the device out of the 
packet without compromising the sterility of the device. 
 










1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Part of device
Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 135 
 
Table 6-15. Acceptability/intuitiveness of device 
 Step(s) Number of 
participants 
describing this 
step(s) (n = 34) 
Aspects of device most likely 
to be described as 
“unacceptable/not intuitive” 
or “extremely 
unacceptable/not at all 
intuitive” 
  
 How easy is it to take 
the device out of the 
packet without 
compromising the 
integrity of the device? 
19 (56%) 
 How easy is it to take 
the device out of the 
packet without 
compromising the 
sterility of the device? 
13 (38%) 






 How acceptable is the 
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6.3.8 Conclusions 
While most participants felt confident, comfortable, and were able to successfully demonstrate a 
simulated OVB using the BD Odon Device after exposure to the IFU and training, this human factors 
engineering analysis has however identified several areas where participants experienced difficulties 
in correctly using the device. The majority of these difficulties were associated with initial 
application of the device: ensuring the applicator was inserted into the sleeve, removing the 
fastening band and pushing the BD Odon Device up into the birth canal in a J-shaped curve were the 
most prominent recurring themes. 
The device itself was mostly felt to be acceptable and intuitive, but several areas for improvement 
were highlighted. These were primarily concerning the removal of the device from the packaging, 
identification of the window that indicates when to stop pushing the device onto the head, and 
removal of the fastening band.  
 
The IFU was felt to be essential by all participants, but significant minorities felt that the current 
iteration was not sufficiently detailed or satisfactory (24% and 30% respectively).  However, the 
addition of a short (less than five minutes) one-to-one training practical training session appeared to 
be sufficient for most participants to correctly use (with confidence) the BD Odon Device.  Alongside 
this training, a short training video may help provide sufficient training to ensure that all 
accoucheurs use the BD Odon Device correctly and safely. A summary of identified deficiencies and 
mitigations is shown in Table 6-16. 
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Table 6-16. Recurrent user difficulties and mitigations after Round 1 HFE testing (physical parts of device in italics) 
  









Device difficult to remove 
from packaging  
Device rotated 1800 in packaging  
IFU altered  
Training video produced 
Difficult for users to locate the 
Viewing window  
Viewing window highlighted with a raised relief edge,  
IFU altered to highlight potential issue 
Training video produced 
During application of the 
device users were not easily 
able to monitor of the 
progression of the insertion   
‘Limited’ depth numeric scale indicator replaced with a 
continuous coloured numeric scale counting down from 
10 to zero, with zero signalling complete insertion 
Shortened sleeve produced   
IFU altered  
Training video produced  
When attempting to withdraw 
the applicator users grasped 
the viewing window as a 
leverage point rather than 
using the handle resulting in 
difficulties in withdrawal and 
user discomfort 
Grip on the handle exaggerated 
Viewing widow given raised edge to reduce likelihood of 
users using the viewing window as grip feature 
IFU altered  
Training video produced 
 
Difficulty gripping handle 
during insertion/removal due 
to slipperiness of handle 
 
Textured finish added to handle to increase friction 
 
Difficulties recalling how and 
when to deflate air cuff on 
crowning 
 
Deflation button recoloured blue to highlight the button 
and colour-match to the deflation line on the sleeve as a 
reminder  
IFU altered  









Users unable to confirm 
adequate pump pressure 
Greater emphasis on presence of pressure limiter on 
bulb in IFU 
Training video produced 
 
Variation in pressures 
generated by users after 
pumping the inflation bulb 
 
Greater emphasis on slow, steady pumps in IFU, training 
video and face-to-face training 
 
Users were unable to 
consistently ensure the sleeve 
was not misaligned  
 
Users informed they must confirm sleeve alignment 
prior to commencing OVB in IFU, training video and face-
to-face training 
 
Users did not optimally 
position the fastening band 
prior to insertion  
 
Greater emphasis on correct positioning and technique 
in IFU and training video 
IFU modified to highlight this feature 
 
Users found it difficult to 
remove the fastening band in 
an effective and timely 
manner 
 
Greater emphasis on correct positioning and technique 
in IFU and training video 
IFU modified to highlight this feature 
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6.4 Formative round two (May 2016) 
6.4.1 Summary 
Following modifications to the training materials in response to the findings of during 
formative round one (Table 6-16) 11 naïve staff (seven midwives and four obstetricians) 
participated in formative round two. No changes have been made to the design of the 
device following formative round one. Formative round two was conducted using version 
two of the IFU (Appendix 2) and version two of the device (Figure 6-4). In addition, a three-
minute video was created to outline the correct technique in the preparation, application 
and delivery of the baby using the BD Odon Device. After exposure to the IFU only, none of 
the five participants who were exposed to the IFU alone were able to successfully assist the 
birth of the fetal mannequin.  However, when participants were able to watch the Training 
Video and were provided with a 10-minute one-to-one training session, all 11 participants 
were able to successfully deliver the fetal mannequin. 
 
6.4.2  Objectives 
Using HFE, the objectives of this study were: 
• to identify any potential risks from how users interact with the BD Odon Device 
version two 
• to evaluate the utility of the BD Odon Device version two, IFU version two and 
Training Video version one to inform any necessary changes and ensure that the 
device has an evidence-base  
 
6.4.3 Primary outcomes 
• To assess the extent to which users are able to demonstrate the correct technique in 
using the BD Odon Device v2 before and after exposure to IFU v2 and brief training 
including Training video v1 
 
6.4.4 Secondary outcomes:  
To identify: 
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• The impact of IFU v2, Training video v1 and face-to-face training on which steps within the 
procedure are most and least likely to contribute to the successful use of the BD Odon 
Device 
• The usefulness and comprehensibility of IFU v2 and Training video v1 to users when 
performing an operative vaginal birth (OVB) using the BD Odon Device v2 
• To what extent users can recall how to perform an OVB using the BD Odon Device after 
exposure to IFU v2 and Training video v1 
• The acceptability of a shortened sleeve to users when performing an OVB using the BD Odon 
Device (additional outcome not assessed separately – the device used in these assessments 
was unchanged from Round One) 
 
6.4.5 Methods 
This was an observational HFE study. 
Participants were selected from four groups of maternity staff representative of the future user 




• Obstetricians/gynaecologists or midwives of 5 or more years continuous experience 
• Obstetricians/gynaecologists or midwives of 4 or less years continuous experience 
 
Eleven participants were recruited, satisfying guidance on the minimum required in each user group 
to achieve saturation of adverse events in FDA guidance on human factors studies (158). 
Participants were again recruited from a single maternity unit in Bristol, UK.  The Principal 
Investigator (SOB) approached participants by email and direct personal contact. Participants took 
part in the study outside of their employed hours.  To compensate for their time participants 
were offered a £20 voucher for a department store, a level of compensation in line with guidance 
from the National Institute of Health Research (NIHR) (163). 
All participants were asked to attempt a number of simulated delivery with the BD Odon Device on a 
maternal/fetal dyad (PROMPT Flex), with the baby in an OA position and station +2 spines. 
Participants were asked to undertake their first attempted simulated OVB in the conditions above 
with either access to the IFU alone, or following access to the IFU and training. The steps required in 
this round to perform an OVB using the BD Odon Device were modified from Round 1, and are 
shown in Table 6-17. 
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Following this first attempted birth, participants were granted access to the IFU and full training (if 
not given already), and undertook a second attempted OVB. Following this, participants were fully 
trained again, and undertook a third attempted OVB. Participants were also questioned about how 
comfortable and intuitive they found the device, and were tested on how well they recalled the 
contents of the IFU. These procedures are laid out in the study flow chart (Figure 6-12). 








1. To assess the impact of the IFU in the task to ensure success of the procedure
2. To identify (IFU and non-IFU users) risks/recurring user patterns/errors that 
may influence future study design change sand IFU improvement
Part II
IFU compliance/training (with IFU, video and training)
1. To understand user training needs in conjunction with IFU, video and trainer 
demonstration
2. To assess IFU compliance with regards to rates of success or deviations 
leading to risks or artifacts
Part III
IFU content and comprehensibility (w/o IFU)
1. To assess the ability of the end user to understand the steps needed to 
perform application for a safe birth
2. To assess if the IFU content is perceived as sufficient by the user
Part IV
Design assessment
1. To identify potential design changes to ensure the device can be used safely 
and efficiently
2. To assess device acceptability, comfort and confidence
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Table 6-17. List of steps for performing an OVB with the BD Odon Device in Round 2 
Step Procedure 
3 With the fastening band still intact, generously lubricate the inside and outside of the sleeve 
and the cup. 
4 Lubricate birth canal 
5 While holding the sleeve handle gently slide the fastening band to the top of the sleeve. 
6a Fold the cup and gently insert it into the vulva and check it has regained it’s circular shape. 
6b Check that there is no maternal tissue trapped between the cup and the fetal head. 
7 While gently pushing, continue inserting the sleeve and applicator into the vulva until the top 
of the fastening band is inside the vulva. 
8 Open and remove the fastening band while the sleeve and applicator remains inside the 
vulva. 
9 Between contractions, continue to gently insert the applicator, starting at 45º below the 
horizontal and following the curvature of the birth canal. Monitor progress by looking through 
the viewing window 
10 Continue to insert the device and stop when “0” appears in the viewing window 
11 Inflate the cuff by fully squeezing the bulb pump at least 8 times 
12 While protecting the perineum with one hand, use the other hand to completely withdraw 
the applicator and cup, leaving only the sleeve in place 
13 To compensate for possible reduction in cuff pressure after removing the applicator, squeeze 
the bulb pump 2 more times. 
14 Grasp the sleeve handle, and during contractions pull gently and progressively following the J-
shape of the birth canal 
15 While continue to pull gently along the J-shape of the birth canal. Confirm the fetal head is 
descending with pulling efforts 
16 Once you see the blue deflation line completely (approximately at crowning) deflate the cuff 
by pushing on the deflation button. Pull the sleeve handle continuing to press the deflation 
button following the J-shape of the birth canal 
17 Continue to pull the sleeve handle while pressing the deflation button to pull the fetal head 
until the sleeve detaches from the head 
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6.4.6 Statistical analysis 
Frequency data for outcomes is presented using descriptive statistics. No further inferential statistics 
were undertaken as this was a complete sample. 
 
6.4.7 Results 
Eleven participants undertook the study procedure. Demographics of study participants are 
described in Table 6-18. 
Table 6-18. Participant demographic details 
Characteristic  Results  
(n = 11) 
Age   
 Mean 35.9 
 Stan Dev 8.1 
 Range 26 to 52 
Gender   
 Male 0  (0%) 
 Female 11 (100%) 
Handedness   
 Right 10 (91%) 
 Left 1 (9%) 
Professions   
 Midwife 7 (64%) 
 Obstetrician 4 (36%) 
Years of experience   
 4 or less 6 (55%) 
 ≥5 5 (45%) 
 
Number of operative vaginal births 
observed/performed per month 
  
 Mean 7 
 Stan Dev 5.2 
 Range 2 to 18 
(If obstetrician)    
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What is your instrument of choice? 
(n = 4) 
 Forceps 0 (0%) 
 Ventouse 0 (0%) 
 No preference 4 (100%) 
 
The experience levels of participants in each study group are described in Table 6-19. 





Midwife (n=7) 3 4 
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6.4.8 Primary Outcomes 
6.4.8.1 Successful performance of steps of an OVB using the BD 
Odon Device 
Participants were significantly more likely to be able to successfully perform 
the steps of an OVB using the BD Odon Device after exposure to the IFU, face-
to-face training and training video than after exposure to the IFU alone 
(Figure 6-13). Following exposure to IFU, training and training video all 
participants were able to successfully complete an OVB using the BD Odon 
Device once it had been inserted through the vulva (Step 7 in IFU v2). All steps 
are listed in Table 6-17. 
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Step in performing OVB











band to top 
6a 













9 Insert device 
10 Stop at “0” 












16 Deflate cuff 
17 Detach cuff 
18 Assist birth 
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6.4.9 Secondary outcomes 
6.4.9.1 Steps of procedure most likely to succeed or fail by training 
level 
The specific steps that participants were most likely to succeed or fail at for 
each training group are described in  Table 6-20 and Table 6-21. 
 
Table 6-20. Success/failure for participants IFU only 




likely to be 
successful 
Fold the cup and gently insert it into 




Check that there is no maternal tissue 





While gently pushing, continue 
inserting the sleeve and applicator into 
the vulva until the top of the fastening 
band is inside the vulva 
 
5 
   
Steps most 
likely to fail 
All steps beyond Step 9: 
Between contractions, continue to 
gently insert the applicator, starting at 
45º below the horizontal and following 
the curvature 
of the birth canal. Monitor progress by 
















band to top 












9 Insert device 
10 Stop at “0” 












16 Deflate cuff 
17 Detach cuff 
18 Assist birth 
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Table 6-21. Success/failure for participants following exposure to IFU, face-to-face training and 
training video 
 Step(s) Number of 
participants 
succeed/fail at this 
step 
n = 11 
Steps most 
likely to be 
successful 
Steps 6a, 6b, 7, 9, 10, 11, 12, 14, 15, 
16 & 18 
11 
   
Steps most 
likely to fail 
With the fastening band still intact, 
generously lubricate the inside and 
outside of the sleeve and the cup 
7 
  




Continue to pull the sleeve handle 
while pressing the deflation button 
to pull the fetal head until the 
















band to top 












9 Insert device 
10 Stop at “0” 












16 Deflate cuff 
17 Detach cuff 
18 Assist birth 
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6.4.9.2 Encountering difficulty – before and after IFU, video and training 
Participants encountered significantly fewer difficulties in using the BD Odon Device in simulated 
circumstances after exposure to the IFU, face-to-face training and training video compared to IFU 
alone (Figure 6-14). All participants reported difficulties with applying the device after exposure to 
the IFU alone, whereas only 2/11 (18%) did so following exposure to IFU, video and training. 
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6.4.9.3 Participant reported usefulness, sufficiency and understandability of IFU and 
training video in performing simulated OVB with BD Odon Device 
Almost all participants (100%) felt that both the IFU and training video were necessary to perform a 
simulated OVB with the BD Odon Device. However, some participants did not feel that the current 
IFU or training video were sufficient (10% and 20% respectively, Figure 6-15). 
Interviews with these participants suggested that the dissatisfaction with the IFU could be resolved 
by simplifying the IFU, and the training video should be slower, with more detail paid to the initial 
steps in the procedure. 
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6.4.9.4 Recollection of steps for performing OVB after exposure to 
IFU and training 
The package of IFU, video and one-to one training appeared very successful at 
helping participants recall the 17 steps necessary to perform a simulated OVB 
using the BD Odon Device. Almost all users were able to correctly describe 
the majority of the steps (Figure 6-16). However, the steps required at the 
beginning of the procedure were the steps that the least number of 
participants were able to recollect. This is also illustrated in Table 6-22.  The 
initial steps of inserting the Odon device are the most-novel and are unique to 
the BD Odon Device; it is therefore not surprising that these are the steps that 
participants had the most trouble achieving and recalling. 
Figure 6-16. Percentage of participants correctly describing steps of an OVB using BD Odon 
Device 
 
Table 6-22. Steps most likely to be incorrectly described by participants 
 Step(s) Number of participants 
incorrectly describe this step 
(n = 11) 
Steps most likely to be 
incorrectly described 
Lubricate birth canal 6 
 With the fastening band still intact, 
generously lubricate the inside and outside 
of the sleeve and the cup 
4 
 While holding the sleeve handle gently slide 
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band to top 












9 Insert device 
10 Stop at “0” 












16 Deflate cuff 
17 Detach cuff 
18 Assist birth 
17  18 
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6.4.9.5 Comparison of short and long sleeve 
One goal of this HFE was to examine whether participants preferred to use the BD Odon Device with 
a shorter sleeve.  
Participants were asked to undertake a simulated OVB using the shorter sleeve BD Odon Device 
after completing the formal HFE evaluations in this round.  
Participants were asked whether they found the shorter sleeve to be usable, acceptable, and 
whether they had a preference for a shorter or longer sleeve. All participants (11/11, 100%) found 
the shorter sleeve to be usable and acceptable. 
Participants either favoured the shorter sleeve or had no preference. No participants preferred the 
longer sleeve (Figure 6-17). 
In interview responses, participants particularly mentioned the increased ability to see the viewing 
window with the shorter sleeve as a reason for this preference. 
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6.4.10 Conclusions 
All participants were able to successfully demonstrate a simulated OVB using the BD Odon Device 
after exposure to the IFU, training video and face-to-face training.  
This HFE analysis has however again demonstrated that, like the previous HFE analysis (round one) 
there are several areas where participants experienced difficulties in correctly using the device. 
These difficulties were associated with initial application of the device: particularly ensuring the 
applicator was inserted into the sleeve and removing the fastening band. 
 
Both the IFU and training video were felt to be useful or essential by most participants, but some felt 
that the current iterations were not sufficient. Specifically, participants suggested the training video 
be made longer, more detailed, and go through the initial steps in greater detail. Suggestions 
concerning the IFU were conflicting – while some wanted the IFU to be simplified, while others 
wanted more detail.  
A clear majority of participants favoured using a shorter sleeve – this appeared to be particularly 
helpful in allowing participants to identify the viewing window. 
A list of recommendations and the subsequent changes made to the device and training materials is 
shown in Table 6-23. 
 
Table 6-23. Recurrent user difficulties and mitigations after Round 2 HFE testing (physical parts of device in italics) 









Inflation of the air chamber was difficult as 
the pumping bulb was slippery dislodged 
from its housing 
Fabric cover added to pumping bulb to 
increase friction  
Pumping bulb secured in position with 
fabric cover  
Difficult for users to locate the Viewing 
window as it was obscured by the sleeve 
Sleeve shortened so as not to obscure the 
Viewing window 
Difficult to pull down the fastening band to 
lubricate the sleeve and then pull the 
fastening band back up prior to insertion 
Fastening band re-designed to cover whole 
length of applicator 
Users struggled, or forgot, to remove the 
fastening band 









 Training video too fast Training video remade at slower pace with 
longer pauses/segments 
Users unsure of names of device parts  Key device parts illustrated and labelled 
more prominently at beginning of IFU & 
training video 
Users did not keep the deflation button 
depressed when required 
Greater emphasis on keeping the deflation 
button depressed in IFU & video 
 
  
Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 152 
6.5 Formative round three (September 2016) 
6.5.1 Summary 
Prior to formative round three, modifications were made to the design of the device (those 
generated from both formative one and two, Table 6-16 and Table 6-23). For example, the 
grip on the ‘Applicator’ was enhanced to enable greater traction during removal of the 
‘Applicator’, and the ‘Viewing Window’ (through which the operator can gauge how far the 
air cuff has travelled over the fetal head) was given a larger, relief border, to make it easier 
for the ‘Viewing Window’ to be recognised by users.  Minor modifications were also made 
to the training materials and IFU. 
Eighteen naïve staff (eight midwives and ten obstetricians) participated in formative round 
three, which was conducted using versions three of the BD Odon Device and training video, 
and version three of the IFU.  
Participants were more likely to be able to correctly use the BD Odon Device in all three 
stages (preparation, application and delivery) following exposure to the device and IFU 
alone compared to formative round one (78% during formative round three, compared to 
25% in formative round one). Following exposure to all training materials, all participants 
(18) were able to complete more than 75% of steps correctly in all stages of an OVB using 
the BD Odon Device.  All 18 participants who successfully applied the device were able to 
successfully deliver the fetal mannequin. 




6.5.2 Alterations to device and training materials since round two HFE 
Since the previous round of HFE, several changes have been made by the design team to the IFU, 
device, and training materials, incorporating both design and training material alterations suggested 
in round one and two. 
IFU 
• Amount of text reduced per step 
• Steps re-numbered 
• Greater emphasis placed on keeping deflation button depressed 
• Key device arts illustrated and labelled more prominently 
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• Fabric cover added to bulb to increase friction and facilitate easy pumping, also to secure 
position of pumping bulb (Figure 6-18 and Figure 6-19) 
• Sleeve shortened so as not to obscure viewing window (Figure 6-20) 
• Fastening band redesigned to cover whole length of applicator 
• Red unfastening button added to base of fastening band 
 
Figure 6-18. Assembled BD Odon Device v3 
 
Figure 6-19. BD Odon Device v3 inserter 
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• Training Video developed with slower segments and more detailed captions 
 
The purpose of this HFE study is to evaluate to what extent these modifications have enhanced the 
use of the device, and how they might be further improved. 
 
6.5.3 Objectives 
Using simulation, the objectives of this study were: 
• to identify potential risks from how users interact with the BD Odon Device v3  
• to evaluate the utility of IFU v3 (shown in Appendix 3) to inform any necessary changes and 
ensure that the product has an evidence-base 
In clinical practice, all users will be exposed to the IFU and face-to-face training prior to using the BD 
Odon Device; therefore the performance of users following exposure to the IFU or Training Video 
alone has not been assessed. 
 
6.5.4 Primary outcomes 
• To assess the extent to which users are able to demonstrate the correct technique in using 
the BD Odon Device after exposure to IFU v3, Training Video v2 and face-to-face training 
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6.5.5 Secondary outcomes:  
• To identify specific steps where users struggle to use the BD Odon Device v3 correctly to 
improve the performance and intuitiveness of the device 
• To identify how IFU v3 might be improved further  
• To identify how Training Video v2 might be improved further 
• To determine how successfully users are able to recall the steps required to perform an OVB 




This was an observational HFE study. 
Each participant was given the opportunity to have five attempts at conducting a vaginal birth using 
the BD Odon Device v3. Half of the participants were only exposed to the Training Video v2 when 
they used the device for the first time. They were then given the IFU v3 to read and brief one-to-one 
practical instruction prior to their second attempt. The other half of the participants were given the 
IFU v3 to read before their first attempt, followed by brief (less than 5 minutes) one-to-one practical 
instruction provided by an experienced obstetrician prior to their second attempt.   
Prior to their final attempt, all participants had been exposed to the IFU v3, Training Video v2 and 
face-to-face training. These steps are shown in the study flow-chart (Figure 6-21). 
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1. To assess the impact of the IFU in the task to ensure success of the procedure
2. To identify any recurring user patterns/errors that may lead to hazardous 
situations
Part II
IFU compliance/training (with IFU, video and training)
1. To understand user training needs in conjunction with IFU, video and trainer 
demonstration
2. To understand further training requirements (if any) in conjunction with IFU, 
video and training
Part III
IFU content and comprehensibility (w/o IFU)
1. To assess the ability of the end user to understand the steps needed to 
performe application for a safe birth
2. To assess if the IFU content is perceived as sufficient by the user
Part IV
Design assessment
1. To evaluate that design modificaiton changes to the device have resulted in a 
device that can be used safely and efficiently
2. To assess device acceptability, comfort and confidence
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Table 6-24. List of steps for performing an OVB with the BD Odon Device in Round 3 
Step Procedure 
3 Pull back the fastening band until the blue deflation line is exposed 
4 With the fastening band still intact, generously lubricate the inside and outside of the sleeve and 
the cup 
5 Lubricate birth canal 
6 While holding the sleeve handle and applicator handle gently slide the fastening band to the top of 
the sleeve 
7 Grip the applicator handle and ensure the viewing window is facing upwards 
8a Fold the cup and gently insert it through the vulva and check it has regained its circular shape 
8b Check that there is no maternal tissue trapped between the cup and the fetal head 
9 With your hand on the handle of the applicator, gently push the device through the vulva. Use your 
other hand to guide the device and do not apply any force with it 
10a Unfasten the red button 
10b Open and remove the fastening band while ensuring that the sleeve and applicator remain in place 
inside the vulva 
11 Between contractions, continue to gently insert the applicator, starting at 
45° below the horizontal and following the curvature of the birth canal. Monitor progress by 
looking through the viewing window 
12 Continue to insert the device and stop when “0” appears in the viewing window. 
13 Inflate the cuff by fully squeezing the bulb pump at least 8 times 
14 While protecting the perineum with one hand, use the other hand to completely withdraw the 
applicator and cup, leaving only the sleeve in place 
15 To compensate for possible reduction in cuff pressure after removing the applicator, squeeze the 
bulb pump 2 more times 
16 Grasp the sleeve handle, and during contractions pull gently and progressively following the J-
shape of the birth canal 
17 While continuing to pull gently along the J-shape of the birth canal. Confirm the fetal head is 
descending with pulling efforts 
18 Once you see the blue deflation line completely (approximately at crowning) deflate the cuff by 
pushing on the deflation button. Pull the sleeve handle continuing to press the blue deflation 
button following the J-shape of the birth canal 
19 Continue to pull the sleeve handle while pressing the blue deflation button to pull the fetal head 
until the sleeve detaches from the head 
20 Proceed to assist the birth of the baby as per normal procedure 
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Participants were selected from four groups of maternity staff representative of the future user 




• Obstetricians/gynaecologists or midwives of 5 or more years continuous experience 
• Obstetricians/gynaecologists or midwives of 4 or less years continuous experience 
 
Eighteen participants were recruited, satisfying guidance on the minimum required in each user 
group to achieve saturation of adverse events in FDA guidance on human factors studies (158). 
 
Participants were recruited from a single maternity unit in Bristol, UK. The Principal Investigator 
(SOB) approached participants by email and direct personal contact. Participants took part in the 
study outside of their employed hours.  To compensate for their time participants were offered a 
£20 voucher for a department store, a level of compensation in line with guidance from the National 
Institute of Health Research (NIHR) (163). 
 
 
6.5.6.2 Statistical analysis 
Frequency data for outcomes is presented using descriptive statistics. No further inferential statistics 
were undertaken as this was a complete sample. 
 
6.5.7 Results 
Eighteen participants undertook the study procedure. Demographics of study participants are 
described in Table 6-25. 
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Table 6-25. Participant demographic details 
Characteristic  Results  
(n = 18) 
Age   
 Mean 37.1 
 Stan Dev 8.7 
 Range 25 to 52 
Gender   
 Male 1 (6%) 
 Female 17 (94%) 
Handedness   
 Right 16 (88%) 
 Left 1 (6%) 
Professions   
 Midwife 8 (44%) 
 Obstetrician 10 (56%) 
Years of experience   
 4 or less 4 (22%) 
 >5 14 (78%) 
 
Number of operative vaginal births 
observed/performed per month 
  
 Mean 11.6 
 Stan Dev 7.5 
 Range 2 to 30 
(If obstetrician)  
What is your instrument of choice?  
(n = 10) 
  
 Forceps 4 (40%) 
 Ventouse 4 (40%) 
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The experience levels of participants in each study group are described in Table 6-26.  
 





Midwife (n=8) 5 3 
Obstetrician (n=10) 9 1 
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6.5.8 Primary Outcomes 
6.5.8.1 Successful performance of steps of an OVB using the BD 
Odon Device 
All participants were able to successfully complete a simulated OVB using the 
BD Odon Device after exposure to IFU v3, Training Video v2, and face-to-face 
training. All steps were performed successfully by more than 75% of users. 
Moreover, only one step was not successfully completed by more than one 
participant (step 15, re-inflation of the cuff after removal of the applicator). 
This high level of completion of steps is sufficient to allow the current training 
materials, with minor modifications, to be analysed in a formal validation study 
without further major alterations. 
Participant success rates for each step of a simulated OVB are given in Figure 
6-22. 
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6.5.9 Secondary outcomes 
6.5.9.1 Steps where users fail to use to BD Odon Device correctly 
In only one step did more than one user fail to use the BD Odon Device 
correctly (step 15, re-inflation of the air cuff following removal of the 
applicator). This was not done by 3 (17%) of participants. These errors occurred 
due to user oversight (forgetting to re-inflate) rather than difficulty in physically 
performing the step. This is shown by the recorded comment of the observer 
during this step; “Did not do pumps”. Failure to perform this step will not 
generate harm to the mother or baby, but may reduce the clinical effectiveness 
of the BD Odon Device due to resulting in a lower cuff pressure. 
To reduce the risk of the step not being completed, the step will be highlighted 
further within the Training Video and face-to-face raining.  
 
No other steps were not successfully completed by more than one participant 
and as such do not require further alteration. 
 
6.5.9.2 Participant reported sufficiency of IFU v3 in performing 
simulated OVB with BD Odon Device 
Seventeen of eighteen participants (95%) agreed that IFU v3 is sufficient to 
provide birth practitioners with a satisfactory level of knowledge of the steps 
required to perform an OVB using the BD Odon Device. Interviews with 
participants suggested that the IFU could be improved by; 
• Reducing the number of words used 
• Highlighting the location of the deflation button 
• Highlighting the importance of lubricating the inside surface of the sleeve 
 
6.5.9.3 Participant reported sufficiency of Training Video v2 in 
performing simulated OVB with BD Odon Device 
Sixteen of eighteen participants (89%) agreed that Training Video v2 is 
sufficient to provide birth practitioners with a satisfactory level of knowledge of 
the steps required to perform an OVB using the BD Odon Device.  
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• Highlighting the individual steps using bullet points within the video 
• Explain how the device works in different fetal positions 
 
Recall of steps required to perform an OVB using the BD Odon Device 
Participants were able to correctly recall 88% of steps required to perform an 
OVB using the BD Odon Device following exposure to IFU v3, Training Video v2 
and face-to-face training. The successful recall rate per step is given in Figure 
6-23. The level of successful recall demonstrated most often by participants for 
any step (the mode) was 95%; most commonly all participants except one could 
successfully recall any given step. 
Participants has most difficulty recalling the steps at the beginning of the 
procedure. The step most often not recalled correctly was step 5 (lubricate 
birth canal, 44% successful recall rate). Given the marked differences between 
the preparation of the BD Odon Device and preparation of current obstetrical 
instruments (ventouse and forceps) prior to use, it is to be expected that 
participants will have more learning needs surrounding these unfamiliar steps 
compared to the more familiar steps later in the procedure, such as traction 
and delivering the fetal head. 
 
Figure 6-23. Percentage of participants successfully recalling steps of OVB after exposure to IFU 
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All participants were able to successfully perform a simulated OVB using the BD Odon Device after 
exposure to IFU v3, Training Video v2 and face-to-face training.  
 
This HFE analysis has demonstrated that a minority of users may fail to correctly recall the initial 
steps required to use the BD Odon Device. However, given that all participants were able to 
successfully perform an OVB using the BD Odon Device, this deficit is not expected to significantly 
reduce the likelihood that the BD Odon Device can be correctly used in clinical practice.  
Both the IFU and Training Video were felt to be sufficient by almost all participants. Participants did 
suggest areas where both could be improved. Specifically, participants suggested the Training Video 
include more information regarding the position of the baby and highlight each step individually. 
Participants suggested that the IFU should contain fewer words and highlight the importance of the 
deflation button and of lubricating inside the sleeve of the device.  
A list of recommendations and the subsequent changes made to the device and training materials is 
shown in Table 6-27. 
 
 
Table 6-27. Recurrent user difficulties and mitigations after formative round 3 HFE testing (physical parts of device in italics) 








 Button securing the sleeve to the 
applicator dislodged during preparation 










Users would find it useful to have 
importance of lubricating inside of 
sleeve highlighted 
Need to lubricate inside sleeve stressed in 
face-to-face training 
Users would find it useful to have 
location of deflation button highlighted 
Location of deflation button highlighted in 
IFU 
Users would find it useful to have steps 
expressed as bullet points within 
training video 
Captions in video enlarged 
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6.6 Human Factor Validation Testing (March 2017) 
6.6.1 Summary 
Following minor modifications to the device and training materials made after formative 
round three, a Human Factors Validation Test was undertaken. The purpose of the HFVT 
was to definitively demonstrate that the BD Odon Device and corresponding IFU and 
training can be used by accoucheurs without producing patterns of failures that could result 
in a negative impact to patients or harm to users. 36 naïve staff (18 obstetricians and 18 
midwives) from 14 countries (UK, Ireland, Germany, Italy, Spain, Denmark, Nigeria, South 
Africa, Kenya, Egypt, Jordan, India, Nepal and Australia) participated in the HFVT. 
Following exposure to face-to-face training and the IFU, at their third assessed attempt, all 
participants were able to successfully complete more than 75% of all steps required for use 
of the device (Table 6-4). All participants were able to successfully deliver the fetal 
mannequin. 
 
6.6.2 Aims and objectives 
This Human Factor Validation testing aimed to validate the performance of the BD Odon 
Device v3 and Instructions for Use v4 (Appendix 4) to provide evidence to ensure that the 
device does not lead to failures and that the risk controls by design are effective. The 
Training Video was not assessed as the study team did not want it to be considered as a 
sufficient training tool if used independently of face-to-face training. 
 
6.6.3 Primary objective 
To validate that the BD Odon Device v3 and IFU v4 can be safely and efficiently used by all 
user groups. 
 
6.6.4 Secondary objectives 
6.6.4.1 Mitigation of previously identified risks 
To demonstrate that risks and user errors identified in previous human factors evaluations 
have been eliminated or reduced to acceptable low levels.  
1.1.1.1 IFU understanding 
To validate that users are able to understand and use the BD Odon Device IFU 
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6.6.4.2 Exploratory objective 
To determine the acceptability and usability of additional training tools training (video) is to 
the intended user population. 
6.6.4.3 Design process validation 
To validate that a pre-chosen list of criteria that demonstrate a successful design and IFU 
process development have been fulfilled in simulated use. 
 
6.6.5 Methods 
This was a multi-centre human factors validation test to support the validation of the BD 
Odon Device design and IFU to demonstrate the ability of the of the end user to use the 
device and IFU safely and effectively by a sample of the likely user population to perform a 
simulated operative vaginal birth.  
Simulations took place in Southmead Hospital, Bristol, UK, the Assembly Rooms, Bath, UK, 
and The Cape Town International Convention Centre, Cape Town, South Africa between 
28.02.2017 and 22.03.2017. Simulations conducted in the Cape Town International 
Convention Centre took place alongside the Royal College of Obstetricians and 
Gynaecologists World Congress 2017. 
Participants were required to attempt at least three simulated operative vaginal births. For 
all simulations, the fetus was in an occipito-anterior position with the vertex 2 cm below the 
ischial spines.  
Participants were asked to recall the steps of an OVB performed using the BD Odon Device, 
and were asked questions regarding the design of the BD Odon Device.  In addition, a subset 
of participants was asked about the acceptability and usefulness of a supplementary 
training video. This process is illustrated in Figure 6-24. 
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Figure 6-24. Validation test flow-chart 
 
 
The steps required to correctly perform a simulated OVB with the BD Odon Device v4 in this 
round are shown in Table 6-28. 
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Table 6-28. List of steps required to correctly perform an OVB with BD Odon Device in Round 4 
Phase Step Description 
 
2 Open BD Odon Device packaging while maintaining sterility 
3 Pull back the fastening band until the blue deflation line is exposed 
4 With the fastening band still intact, generously lubricate the inside and outside of the sleeve and 
the cup 
5 While holding the sleeve handle gently slide the fastening band to the top of the sleeve 







7 Fold the cup and gently insert it into the vulva and check it has regained its circular shape 
8 Check that there is no maternal tissue trapped between the cup and the fetal head 
9 While gently pushing, continue inserting applicator into the vulva until the top of the fastening 
band is inside the vulva 
10 Unfasten the red button 
11 Open and remove the fastening band while the sleeve and applicator remains inside the vulva 
12 Between contractions, continue to gently insert the applicator, starting at 45º below the horizontal 
and following the curvature of the birth canal. Monitor progress by looking through the viewing 
window 
13 Continue to insert the device and stop when “0” appears in the viewing window 
14 Inflate the cuff by fully squeezing the bulb pump at least 8 times 
15 While protecting the perineum with one hand, use the other hand to completely withdraw the 





16 To compensate for possible reduction in cuff pressure after removing the applicator, squeeze the 
bulb pump 2 more times 
17 Grasp the sleeve handle, and during contractions pull gently and progressively following the J-
shape of the birth canal 
18 While continue to pull gently along the J-shape of the birth canal. Confirm the fetal head is 
descending with pulling efforts 
19 Once you see the blue deflation line completely (approximately at crowning) deflate the cuff by 
pushing on the deflation button. Pull the sleeve handle continuing to press the deflation button 
following the J-shape of the birth canal 
20 Proceed to assist the birth of the baby as per normal procedure 
 21 Discard the used sleeve and applicator as per local policy. Do not reuse 
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Participants were asked to attempt three OVBs using the BD Odon Device, in the set-up 
previously described.  
The ability of the participant to perform each step was assessed by the study team and 
recorded as either “success”, “success with operational difficulty”, “close call”, “failure”, 
“assistance” or “not applicable”. If the participant performed a step to the standard of 
“failure”, “assistance” or “not applicable”, the participant was debriefed by the study team 
to elicit the underlying reason as the why the participant had performed the way they had. 
The response was then recorded as either “artifact”, “device error”, “user misunderstood”, 
“abnormal use” or “user forgot”. 
 
6.6.5.1 Structure of Part 1 
In Part 1 of the study, participants were asked to attempt three OVBs using the BD Odon 
Device. Each attempt had a number of pre-conditions: 
Attempt 1: Prior to this, participants had to undergo formal, face-to-face training in using 
the BD Odon Device, including two formative, non-recorded attempts at an OVB. They 
could, but did not have to, read the IFU. 
Attempt 2: Prior to this, participants had to read the IFU 
Attempt 3: Prior to this, participants could, but did not have to, read the IFU. 
During Part 1, the pressure that participants were able to generate in the air cuff of the BD 
Odon Device was determined using a non-invasive pressure meter. 
 
6.6.5.2 Contents of Part 2 
Participants were asked open-ended questions regarding the procedure to perform an OVB 
using the BD Odon Device (as listed in Table 6-28). Responses were initially categorized as 
“correct answer”, “incomplete answer”, “incorrect answer” or “no answer/don’t know”. 
Following this, if they participant provided an answer that was categorized as either 
“incomplete answer”, “incorrect answer” or “no answer/don’t know”, they were debriefed 
by the study team. Following this, they were then re-categorized as either being able to 
provide, after prompting, a correct answer or not, and whether or not they had thought the 
instructions were clear.  
Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 170 
6.6.5.3 Contents of Part 3 
Seventeen out of 36 participants who chose to continue in the study were then exposed to 
and asked about a training video. Answers concerned the videos usefulness and 
acceptability, as well as suggestions as to how the video could be improved. 
 
6.6.6 Sample Size 
 
Thirty-six participants were recruited, fulfilling the FDA requirements of sample size in 
human factors studies in medical devices (158). Participants were recruited from 13 
countries, providing a representative sample of the intended user population (birth 
practitioners in high, mid and low-resource settings). A list of participants and their counties 
of origin is shown in Table 6-29. 
 
Table 6-29 Countries of origin of participants 
Country Midwives Obstetricians Total 
United Kingdom 11 3 14 
Spain 1 3 4 
Italy 1 2 3 
Germany 1 1 2 
India 0 2 2 
Nigeria 0 2 2 
South Africa 0 2 2 
Australia 0 2 2 
Ireland 1 0 1 
Nepal 0 1 1 
Denmark 0 1 1 
Jordan 0 1 1 
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6.7 Results  
6.7.1 Participant demographics 
Participant demographics are shown in Table 6-30. 
Table 6-30. Demographics of participants in summative human factors evaluation 
Characteristic Count 
(n=36) 
Age   
 Mean 44.8 
 Std Dev 9.9 
 Range 32 to 69 
Gender   
 Male 11 (30%) 
 Female 25 (70%) 
Handedness   




Profession   
 Midwife 18 (50%) 
 Obstetrician 18 (50%) 
Years of experience   
 4 or less 3 (8%) 
 >5 33 (92%) 




 Mean 8.1 
 Stan Dev 5.8 
 Range 1 to 20 
Instrument of choice 
(If obstetrician) 
  
 Forceps 7 (39%) 
 Vacuum 8 (44%) 
 No preference 3 (17%) 
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6.7.2 Primary outcome – ability of participants to successfully 
perform an OVB using the BD Odon Device 
Participants were asked to perform an OVB using the BD Odon 
Device in accordance with the study flowchart (Figure 6-24). In these 
practical assessments, steps 1 & 21 (assess the suitability of the 
patient & disposal of the device according to local policies) were not 
examined. 
Results of participant success rates in attempts one, two and three 
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6.7.2.1 Attempt One 
Following attempt one, 35 of the 36 (97%) participants were able to 
successfully perform an OVB using the BD Odon Device. One 
participant was not able to complete the procedure (they could not 
proceed past step 12 – the participant neglected to insert the device 
at the correct angle, but did recall the correct step on direct 
questioning). Percentage success rate of completing each step for all 
participants are shown in Figure 6-25. All steps were completed 
successfully by a high proportion of participants. There were a 
number of isolated errors (for example step 12 was not completed 
successfully initially by two participants who were able to complete 
the procedure). However, on this occasion both participants 
spontaneously realized their error and the overlooked or miss-
performed was performed correctly in subsequent attempts. This 
type of oversight is commonly observed during initial use of a new 
device and amended during subsequent use of the device. This 
occurrence is not considered to be a risk for the ability of the end 
user to use the device safely and effectively. 
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6.7.2.2 Attempt Two 
Following attempt two (prior to which all participants read the IFU), all 
participants were able to successfully complete a simulated OVB using 
the BD Odon Device. Percentage success rates for individual steps in 
the second round are shown in Figure 6-26. There were a number of 
isolated errors (for example step 16 was not completed successfully 
initially by three participants). However, all three participants realized 
their error when prompted and the miss-performed was performed 
correctly in subsequent attempts. This occurrence was independent 
from the ability of the participants to use the device, and is not 
considered to be a risk for the ability of the intended end user to use 
the device safely and effectively. 
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6.7.2.3 Attempt Three  
Following attempt three, all participants were again able to 
successfully perform an OVB using the BD Odon Device. Percentage 
success rates for individual steps in the third round, prior to de-
briefing, are shown in Figure 6-27. There were a number of isolated 
errors (for example step 16 was not completed successfully initially 
by three participants). All participants who did not complete this step 
at their first attempt were aware of their error, were able to vocalize 
it when prompted and spontaneously self-corrected. This did not 
impair the completion of the whole task (birth of the baby). This 
occurrence was independent from the ability of the participant to 
use the device, and is not considered to be a risk for the ability of the 
intended end user to use the device safely and effectively. 
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6.7.2.4 Attempt three following debriefing 
Following their third attempt, participants who did not complete a 
step successfully were debriefed to explore why and determine a 
root cause. A step was considered to be able to be performed 
successfully by the participant if, after debriefing, the cause for the 
initial error was either an artifact, a device error, or a 
misunderstanding by the user. If any of these were present, the 
participant must have been able to spontaneously self-correct after 
an initial prompt without interruption to their ability to successfully 
perform the task. A step where the original error was determined to 
be due to either abnormal device use or a user forgetting the step 
was not considered to be successful. The rate of successful 
performance of each step, as determined following debriefing, is 
shown in Figure 6-28. In total, there were two errors which were not 
found to be artifact following debriefing. This gives an overall rate of 
success of 682 out of a total of 684 steps performed in the third 
attempted OVB (>99%). 
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The individual participants and steps which were initially classed as 
an error, along with the root cause determined by the study team at 
debriefing, and the subsequent coding of the step are given in Table 
6-31. 
 Table 6-31. Participant errors and root causes in attempt three 
   
Step Participant Original 
performance 

















Artifact N/A Yes 
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to do when 
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6.7.2.5 Success rates of obstetricians only following debriefing at 
third attempt 
The success rates of users by profession is given below. Obstetricians 
were all able to perform all steps successfully following debriefing (see 
Figure 6-29), with the exception of step 19 (one participant did not 
complete this successfully on their third attempt). However, this did 
not substantially impede the performance of the OVB and is not 
considered a risk for the ongoing safe and efficacious use of the device 
– failure to complete step 19 (detach the cuff) will not affect the ability 
of the user to deliver the baby, although it may increase the chance of 
a maternal perineal tear. A greater risk to the ability of the user to 
deliver the baby would be to deflate the cuff early (prior to birth).  
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6.7.2.6 Success rates of midwives only following debriefing at 
third attempt 
Examined in isolation, all midwives correctly performed all steps of 
the OVB with the exception of two failures, at steps 15 and 16 (see 
Figure 6-30). Both of these errors (failure to re-inflate the cuff 
following withdrawal of the applicator and failure to withdraw the 
applicator would not substantially prevent a user from delivering a 
baby using the BD Odon Device. Of note, both participants self-
corrected their error when prompted and assigned the cause of their 
error to the novelty of the device. Therefore neither error is 
considered a risk for the ongoing safe and efficacious use of the 
device. 
Figure 6-30. Percentage success of midwives per step in third attempted OVB following 
debriefing 
 
Success rates for both professional groups are given in tabular form 














































13 Stop at “0” 








19 Deflate & 
detach cuff 
20 Assist birth 
 
Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 180 
 
Table 6-32. Correct responses per step on third attempt following debriefing 
Step 
Obstetricians Midwives 
Number of successes   
(%) (n = 18) 
Number of successes   
(%) (n = 18) 
2 18 (100%) 18 (100%) 
3 18 (100%) 18 (100%) 
4 18 (100%) 18 (100%) 
5 18 (100%) 18 (100%) 
6 18 (100%) 18 (100%) 
7 18 (100%) 18 (100%) 
8 18 (100%) 18 (100%) 
9 18 (100%) 18 (100%) 
10 18 (100%) 18 (100%) 
11 18 (100%) 18 (100%) 
12 18 (100%) 18 (100%) 
13 18 (100%) 18 (100%) 
14 18 (100%) 18 (100%) 
15 18 (100%) 17 (94%) 
16 18 (100%) 17 (94%) 
17 18 (100%) 18 (100%) 
18 18 (100%) 18 (100%) 
19 17 (94%) 18 (100%) 
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6.7.2.7 Significance of different professional groups 
The differing rates of success per step after debriefing of the 
professional groups was examined. Using students t-test with a two-
tailed distribution and assuming paired samples, the chance that the 
difference between the two groups was not due to chance was 0.33. 
Therefore, the null hypothesis is not rejected and the statement that 
there is no significant difference in the performance of a simulated 
OVB using the BD Odon Device between midwives or obstetricians is 
supported.  
 
6.7.3 Secondary objectives 
6.7.3.1 IFU understanding 
In order to assess participant understanding of the IFU, participants 
were asked to describe the steps required to use the BD Odon Device 
to perform a simulated OVB. Thirty-five participants took part in this 
phase of the study. Participants were successful if they described 
accurately the steps required, in the correct order. If a participant 
provided an incomplete answer, they were given a non-directive 
verbal prompt by the assessor to expand on the point (“could you 
describe that in more detail”). Participants who either gave a 
complete answer initially, or after a verbal prompt, were classified as 
being successful at describing that step. Success rates of participants 
in correctly describing each step, both before and after debriefing, 
are given in Figure 6-31. 
Note – to fully assess participant understanding, extra steps were 
included in this assessment. Step 1 (Asses the woman) was added. 
Step 19 (“Deflate cuff and continue to pull the sleeve handle”) was 
split into two (Steps 19 & 20 in the side bar – “Push button” and 
“detach cuff”). Disposal of the device was also assessed (step 22 in 
the side bar). Therefore all charts in this section will list 22, rather 
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Figure 6-31. Success rates of participants describing steps before and after debriefing 
 
Following debriefing, the great majority of participants were able to 
successfully describe each step in order to perform an OVB using the 
BD Odon Device. There was one failure to successfully describe the 
step at step three. However, this would not have prevented the 
participant from successfully performing an OVB using the BD Odon 
Device, as the pulling of the fastening band is to facilitate the 
insertion of the sleeve, however, the sleeve can also be inserted if 
kept together without the fastening band.  Moreover, the user 
realised their error.  Therefore, this failure is not considered a risk in 
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6.7.3.2 Sufficiency and satisfaction with IFU 
 Thirty-two out of 35 participants (92%) agreed that the IFU was both sufficient and 
satisfactory. Participants were asked how the IFU might be improved – these comments are 
given in Table 6-33.  
Table 6-33. Attitudes of participants toward IFU and suggested improvements 
Question Yes No Comments by participant 




32 3 “You need to put somewhere not to pull the device 
out before pumping”; “you could add a better 
picture for showing a hand lubricating;”; “show 
perspective to the audience whereas it should be 
from the user”; “add that the initial push should be 





32 3 “Steps 11 and 12 can be a little unclear”; “could be 
done with simpler pictures and then writing”; 
“there's a lot, makes it seem more complicated”; 
“could be simpler - have 'quick steps' to go 
through”; “pictures bigger, writing bigger” 
 
 
With the exception of a desire from some participants for the IFU to be simplified, there was 
no overall pattern of suggestions. The desire to simplify the IFU, although shared by the 
design team, is not considered to be practicable or compatible with the requirement to 
include enough information to enable safe use of the BD Odon Device. Moreover, all steps 
within the IFU were able to be recalled successfully by a large majority of participants 
(Figure 6-31). 
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6.7.4 Mitigation of previously identified risks 
The mitigation of previously identified risks consisted of ensuring that patterns of miss-use 
of the BD Odon Device, observed in the prior formative rounds of HFE, were not observed in 
this summative study.  
 A list of patterns of miss-use observed in the most recent formative HFE study is given in 
Table 6-34, along with the subsequent mitigations to the device and IFU design. 
Table 6-34. Recurrent user difficulties and mitigations after formative HFE testing 







n Button securing the sleeve to 
the applicator dislodged 
during preparation 
• Button re-manufactured 











Users would find it useful to 
have importance of lubricating 
inside of sleeve highlighted 
• Need to lubricate inside 
sleeve stressed in face-to-
face training 
Users would find it useful to 
have location of deflation 
button highlighted 
• Location of deflation 
button highlighted in IFU 
Users would find it useful to 
have steps expressed as bullet 
points within training video 
• Captions in video 
enlarged 
 
Following the summative study, no users reported spontaneous dislodging of the fastening 
button, nor did they express confusion as to its location. Similarly, no users expressed a 
desire for the need to lubricate inside the sleeve to be made more explicit. Therefore, all 
previously identified risks are deemed to have been mitigated to an acceptable level as to 
not impede the safe and effective use of the BD Odon Device, and further mitigation, 
although potentially possible, would not be practicable.  
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6.7.5 Exploratory Objective - To determine how useful and acceptable a training 
video is to the intended user population 
A training video was developed alongside the face-to-face training and IFU. The future user 
population will be exposed to the face-to-face training and IFU prior to using the BD Odon 
Device. Completing the training and reading the IFU will be mandatory for practitioners to 
be able to use the BD Odon Device. However, alongside these compulsory training 
elements, some users expressed a desire for a training video. This was developed by the 
study team. Following attempted simulated OVBs and IFU content assessment, participants 
who were willing to continue in the study (17) were exposed to the training video. After this 
they were asked to perform a simulated OVB using the BD Odon Device, and were then 
asked about relevance and quality of the training video. 
6.7.5.1 Performance of OVB after viewing the training video 
After viewing the training video, all participants (n = 17) were able to correctly demonstrate 
all steps required to perform a simulated OVB using the BD Odon Device. There were no 
mistakes or errors.  
Participants were then questioned as to how comprehensible they found the video. All 
participants found the video to be either “comprehensible” or “strongly comprehensible”.  
Participants were then asked a series of other questions exploring the video. While 
participants were generally positive, particularly of the ability of the video to show the 
precise mechanism of the device, they did suggest several alterations which may make the 
video more effective in the future. Specifically, participants highlighted the need to stress 
how many times the practitioner may apply traction on the device before abandoning the 
procedure. This will be included in future versions of the video. All questions asked, along 
with the responses, are given in Table 6-35. 
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Table 6-35.  Attitudes of participants toward training video 
Question Yes No Comments by participant 
Is this training video useful to 
be able to use the product? 
17 0 Prefers training and IFU and video as a 
complement 
Do you feel the current 
training video provides you 
with enough information 
about the usability of the 
device? 
16 1 Just complementary in conjunction with 
IFU and training 
Is the current training video is 
providing you with the same 
information as the IFU and 
Training? 
17 0 “easier than IFU”; in the IFU it does not 
clearly explain that the numbers are going 
to go 9 to 0, but it became clear during the 
training; “use computer-based 
animations”; “explains the position of the 
device”; “shows you how the device is 
actually working inside so it would be best 
to show the video 1st and then training” 
Would you suggest any further 
changes to improve the 
training video? 
8 8 “could be clearer at explaining how to 
deflate in a rapid way and how much 
traction to apply with pulling”; “here we 
have a thing which is the best of the 
forceps and the best of the vacuum”; 
“could add how many times we can pull if 
baby is not coming down – perhaps 2 or 3 
times?”;  “explains position of device”; 
“correct, professional and clear”; “add the 




Notwithstanding the suggestions by participants regarding how to improve the training 
video, the universal success of participants to perform an OVB using the BD Odon Device 
following exposure to the training video suggests that the video does not decrease 
understanding or performance and may be a useful adjunct to training future users in how 
to use the BD Odon Device safely.  
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6.7.6 Discussion 
6.7.6.1 Primary outcome 
Following face-to-face training and exposure to the IFU and following debriefing, 
obstetricians and midwives performed 99% of steps correctly (682 out of 684 individual 
steps). 
The two steps that two participants performed incorrectly (steps 15 and 16, removal of 
applicator prior to re-inflation of cuff, and failure to re-inflate cuff prior to applying traction) 
were not repeated by any other participants, and were not felt by the participants in 
question to be due to a design or IFU fault, but rather due to the novelty of the device and 
application method. Therefore there does not appear to be an established pattern of 
misuse.  
There was no significant difference in the rate of success between the two participant 
groups (midwives and obstetricians).  
 
6.7.7 Secondary objectives 
6.7.7.1 Understanding of the IFU 
Participants found the IFU to be understandable. This was demonstrated by all participants 
being able to recall the steps required to perform an OVB using the BD Odon Device, with 
the exception of one step by one participant (step three). This equates to a success rate of 
99.9% (769 out of 770 steps). In addition, 32 out of 35 participants found the IFU to be 
sufficient and satisfactory.  
6.7.7.2 Mitigation of previously identified risks 
Risks identified in previous formative rounds of human factors evaluation were addressed in 
design changes to the IFU and device prior to this validation study (see Table 6-5). In this 
study, none of the previously identified patterns of misuse were identified. This supports 
the conclusion that all previously identified risks have been successfully mitigated to a level 
unlikely to pose a significant risk to the safe and effective operation for the BD Odon Device.  
1.1.1.2 Exploratory outcome – utility of a training video 
Following exposure to the training video, all participants were able to successfully perform 
an OVB using the BD Odon Device. This confirms that a training video, while not in itself 
sufficient, may be a useful adjunct to formal face-to-face training and exposure to the IFU. 
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Participants made a series of comments highlighting how the video can be improved – these 
will be actioned in any future production of the video. 
 
6.7.8 Safety 
No adverse events were observed during the study. During all 124 observed attempted 
simulated OVBs the BD Odon Device performed correctly, with no incidents of mechanical 
fault or device failure.  
 
6.7.9 Conclusion 
The main purpose of this Human Factors Validation Testing was to support the validation of 
the ability of the end user to use the BD Odon Device and corresponding IFU. Pre-
determined tasks (as per the IFU) to successfully conduct an OVB as well as user acceptance 
on the usability of the device were evaluated. The data collected during this study indicates 
the ability of the end user to use the device and IFU safely and effectively (with high rates of 
success of participants being correctly able to perform a simulated OVB using the BD Odon 
Device (99%), and high levels of satisfaction with IFU). 
Furthermore, exploratory data was collected to assess the usability and comprehensibility of 
a training video to the end user which indicated that such a training video may be a useful 
adjunct to current validated training in the use of the BD Odon Device.  
In conclusion, the Human Factors study for the validation of the BD Odon Device and IFU 
demonstrated that the device and IFU can be used safely and efficiently.  Based on the 
results, the BO Odon Device and IFU are deemed to be validated. 
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This is the first published study of the use of Human Factors Evaluation to systematically 
evaluate and iteratively improve the design and training materials of a new obstetrical 
instrument to expedite vaginal birth. The findings highlight the value of formal human 
factors testing before a novel device is introduced into clinical practice.  The observation of 
midwives and obstetricians using the device in a simulated setting revealed numerous 
potential user errors and difficulties that have now been mitigated through revision of both 
the device design and the associated training materials.  All simulated births were observed 
by an Obstetrician, R&D Engineer, the device Inventor and an expert in Human Factors.  This 
multi-professional approach ensured that when a problem was identified, a solution could 
be rapidly developed, implemented and evaluated.   
When presented with version four of the BD Odon Device and the associated training 
materials, all accoucheurs were able to successfully deliver a fetal mannequin using the 
device in a safe and competent manner, compared to 25% of accoucheurs using version two 
of the device and training materials.  This finding suggests that the version four of the BD 
Odon Device is more intuitive and the training materials are more accessible and 
understandable to accoucheurs; a significant improvement when compared to version two. 
 
The observation of 390 simulated operative vaginal births using the BD Odon Device 
informed numerous improvements to the device design, and also provided an opportunity 
to modify the associated IFU and training materials after the identification of common user 
errors.  The use of simulation for investigation, rather than training, has previously been 
successfully used in obstetrics and has been associated with reduction in neonatal injury - 
an observation of 450 simulated births complicated by shoulder dystocia highlighted 
common user errors and provided an evidence base for practical training (115). The 
subsequent implementation of evidence based shoulder dystocia training was associated 
with an elimination of permanent neonatal brachial plexus injury associated with shoulder 
dystocia in one unit (110). Many neonatal injuries associated with vacuum or forceps are 
linked to user error (64), and therefore it is vital to learn from user errors and adapt training 
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to mitigate risks associated with misuse before the BD Odon Device is introduced into 
clinical practice.  
 
Participants had most difficulty preparing and applying the device, and comparatively little 
difficulty in using the device to deliver the fetal head once the device had been applied. In 
the second and third round of testing all participants who successfully applied the device 
were able to successfully deliver the fetal head.  It is perhaps not surprising that participants 
struggled with the initial stages as the preparation and application of the device requires a 
completely novel technique.  However, once the BD Odon Device is applied, the technique 
required to achieve a vaginal birth has similarities to that used during births assisted with 
both forceps and vacuum.  Indeed, delivering the fetal head using a BD Odon Device mimics 
the dynamics of a spontaneous vaginal birth, a concept that should be familiar to all 
accoucheurs.  When training accoucheurs to use the BD Odon Device the relative novelty of 
the preparation and application stages must be considered. 
 
We chose to recruit both midwives and obstetricians to the study.  Whilst specifically UK 
midwives are not the initial intended end-users of the BD Odon Device (although midwives 
in other international settings where midwifery practice routinely includes OVB may be), UK 
midwives in this study (represented in formative rounds one, two and three) represent a 
cohort of accoucheurs who are clearly familiar with the dynamics of a spontaneous vaginal 
birth, but have never performed an instrumental birth.  When launched into practice it is 
hoped the BD Odon Device will be used to reduce morbidity in settings where instrumental 
birth is not currently commonly performed (164). Accoucheurs working in this environment 
will be familiar with the dynamics of a spontaneous vaginal birth, but are likely to be 
relatively unfamiliar with instrumental births. The device will also provide an alternative 
instrument to obstetricians who frequently perform instrumental births using forceps 
and/or vacuum.  As such the intended end-users of the BD Odon Device will have vastly 
different prior experience of instrumental birth; this may affect how users interact with, and 
use, the device.  In an attempt to address this issue, we recruited midwives and 
obstetricians across a spectrum of clinical experience to participate in the study. It is 
encouraging, therefore, that following training there was no significant difference between 
Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 191 
the performance of midwives and obstetricians, using either the initial or final version of the 
BD Odon Device, IFU and training materials (Table 6-5).  
The techniques required to perform an operative vaginal birth using non-rotational forceps 
or vacuum are broadly standardised in internationally recognised national guidelines (Royal 
College of Obstetricians and Gynaecologists (12), American College of Obstetricians and 
Gynecologists (165), Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists (137) and the Collège National des Gynécologues et Obstétriciens Français 
(138)) and we therefore do not anticipate that experienced users from different settings will 
interact with the device is a significantly different manner. This is in addition to the results 
of the Human Factors Validation Test within our study, which demonstrated similar levels of 
success across participants of 14 separate national backgrounds (Table 6-29). This suggests 
that there is a common degree of understanding of the process of normal and assisted birth 
amongst the intended future end-users of the BD Odon Device. This commonality of 
knowledge would potentially allow a desirable distributed model of training to be 
successful. Models such as this, where skills are taught by centrally-trained local faculty to 
local trainees, and which have previously been used to disseminate ‘best-practice’ strategies 
to deal with universal obstetric procedures, such as manoeuvres for shoulder dystocia, have 
been demonstrated to result in sustained knowledge acquisition (166), to be relatively low-
cost (167), and to improve real-world outcomes in a variety of settings (93,110,168). 
 
The adoption of the BD Odon Device into clinical practice necessitates the acquisition of a 
new skill by accoucheurs. This study has demonstrated that, with an appropriately designed 
device and simple training package, clinicians of all abilities are able to acquire and utilise 
the required skills efficiently and effectively. The challenge of introducing a novel medical 
device into obstetric practice should not be underestimated. However, the collaboration 
between clinicians, R&D engineers and human factor specialists has provided a rigorous 
evaluation and rapid cycles of iterative improvement of both the device and training 
package. The Human Factors Evaluations have not only aided in the development of the BD 
Odon Device and IFU, but have also ensured that the BD Odon Device is able to be used 
safely and intuitively as practicably possible prior to in-vivo testing.  
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Appendix 1 IFU v1
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Appendix 2 IFU v2
 
Chapter 6 - Development of the design and training of the BD Odon Device: a human 





Chapter 6 - Development of the design and training of the BD Odon Device: a human 
factors engineering process 
 196 
Appendix 3 IFU v3
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Appendix 4 IFU v4
 
1. Ensure conditions for safe application of device are met:
a. Full dilation of cervix, fetal head +2 station or below,     
   cephalic vertex presentation (OA, OP, OT positions), 
   rupture of membrane            
b. Provide adequate analgesia according to facility procedures
c. Position women in lithotomy position 
d. Empty bladder
e. Re-confirm fetal position
f. Lubricate the birth canal
2. Remove BD Odon Device from packaging without compromising 
the sterility of the device.
3. Pull back the fastening band until the blue deflation line is exposed.
4. With the fastening band still intact, generously lubricate the inside 
and outside of the sleeve and the cup.
5.  While holding the applicator handle gently slide the fastening band 
back to the top of the sleeve.
6. Grip the applicator handle and ensure the viewing window is 
facing upwards.
7. Fold the cup and 
gently insert it through 
the vulva and check it 
has regained its circular 
shape.
INSTRUCTIONS FOR USE (FOR SIMULATION ONLY NOT FOR USE IN PATIENTS)
A
9. With your hand on the handle of the applicator, gently push the 
device through the vulva. Use your other hand to guide the device 
zand do not apply any force with it.
8. Check that there is 
no maternal tissue 
trapped between the 
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18. While continuing to pull 
gently along the J-shape 
of the birth canal, 
confirm the fetal head is 
descending with pulling 
efforts.
Note: if baby is not delivered 
at the first contraction repeat 
steps 16, 17 and 18 with any 
subsequent contractions.
B
INSTRUCTIONS FOR USE (FOR SIMULATION ONLY NOT FOR USE IN PATIENTS)
12. Between contractions, 
keeping both hands away 
from the sleeve, continue 
to gently push the 
applicator, starting at 45° 
below the horizontal and 
following the curvature of 
the birth canal. Monitor 
progress by looking 
through the viewing 
window.
13. Continue to insert the 
device and stop when 
“0” appears in the 
viewing window.
Note: device is fully inserted 
when “0” appears in the 
viewing window.
14. Squeeze the bulb 
pump fully and firmly at 
least 8 times to inflate 
the cuff.
Note: There is a pressure 
limiter in the bulb which 
prevents over inflation in to 
the cuff.
15. While protecting the 
perineum with one hand, 
use the other hand to 
completely withdraw the 
applicator and cup, 
leaving only the sleeve 
in place.
11. Open and completely 
remove the fastening 
band.
Note: ensure the sleeve 
and applicator remain in 
place inside the vulva.
17. Grasp the sleeve 
handle, and during 
contractions pull gently 
and progressively 
following the J-shape of 
the birth canal.
19. Once you see the blue 
deflation line completely 
(approximately at 
crowning) deflate the cuff 
by pushing on the blue 
deflation button. Pull the 
sleeve handle continuing 
to press the deflation 
button following the 
J-shape of the birth canal.
20. Continue to pull the 
sleeve handle while 
pressing the blue deflation 
button to pull the fetal 
head until the sleeve 
detaches from the head.
21.  Proceed to assist the birth of the baby as per normal procedure.
22.  Discard disposable applicator and sleeve according to local
       appropriate procedure. Do not reuse.
10. Unfasten the red button
16. To compensate for 
possible reduction in cuff 
pressure, squeeze the 
bulb pump fully and 
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Chapter 7 Discussion 
 
7.1 The problem of complications in the second stage of labour 
Complications in the second stage of labour make a significant contribution to maternal and 
neonatal morbidity and mortality worldwide - they are responsible for 4 to 13% of maternal 
deaths in Africa, Asia, Latin America and the Caribbean (5), and at least 0.4 deaths per 
100,000 women worldwide (3). 
OVB, in well-trained hands, remains the most effective tool to manage these complications 
(6). However, OVB is relatively under-used worldwide (26), and there are significant barriers 
to arresting the decline of OVB, let alone promoting its increased use. These downward 
pressures on the use of forceps and ventouse include poor public perception (16), a lack of 
provider awareness (50) and financial resources (27,53) and poor availability of training 
(53,90). Moreover, there are reasonable concerns about associated severe complications 
such as maternal anal sphincter injury, fetal skull fracture and subgaleal haemorrhage (11). 
Therefore, although they are to commended and supported, attempts to promote the use 
of current instruments (36,53,169) are unlikely to be sufficient in and of themselves – the 
development of a new device for OVB which has the potential to surmount some of these 
barriers is a reasonable and practicable strategy (8,50,170). 
 
7.2 The proposed solution 
The BD Odon Device is a new device for OVB. Since its first development by Jorge Odon, an 
Argentinian car mechanic in 2005, the BD Odon Device has been adopted, promoted and 
championed by the Chair of the WHO (170), a US Secretary of State (171), the United States 
Agency for International Development, the Government of Norway, the Bill & Melinda Gates 
Foundation, Grand Challenges Canada, the UK Government, the Korea International 
Cooperation Agency (172) and the world’s largest medical device manufacturer (173). 
However, despite these hopes and expectations, there is a clear ethical (174) and legal 
(109,156) obligation to ensure that any new device is as; (i) safe, (ii) effective, and (iii) easy 
to use as possible prior to clinical use. 
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Given these demands, simulation may be the ideal medium in which to improve iteratively 
the design of any new device and its associated training materials.  
 
7.3 Simulation as an evaluation and risk reduction methodology 
Simulation has a proven track record in obstetrics for providing useful learning that can be 
leveraged by clinicians to improve outcomes. Simulation has provided raw quantitative data 
on the characteristics of specific obstetric manoeuvres (63,115) which can then be used to 
improve practice (88,116) and subsequently outcomes (110). In addition, simulation can 
provide a useful training space, and allows practitioners to learn and retain both knowledge 
(166) and skills (88) in an environment in which patients are not at risk of harm.  
We therefore chose to develop and utilise a simulation methodology to identify 
systematically, quantify, and reduce where possible the risks associated with the use of the 
BD Odon Device.  
Specifically, we sought to understand and mitigate the risks associated with the device’s (i) 
location (ii) distention of the perineum (iii) traction force (iv) pressure and (v) pattern of use. 
 
7.4 Summary of results 
We found that: 
(i) Location 
The BD Odon Device sat in a repeatable location, between the fetal chin and nose 
anteriorly and at the level of C7 posteriorly, in all positions, stations, head sizes and 
inflation pressures, with the exception of OP and face presentation.  
In OP positions, the device sat at or below the level of the fetal chin for 
approximately 1/3rd of simulations. As the device did not visibly compress the neck, 
there may be no contraindication to use the device in this situation. Further research 
is needed to establish the safety of neck placements.  
The device could not be applied consistently and safely in face presentations. 
 
(ii) Perineal distention 
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When used correctly (deflated prior to crowning), the BD Odon Device generated the 
same perineal distention, and is likely to be associated with similar risks to the 
perineum and anal sphincter, as Kiwi ventouse. When not deflated prior to 
crowning, the BD Odon Device generated greater perineal distention, and is likely to 
be associated with greater risks to the perineum and anal sphincter, than forceps.  
Therefore training in the appropriate use of the device is a critical component of its 
safe dissemination. 
 
(iii) Traction  
The BD Odon Device ‘popped-off’ at a lower traction force than forceps, but more 
than Kiwi ventouse. Therefore, the BD Odon Device may be able to deliver babies 
which cannot be delivered with Kiwi ventouse, but may not deliver those who 
require the level of traction that can only be provided by forceps. This may result in 
the BD Odon Device generating levels of traction-dependent adverse outcomes that 
are greater than Kiwi ventouse but lower than forceps. 
 
(iv) Pressure 
When correctly sited and using 80kPa inflation pressure on the cuff, the BD Odon 
Device generated a lower peak pressure on the fetal head than forceps. 
When instruments were purposefully misplaced over the eyes, the BD Odon Device 
generated a lower peak pressure on the orbits than forceps. The BD Odon Device 
should therefore be associated with fewer pressure-related adverse events than 
forceps. When purposefully misplaced over the neck the BD Odon Device, compared 
to forceps, generated a greater peak pressure on the anterio-lateral aspect of the 
neck. While this pressure is sufficient to be able to theoretically occlude the carotid 
arteries, studies of complete carotid arterial occlusion in animals did not 
demonstrate a significantly reduced and sustained reduction in cerebral perfusion 
(152). Therefore it is unlikely that routine use of the BD Odon Device would result in 
clinically significant cerebral hypoxia to the fetus. 
 
(v) Pattern of use 
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Human Factors Engineering evaluations revealed multiple shortcomings with the 
original device design which impeded safe and effective use. These were mitigated 
through alterations to both the design of the device and the associated training 
materials. Following all alterations, all participants in a representative sample of 
users were able to correctly use the device to successfully complete a simulated 
OVB. 
 
These findings suggest that the BD Odon Device has the potential to improve maternal and 
neonatal outcomes in the setting of complications in the second stage of labour, and should 
be evaluated in a clinical trial. 
 
7.5 Strengths 
This project was the first systematic attempt to identify, quantify and mitigate the risks 
associated with a new device in the field of obstetrics, and as a result the methodology was 
necessarily pragmatic.  However, while the specific questions this study sought to address 
(location, perineal distention, traction, pressure and pattern of use) were original within this 
field, the chosen methodologies were not. Previous work using these techniques supports 
our contention that taken as a whole, the use of simulation provides a useful insight into 
how and why a device behaves the way it does, can suggest ways to improve its 
performance and validate any subsequent changes to design and training materials. 
Simulations were conducted using models, technologies and techniques which have been 
previously used in related fields and found to be useful. Specifically, the chosen 
maternal/fetal mannequin (the PROMPT Flex) has been previously evaluated and confirmed 
as having both construct and external validity (162). While the specific setting in which the 
mannequin was used in these experiments was different to those in which validity had 
previously been demonstrated, it is still reasonable to assume that the useful internal 
features of the mannequin (anatomically correct pelvic markers, accurate fetal head 
dimensions) will be preserved in the new setting and thus this choice of mannequin is 
justified. Moreover, these models (including those used to measure traction) have been 
widely utilised in the teaching of practical manoeuvres within obstetrics, and have shown 
improvements in clinical outcomes secondary to teaching interventions (92,110). 
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Furthermore, the use of pressure sensors, while new in obstetrics, is common within other 
medical specialities for the quantification and determination of distribution of pressure 
within biological processes (175). 
The use of HFE has been found to be such a useful adjunct in the development of new 
medical tools, for both highly skilled practitioners (161) and unskilled care-users (160), that 
regulatory agencies within the USA (158), the UK (156) and the EU (109) have recently made 
it a compulsory part of new device development. In addition to this, the significant increases 
observed in the rate of successful use between the first and final versions of the BD Odon 
Device and its associated training materials makes a strong prima facie case for the utility of 
HFE in this context.  
 
Lastly, this project benefitted from a close working relationship between clinicians and 
engineers. Within this relationship individuals felt able to share uncertainties and vocalise 
criticisms of both the device design and testing methodology. This free exchange of 
information and rapid cycles of risk identification, mitigation and validation enabled the 
project to comprehensively evaluate the behaviour of a new device in a relatively short 
space of time, limiting the delay in provision of this potentially useful technology to the 
mothers and babies who could benefit from it. 
 
7.6 Limitations 
As previously stated, the chosen methodology in this project was necessarily pragmatic. 
Within each study there are acknowledged limitations which may impact on the validity and 
generalisability of the findings.  
Within all of the risk determination studies (location, perineal distention, traction and 
pressure), a single operator (SO’B) performed all simulations. While this reduces the risk of 
inter-operator errors, it also introduces the possibility of systematic error due to the 
specific, non-generalisable technique of this operator, which I acknowledge.  
The chosen maternal/fetal mannequins, although accurately reflecting mean maternal and 
neonatal anatomy within the UK, may not accurately reflect the anatomy and therefore the 
behaviour of the BD Odon Device in populations with a higher rate of anthropoid-type 
pelvises. 
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Regarding the pressure studies, it is unlikely that the absolute pressures detected are 
accurate quantification of the pressure experienced by the fetus in-vivo, given our inability 
to mimic maternal tissues and contractions. 
The HFE studies suffers from positive selection bias. We recruited participants from an 
acknowledged centre of excellence within the UK, and from international academic 
conferences within the specialty. Therefore, the participants may be more experienced, 
skilled or simply engaged than the average future user of the BD Odon Device, and may 
therefore demonstrate a shorter learning curve. While this is a strong possibility, it is 
unclear as to how this could be overcome. Participation in any research study must be 
voluntary, and so it will always be challenging to engage those who, through lower levels of 
enthusiasm and engagement, do not wish to do so. This is a systematic problem across all 
HFE studies and no consensus has yet emerged as to how this can be reduced. While the 
true learning-curve can and should be studied in both the clinical trial (174) and post-market 
surveillance (109) of any new device, the question of how to estimate this from results 
generated by a group of engaged early-adopters in simulation-based HFE studies remains 
unanswered. 
 
7.7 Generalisability of findings and methodology 
Given the lack of any clinical validation of these simulation methodologies, it is unknown 
how generalisable the results of the location, perineal distention, traction and pressure 
studies are. Should clinical testing confirm that the BD Odon Device does indeed sit between 
the fetal nose and chin anteriorly and C7 posteriorly, and generates similar levels of perineal 
tearing as Kiwi ventouse when correctly deflated prior to crowning, the simulation findings 
should be considered to be validated and generalisable to the population of women and 
babies with similar anatomy to the mannequins used in the study.  
Regarding the pressure study findings, while it is likely that the reported pressure values are 
not quantitatively accurate to those experienced by the fetus, it is likely that the results are 
internally consistent. The pressure experienced by a fetus undergoing a BD Odon Device 
birth, whatever it may be, is likely to be less than forceps and greater than Kiwi ventouse. 
HFE as a methodology is already widely implemented in other settings and fields, and this 
project adds weight to the contention that it has a useful role to play within obstetrics too.  




7.8 Recommendations for further work 
This thesis has demonstrated a new methodology for evaluating and reducing the risks of a 
new device for OVB. The next step to validate this methodology is a clinical trial of the 
device studied to determine if my findings (such as a lower rate of successful birth and 
neonatal trauma than forceps and widespread ease of use by practitioners) are reflected in 
clinical practice. While these findings could be evaluated through comparisons of clinical 
outcomes between single-device non-comparative studies (case series), internal validity can 
only be established through a comparative study of the BD Odon Device versus either Kiwi 
ventouse or forceps. Given the worldwide pattern of use of instruments and similarities of 
device and indication (single use, any position, able to generate flexion and rotation), a 
clinical trial versus Kiwi ventouse may be the most practical and useful comparison. 
Such a clinical trial is currently in development in Bristol, UK and Besancon, France, with 
funding provided by the Bill & Melinda Gates Foundation.  
The results of this complex trial will either confirm or reject the hypotheses of this thesis 
that it is possible to use simulation technology to prospectively quantify the likely 
characteristics of a new instrument for operative vaginal birth. 
 
7.9 Conclusion 
The findings of this thesis suggest that the BD Odon Device has the potential to improve 
maternal and neonatal outcomes in the setting of complications in the second stage of 
labour and should be evaluated in a clinical trial. 
Moreover, the findings and alterations made to the device design, instructions and training 
materials clearly demonstrate the utility of simulation evaluation of new devices for OVB as 
being a useful and practical way of reducing the burden of risks on women and their babies 
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